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SUMMARY
THE NATURAL HISTORY OF POST-TRAUMATIC ALGODYSTROPHY
DEREK RICHARD BICKERSTAFF
Algodystrophy, particularly in it's less severe form, is a poorly recognised and ill-
understood condition which, when it occurs after fracture, delays rehabilitation. This
study investigated the incidence, natural history and morbidity of post-traumatic
algodystrophy. In addition a therapeutic trial of nasal calcitonin was undertaken.
Quantitative and semi-quantitative techniques were devised to assess the
clinical, skeletal and biochemical features of the condition. Several were shown to be
sufficiently sensitive and specific to be of value in assessing the disorder and were
applied prospectively to 274 patients who had sustained a Colles' fracture.
The features of algodystrophy were significantly clustered (p <0.0001),
confirming the presence of a distinct syndrome which affected 28% of patients with
Colles' fracture. Six months after fracture, the proportion of algodystrophic patients
complaining of swelling had fallen to 20-30%, vascular instability and tenderness to
50%, and stiffness to 80%. These abnormalities were associated with a significant (p <
0.0001) loss of function. At one year stiffness was still apparent in 50% of cases. In the
absence of the other features, stiffness would not necessarily be attributed to
algodystrophy and may explain the low reported incidence of this condition following
fracture. It may, however account, at least in part, for the permanent loss of hand
function seen following Colles' fracture. The present survey also showed a more marked
and persistent loss of bone in patients with algodystrophy than in Colles' fracture
controls. This was associated with a significantly increased uptake on bone
scintigraphy and decrease in bone formation as measured by serum osteocalcin. The
mechanism causing these skeletal changes and their implications are discussed.
Treatment with nasal calcitonin did not alter the natural history of the disorder.
This study has shown that post-traumatic algodystrophy is more common than
originally thought, is associated with significant short-term morbidity and may be
responsible, at least in part, for long-term loss of function after Colles' fracture. In
addition, it is associated with a persistent loss of skeletal mass.
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1INTRODUCTION
2CHAPTER 1: HISTORICAL REVIEW
The first record of algodystrophy is probably in the sixteenth century when
Ambrose Pare reported that after phlebotomizing Charles LX, the king developed severe
pain in the arm. Fortunately, the pain eventually resolved spontaneously. Two
centuries later, in 1766, John Hunter described a sympathetic effect on muscles which
atrophied and lost their power following trauma. This was followed by Percival Potts in
the late eighteenth century who described "certain painful afflictions of the nerves" in
connection with injuries of the extremities (Webb and Davis 1948). Algodystrophy was
first recognisably described in 1813 by Alexander Denmark. During the battle of
Badajoz in 1812, one of Wellington's troopers was struck by a musket ball in the distal
humerus resulting in a radial nerve palsy. Denmark described the intense burning
pain, trophic changes and loss of function following this injury. The patient was treated
successfully by above elbow amputation even though Denmark originally believed that
section of the nerve above the level of the lesion would have been equally effective.
During the American Civil War, Mitchell, Morehouse and Keen, in 1864 were the
first to give an accurate account of the various aspects of the clinical syndrome we
recognise today as algodystrophy. The observations were made on soldiers who had
sustained peripheral nerves injuries following gun-shot wounds. They coined the term
causalgia from the Greek, literally meaning "burning pain", but this emphasised only
one aspect of the condition they described. They also drew attention to the fact that:
'The skin affected in these cases was deep red or mottled, or red and pale in
patches."
'The surface of all the affected part was glossy and shining as though it had
been skilfully varnished."
3"In some form, pain has been an invariable attendant upon the diseased state of
the skin which we have tried to describe."
"In other instances, there was associated with this, acute or aching pain which
extended beyond the diseased tissues."
"It consists essentially of a painful swelling of the joints which may attack any or
all of the articulations of a member."
"Once fully established it keeps the joints stiff and sore for weeks or months."
In the same year Sir James Paget (1864) also gave a classical description of the
condition in it's severest form.
Post-traumatic rarefaction of bone was first noted by Volkmann in 1882 and
later by Destot in 1898 who also commented on the intensity of the pain and the
traumatic aetiology in his case report. Sudeck in 1900 at the 29th Congress of the
German Society of Surgery, delivered a paper on "Acute inflammatory bone atrophy'.
This was followed by two articles published in 1901 providing a complete and thorough
radiographic description of algodystrophy following various forms of trauma including
soft tissue injury. He studied the evolution of bone demineralisation with serial
radiographs and noted that the condition resolved spontaneously. In prolonged atrophy
the bone architecture however remained abnormal.
Sudeck (1901) also attempted to describe the pathophysiology of the condition
stating: "It is likely that, in sites distant from the site of the illness, it takes the form of
an inflammatory irritation, which involves nutritional problems... and in consequence
resorption of bone." Evidently, it is not by nature a physiological resorption of inactive
bone but... an active atrophy." He named the condition, acute atrophy of bone but it
was Nonne in 1901, working in the same clinic as Sudeck, who coined the term
Sucleck's atrophy.
4During the First World War, Babinski and Froment published four papers
(1915-1918) which drew attention to the "the vasomotor and thermal problems of reflex
origin" that occurred in algodystrophy. An aspect of the condition largely ignored until
then, despite the vasomotor and trophic changes that had been described in the late
nineteenth century following nerve injury (Charcot 1868). Indeed Vulpian in 1886
described: "the cyanotic or dark pink colour that the skin may exhibit.., the local
cooling, the moisture of the hand or foot,... the oedema." In 1923 the "persistent
vasomotor derangement" was studied by Leriche using clinical observations and
oscillometry, which eventually led to the development of sympathetic ablation as a
successful method of treatment (Leriche 1926). This confirmed Destot's earlier
suggestion in 1904 that the condition occurred as a result of a lesion of the sympathetic
nervous system. He wrote that "in certain bone conditions which develop after an
insignificant trauma, there is skeletal resorption, without any subjective or objective
evidence of a nervous lesion being found. Is one led to ascribe these lesions as well to a
lesion of the sympathetic nervous system?'
In the 1920's and 1930's research into algodystrophy continued to be dominated
by Leriche and his colleagues Policard, Jung and Fontaine such that the condition
became known as painful post-traumatic osteoporosis of Sudeck and Leriche.
In 1926 the phenomenon was first specifically mentioned in the English
literature by Noble and Hauser, followed by Buchmann in 1928 describing osteoporosis
of the carpal bones. In 1926 a paper by Leriche and Policard had been translated into
English by Moore and Key. However, it was not until 1933 that the first significant
contribution was made by Fontaine and Herrmann. This again came from Leriche's
clinic in Strasbourg and not surprisingly recommended sympathectomy almost to the
exclusion of other methods of treatment. Following this and upto the Second World
War many descriptions are found in the English literature (Gurd 1934; Herrmann 1934;
5Cravener 1936; Gurd 1936; Simpson 1937; Livingstone 1938; Miller and de Takats
1941).
A multiplicity of names and syndromes have been used to describe this entity by
various authors who have focused their attention on different aspects of the same
phenomenon (Table 1.1).
In 1937, De Takats coined the term reflex dystrophy to describe the vasomotor
and trophic changes. Later in 1940, Homans used the term minor causalgia in order to
infer a relationship between Mitchell's causalgia (termed major causaLgia) and similar
conditions arising without direct nerve injury. It was shown subsequently that
algodystrophy without nerve injury was much more common, and for this reason de
Takats in 1945 used the term causalgic states. Patrnan et al. (1973) used the Greek
term mimo, meaning to mimic, to coin mirno-causalgia as a collective term for this group
of disorders. In 1973, Glick introduced the term algoneurodystrophy to describe the
changes seen after minor trauma. He thought this stressed the three essential features
of the disorder: pain, neurological origin and the association with tissue dystrophy.
In 1947, Steinbrocker introduced the term shoulder-hand syndrome which is
often considered to be a separate disorder from algodystrophy. The clinical picture had
been first described by Oppenheimer in 1938 in a report on 14 patients with cervical
disc degeneration and subsequently by a number of authors giving the syndrome a
variety of names. Steinbrocker (1947) from a review of the literature, grouped these
syndromes under the heading shoulder-hand syndrome, and suggested that they
represented varying degrees of reflex sympathetic dystrophy. In 1964, de Seze
described retractile capsulitis (frozen-shoulder) which has been likened to the shoulder-
hand syndrome "without the hand" by a number of authors and particularly Lequesne
and Auquier (1968).
6Table 1.1. The various names used to describe algodystrophy in the English and
French literature.
In the English literature:
Acute bone atrophy
Algoneurodystrophy
Causalgia
Major causalgia
Minor causalgia
Migratory osteolysis
Post-traumatic arteriospasm
Post-traumatic oedema
Post-traumatic painful osteoporosis
Post-traumatic sympathetic dystrophy
Post-traumatic vasomotor syndrome
Reflex dystrophy
Reflex sympathetic dystrophy syndrome
Regional migratory osteolysis
Shoulder-hand syndrome
Sympathetic reflex dystrophy
Transient osteoporosis
Transitory osteoporosis
In the French literature:
Algodystrophy
Algodystrophy decalcifiante
Algodystrophy reflexe
Algodystrophy sympathique
Algoneurodystrophy reflexe
Osteoporose algique post-traumatique
Osteoporose algique essentielle du pied
Osteoporose-osteoarthrite dystrophique
Pied decalcifie douloureux idiopathique
Pseudo-rhumatisme
Rhumatisme neurotrophique
Syndrome de Sudeck-Leriche
7The different names for this syndrome reflect the various observations of it's
localisation, and theories as to its aetiology and pathophysiology. Since the 5th
International Conference on Rheumatic Diseases (June 1972) they have been
considered to belong to the same entity. A workshop held at the Royal College of
Physicians under the auspices of the British Association for Rheumatology and
Rehabilitation (BMA Editorial 1978) considered that there were three essential
diagnostic features of algodystrophy. These comprised firstly, intense, ill-defined pain
and hyperaesthesia: secondly, vasomotor and sudomotor changes: and thirdly
osteoporosis. These features are present to some extent in the various syndromes
described over the years. Recently an attempt has been made to group all patients with
an excessive, non-anatomical or otherwise seemingly abnormal pattern of pain by
whatever cause under the general heading of pain dysfunction syndrome (Fields 1987).
Although the nomenclature needs rationalising, this would appear to be an over-
simplification, including conditions without the characteristic sympathetic dysfunction.
The term algodystrophy was introduced by French rheumatologists in the late
1960's. This seems the most satisfactory as it does not imply involvement of any
particular tissue, location or aetiology but reflects the clinical combination of pain and
dystrophic changes. For these reasons this term has been used in this thesis to
describe the disorder.
8CHAPTER 2: AETIOLOGY
A major drawback to the investigation of the aetiology of algodystrophy is the
absence of a satisfactory animal model. The available data comprised mainly
retrospective or anecdotal studies using a variety of diagnostic criteria. The confusion
over nomenclature of the disorder reflects the multitude of factors which have been
thought to be of significance in it's development. Indeed workers in all fields of
medicine and surgery have assumed that there were several distinct clinical entities.
It would appear however that algodystrophy does not have a single cause at
least in terms of it's initiation. There are a variety of precipitating factors which, if they
occur in an individual who has a particular predisposition, results in the characteristic
features of the disease. The features themselves are now thought to be the result of an
abnormal sympathetic reflex, the pathophysiology of which remains unknown.
9A. Precipitating factors
1) Primary or idiopathic algodystrophy
Lee Lankford (1982) stated that a persistent painful stimulus (traumatic or
acquired) was necessary to initiate the condition. However in some cases no
precipitating factors could be found. These idiopathic or primary algodystrophies are
frequently reported but in varying numbers (Table 2.1). Indeed Serre et aL (1973) and
Kleinert et aL (1973) make no mention of idiopathic algodystrophy. It is difficult to
explain the difference in the reported incidence but there may be factors which
remained undetected. Alternatively, the precipitating factors identified in some series
may be chance rather than causal associations.
Duncan et al. (1973) described a type of primary algodystrophy which they
termed "migratory regional osteoporosis". Despite the clinical course of this syndrome
being identical to algodystrophy, they maintain that it should be considered a separate
entity on the grounds that it is recurrent and it has no precipitating factors (although of
his fifteen patients, two may have had a history of some minor trauma).
10
Table 2.1. The prevalence of algodystrophy without obvious precipitating factors
(primary algodystrophy). The prevalence in the literature cited varies from 8% to as
high as 75% when the hip is involved.
No: cases Incidence Site
Steinbrocker (1958) 146 23% Upper limb
Drucker et al.(1959) 61 8.2% All sites
Ravault et al. (1961) ** 33% Upper limb
Lequesne et al. (1968) ** 50% Hip
25% Feet
Pak et al. (1970) 140 15% All sites
Patman et al. (1973) 88 4.4% All sites
Renter et al. (1973) 66 18.4% All sites
Schiano et al. (1974) 103 11.4% All sites
Doury et al. (1981) 250 37% All sites
27% Upper limb
43% Lower limb
75% Hip
Subbarao et al. (1981) 125 10.4% UDDer limb
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ii) Secondary algodystronhv
In the majority of instances there is an obvious precipitating factor responsible
for the initiation of the condition (Table 2.2). These factors may produce unusual
clinical features but the evolution of the syndrome remains the same. It seems
justifiable therefore to group them all under the one heading of secondary
algodystrophy.
Table 2.2. Causes of secondary algodystrophy.
Trauma
Nervous system
Cardiac disease
Pulmonary disease
Miscellaneous
- Soft tissue
- Fracture and dislocation
- Surgery
- Central
- Peripheral
a) Trauma
In Mitchell's original description (1864), the syndrome was associated with
penetrating injuries causing direct trauma to the nerves. Whilst this is still recognised,
it is far outweighed by trauma with no overt evidence of neural damage. Although
Leriche (1939) maintained that trauma was essential for the development of
algodystrophy, it has come to be recognised more often in it's absence. The incidence of
trauma precipitating algodystrophy varies markedly (Table 2.3). The variable incidence
of trauma as a precipitating event no doubt reflects the bias in the clinical interests of
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the authors. Kleinert et ai. (1973) and Serre et al (1973) reported a traumatic incident
In excess of 90% in large series. The lowest incidence appears to occur in association
with the shoulder-hand syndrome (Rosen et al. 1957; Steinbrocker 1958)
Kleinert et aL (1973), reported their experience in 506 cases over a five year
period, and found crush injuries with lacerations and subcutaneous soft tissue
destruction were the commonest types of trauma leading to algodystrophy. Associated
fractures or amputations were present in approximately half of these crush injuries.
Lacerations without soft tissue contusion or crush were the next most common injury.
Interestingly, of the closed fractures reported, there was a higher than expected
Incidence following Colles' fracture. They proposed that this may be due to swelling in
the carpal tunnel and consequent median nerve compression.
Although Kleinert et aL (1973) do not specify the severity of the trauma, Serre et
a (1973) in another large series of 188 cases, noted that approximately 50% of their
patients had suffered minimal trauma. Also it appeared that there was no correlation
between the severity of the trauma and the severity of the subsequent algodystrophy.
To further complicate matters, several authors (Herrmann et al. 1942; Well and Gerard-
Marchant 1954; Fontaine et a 1957; Beasley 1964; Ivins et aL 1969; Serre et al. 1973;
Bernstein et aL 1978; Kim et aL 1979; Goldner 1980; Fam and Stein 1981) have
claimed that immobilisation rather than the initial trauma may be the precipitating
factor. Serre et a (1973) reported that out of 188 cases, 7 were caused and 37 were
aggravated by the immobilisation. Untimely or over-enthusiastic rehabilitation after
injury has been noted to cause or exacerbate algodystrophy (Savin 1974). These
observations however, are subjective and controlled prospective trials on the role of
immobilisation and physiotherapy have not been reported and are clearly needed.
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b) Diseases of the Nervous system
Peripheral nervous system. As discussed, trauma of the peripheral nerves was
the first recognised cause of algodystrophy. Radiculopathy is also described as a
precipitating factor, usually due to disc herniation or root entrapment in the lateral
recess secondary to degenerative disease (Oppenheimer 1938; Rosen and Graham 1957;
Steinbrocker and Argyros 1958; Drucker et al. 1959; Serre et aL 1973; Carlson et aL
1977; Bernard and Perlo 1980; Bernini and Simeone 1981). Oppenheimer in 1938
noted algodystrophy of the upper limb in 14 patients associated with constriction of the
intervertebral foramina in the upper cervical spine on the affected side. Of the 7
patients treated with ultra short wave therapy to the cervical spine, 6 were cured. Serre
et aL in their 188 cases (1973), reported 12 secondary to a radiculopathy. Myelography
(Morretin and Wilson 1970) and spinal anaesthesia (Drucker et al. 1959) have also
resulted in algodystrophy, presumably again due to nerve root trauma. I have seen one
case with algodystrophy of the foot following an LS-S1 decompression for root pain.
Sudeck in 1901 was the first of many authors to associate herpes zoster with
the development of algodystrophy. Most reports describe the shoulder-hand syndrome
as a consequence of this infection (Berthier 1949, Margarot 1952, Richardson 1954,
Steinbrocker and Agyros 1958, Graudal 1959, and Baer 1966).
Central nervous system. It is difficult in reviewing these cases to distinguish
whether the precipitating factor is the disease itself or the associated investigations and
treatments. Of the acute conditions described, cerebral infarction due to cerebro-
vascular accident appears to be the most common aetiological factor, particularly with
regard to the development of the shoulder-hand syndrome (Swan 1954; Rosen and
Graham 1957; Moskowitz and Bishop 1958; Steinbrocker and Argyros 1958; Davis et
aL 1977; Eto et al. 1980). Davis et aL (1977) in a 5 year retrospective study found a
12.5% incidence of shoulder-hand syndrome in hemiplegic patients. Rosen and
15
Graham (1957) also reported algodystrophy following sub-arachnoid haemorrhage,
severe head injury and cervical cord injury.
Of the chronic diseases, brain tumours (Vaernet 1952; Renier and Ceguillaume
1966; Walker et aL 1983), subacute combined degeneration of the cord (De Takats
1945), syringomyelia (De Takats 1945; Evans 1947; Owens 1957) and Guillain- Barre's
syndrome (Serratrice et a/. 1971) have been implicated.
c) Cardiovascular disease
Osler in 1901 described a ''motor disability" following anginal attacks. Originally
this disability was described as only affecting the shoulders but from 1940 there were
several reports of the true shoulder-hand syndrome associated with angina which was
best described by Steinbrocker's in 1947. Lenegre (1946) reported a 4% incidence of
algodystrophy following "scenes douloureuses coronariennes" with Froment et al. (1956)
further subdividing the incidence following cardiac ischaemia to 10-20% following a
myocardial infarct and 1% after an episode of angina. They reviewed 138 cases
reported in the literature and noted that algodystrophy followed 4-8 weeks after the
myocardial episode. The left limb was involved in 58% of cases, the right in 11% with
31% occurring bilaterally, of these the left was more symptomatic. It would therefore
appear that the referred pain can be the trigger for the development of algodystrophy.
Other cardiovascular conditions which have been reported to result in
algodystrophy are arterial or venous thrombosis (De Takats 1945; Evans 1947;
Steinbrocker et al. 1948; Owens 1957; Drucker et aL 1959; Speilman et al. 1981), aortic
injury (Szeinfeld et al. 1982), acute pericarditis (Moreau et al. 1955), mitral valve
disease with paroxysmal tachycardia, constrictive pericarditis (Schiano et al. 1976) and
cardiac surgery (Kohler 1968).
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d) Pulmonary disease
Ravault et al. (1955) cited many instances of algodystrophy, particularly of the
upper limb, following thoracic disease or surgery. Carcinoma of the bronchus,
particularly of the apex of the lung (Cremieux 1974), is one of the more frequent
aetiological factors. This may be associated with Homer's syndrome providing direct
evidence of sympathetic nerve involvement and thus a neurological factor in the
aetiology. The role of pulmonary tuberculosis is more contentious as the precipitating
factor may well be the chemotherapy used in it's treatment. Rosen and Graham in 1957
also described algodystrophy in a patient with pulmonary fibrosis.
In all these conditions, the algodystrophy appears a few days or weeks after the
initiating event with stiffness rather than pain being the dominant feature.
e) Inflammatory conditions
Numerous authors have reported soft tissue infections as a causative factor (De
Takats and Miller 1943, Owens 1957, Rosen and Graham 1957, Steinbrocker and
Argyros 1958 and Wirth and Rutherford 1970). The importance of inflammation may
have been overemphasised since in the early stages of algodystrophy, a
pseudoinflammatory phase may be mistaken for infection.
Non-infective inflammatory conditions such as fasciitis, tendonitis, bursitis and
acute gout have been incriminated (De Takats 1943; Evans 1947; Steinbrocker and
Argyros 1958; Drucker et al. 1959; Pak et a/. 1970; Itzkowitch et aL 1981) so too have
various connective tissue disorders including rheumatoid arthritis, ankylosing
spondylitis, Reiter's syndrome, polymyalgia rheumatica, periarteritis nodosa and
Weber-Christian disease (Steinbrocker et aL 1948; Steinbrocker and Argyros 1958;
Villaumey et al. 1979; Wysenbeek et al. 1981).
17
j) Miscellaneous
Algodystrophy has also been reported following prolonged bed rest (Rosen and
Graham 1957) and with a strong familial history (Albert and Ott 1983).
18
B. Predisposing factors
Although there is usually a precipitating factor, it appears that the chance of
developing algodystrophy is increased in the presence of certain conditions. These
predisposing factors, whilst not triggering the algodystrophic process, provide the most
suitable "terrain" for it's development.
1) Psychogenic
A patient's reaction to pain is modified by the basic organisation of his or her
personality, the meaning of the injured part to the patient, racial and cultural
expectations, support mechanisms that are provided by the family and the community,
age, the cumulative effect of previous losses (physical and psychological), and the
potential for secondary psychological gain in patient-spouse, patient-employer, patient-
physician, or other conflicts (Katon et al. 1982). Litigation and worker's compensation
are other complicating issues that may prevent the amelioration of the symptoms.
The combination of the emotional sequelae of the illness and the disparity
between the degree of pain and the physical examination lead many physicians to think
that the pain is of psychogenic origin (Owens 1957; Bergann and Conn 1968; Wirth and
Rutherford 1970). This, in addition to misguided therapeutic efforts and intractable
pain, further aggravates the patient's psychological symptoms (Wirth and Rutherford
1970; Walton 1983). Anxiety also increases sympathetic discharge, which exacerbates
the pain (Doupe et a/. 1944; Holden 1948; Drucker et a/. 1959).
It had been suggested as early as the 1940's (De Takats 1943 and De Takats
and Miller 1943) that patients with algodystrophy seem emotionally unstable, anxious
and socially withdrawn. Although any "normal" individual can develop algodystrophy,
Hill (1980) states that it is more often seen in inadequate personality types and in
outright neurotics. Pak et al. (1970) found that of 140 patients, 37% had a "history of
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psychiatric problems or emotional disturbances prior to the onset of the present
illness". Twenty-five had normal psychiatric consultations and 7 others were thought to
have psychiatric problems. Omer and Thomas (1971) reported that 45% of their
patients required psychiatric consultation, most of them were manic. Bernstein (1978)
reported similar findings with children suffering from algodystrophy. He found that the
overwhelming majority of children had a history of overt parental conflict in their
families, accepted responsibility beyond their years, had difficulty expressing anger or
being assertive, and were indifferent to the implications of their condition and future
activities.
The use of the MMPI (Minnesota Multiphasic Personality Inventory) or other
personality inventories is frequently helpful in identifying more subtle personality
factors, particularly for the physician who has not had psychiatric training (Cox et a/.
1978; Southwick and White 1983; Rucker et al. 1986). Subbarao and Stillwell (1981)
using this technique showed a hysterical personality, hypocondriasis, and/or
depression in 80% of the 45 cases studied (36% of the study total). Similarly, Pelissier
et a/. (1981) using the same method of assessment noted an increased frequency of
hysterical or depressive neuroticism.
Not all investigations have found associations between abnormal personality and
susceptibility to algodystrophy. Wilson et a/. in 1977, used the MMPI on a consecutive
group of algodystrophic patients as well as on patients with physical injuries that were
not complicated by pain. None of the patients with pain demonstrated any pathological
deviations from normal. They concluded that patients with abnormal personality traits
were not predisposed to the development of algodystrophy. However, when severe pain
occurs, an individual's ability to handle the situation may be compromised by any
personality defects.
Vincent et al. (1982) found great difficulties in applying the MMPI, preferring to
use Rorscharch's test which is based on the influence of the person's personality on his
2 0
perception of visual images. Using this system, he failed to confirm the findings of
Pelissier or Subbarao and was unable to pinpoint a single psychological abnormality.
To my knowledge no study has conclusively proved or disproved the relationship
between a psychiatric condition and the development of algodystrophy. As Subbarao
and Stillwell stated, no definite conclusions could be drawn because of small numbers
and indefinite criteria used to grade the outcome results. Some reports claim that in
patients observed before and after relief of algodystrophy, the emotional disturbance
resolved completely with successful treatment of their condition (Lehman 1934; Echlin
et al. 1945; Spiegel and Milowski 1945). Also, no significant differences could be found
in the personality traits of patients with algodystrophy when compared with patients
with nerve injuries without algodystrophy (Wilson 1981).
ii) Hyperthyroidism
. A number of studies have noted the association between hyperthyroidism and
algodystrophy. Indeed Layani (1946) described this as "thyroid rheumatisms". It
appears that the high incidence may be secondary to treatment, particularly with 1311,
rather than the disease process itself. Schiano et al. (1976) noted that in 14 (13.6%)
cases of algodystrophy were associated with hyperthyroidism; six occurred with
untreated hyperthyroidism and 8 after treatment with antithyroid chemotherapy or
131 1. Methlin et al. in 1971 reviewed 720 patients who had been treated with 131 1 and
found 24 patients (3.3%) with evidence of algodystrophy. Twenty of these occurred after
treatment. Half presented with the shoulder-hand syndrome and the remainder with
capsulitis of the shoulder. These features occurred bilaterally in 75% of cases.
Recently there has been a fall in the reported frequency of algodystrophy following 1311
treatment which may be due to prior control of the disease with other chemotherapeutic
agents.
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ill) Diabetes Mellitus
Algodystrophy is reported to occur in both newly diagnosed diabetics and those
in whom hyperglycaemia is adequately controlled. Schiano et aL (1976) reported two
cases of diabetes mellitus out of 103 (2%) and Doury et aL (1981) reporting eight out of
108 cases (7.4%). Lequesne et aL (1977) reported 11 cases though four had other
precipitating factors. The prevalence of diabetes mellitus in France varyies from 2-20
per thousand of the general community. The upper limb was exclusively involved in
Lequesne and Schiano's series but this was found in only two out of the eight described
by Doury.
• iv) Hyperlinidaemia
Recently there has been some evidence to associate hyperlipidaemia with
algodystrophy. Pinals and Jabbs in 1972 reported three cases of transient osteoporosis
of the hip associated with a type-IV hyperlipoproteinaemia. All three were heavy social
drinkers. Amor et al. (1980) investigated this finding further by studying 34
algodystrophy patients and 11 controls before and after the ingestion of alcohol. They
found that the peak triglyceride levels were higher in the algodystrophy group than in
the control group (p<0.02). They also noted 5 patients with diabetes mellitus and five
with hyperuricaemia.
In a further study Amor et al. (1982), reporting the French Society of
Rheumatology national study of algodystrophy, investigated the association between
hyperlipidaernia, hyperglycaemia and hyperuricaemia and algodystrophy in more detail.
Out of 80 patients, 49 (61.25%) had hypertriglyceridaemia and 54 (67.5%) had at least
one of the three metabolic abnormalities. When hyperglycaemia or hyperuricaemia are
present it was almost always in association with hypertriglyceridaemia.
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v) Iatrogenic 
The role of surgery in the development of algodystrophy has been described in
the section on trauma.
a) Phenobarbitals
Barbiturate induced algodystrophy was first described in 1925 by Maillard and
Renard and then later by Beriel and Barbier in 1934. Since then there have been
numerous reports. It is difficult to estimate the true incidence of this phenomenon but
it must be small considering it's frequent use, particularly in the past. Bouvieret et a/.
(1973) in a series of 100 cases report 25 with a history of barbiturate ingestion.
Although in 21 cases there was another precipitating factor found, it is possible that
individuals taking barbiturates may be predisposed to developing algodystrophy. In the
series reported by Schiano et al. (1976) and Doury et al. (1981), 11 out of 103 cases
(10.7%) and 6 out of 250 (2.4%) respectively had been treated with barbiturates. This
fall in incidence may reflect the decline in the use of barbiturates.
b) Isoniazicl
The introduction of isoniazid as an anti-tuberculous chemotherapeutic agent
seems to be directly associated with a number of cases of algodystrophy. Brouet et a/.
In March 1961 reported the first four cases followed in September of the same year with
a report from McKusick and Hsu. Since then there have been a number of similar
reports but some authors maintain that it is the tuberculosis itself rather than the
treatment which is the cause (Franklin and Nemcick 1959; Johnson 1959; Fisher et a/.
1963; Carriere and Kerambrun 1967). Although there are number of chemotherapeutic
agents used in the treatment of tuberculosis, isoniazid is found to be a common
denominator in all the studies. Clinically, the most characteristic appearance is
bilateral shoulder-hand syndrome which occurs in 50% of cases. Stopping treatment
with isoniazid is usually associated with resolution of the symptoms.
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It is unknown how treatment with isoniazid results in algodystrophy but it has
been shown to accentuate the fibrosis caused by serotonin (Good et al. 1965), a
substance which may be final chemical mediator in the production of the contractures
seen in algodystrophy (page 34).
vi) Miscellaneous
a) Pregnancy
In 1953 Curtiss reported three cases of algodystrophy of the hip during the third
month of pregnancy. Almost all cases reported since then have involved the hip. Of the
250 cases reported by Doury et al. (1981), two occurred during pregnancy. As
Guaquiere (1969) reports, algodystrophy can also occur following delivery.
b) Smoking
An et al. (1988) in a retrospective study on 53 patients with algodystrophy found
a significantly increased frequency of cigarette smoking (p<0.001) using matched
hospitalized controls. They proposed that smoking may cause algodystrophy by
enhancing sympathetic activity or vasoconstriction.
Hyperviscosity
Ernst et aL (1988) showed that plasma viscosity, red cell aggregation and ESR
were significantly higher in 14 patients with algodystrophy compared with matched
controls. During treatment with hydroelectric therapy in a longitudinal study involving
5 patients, all subjects became progressively normal. Although these effects may well
be secondary to an imbalance in the autonomic nervous control, they might contribute
to a disruption of the microcirculation.
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CHAPTER 3: PATHOGENESIS
A wide variety of pathological manifestations have been incriminated in the
aetiology of algodystrophy but all result in similar clinical manifestations which would
suggest a common pathophysiological process.
Attention was directed early to the autonomic system because interruption of
the sympathetic efferent impulses either temporarily or permanently was found to be
effective in treating patients with algodystrophy (Leriche 1924 and 1926). It was
thought that the pain and dystrophic changes were a result of increased peripheral
blood flow due to sympathetic activity. Indeed increased blood flow was recorded by
many authors (Miller and De Takats 1941; Scheibe and Karitzky 1954; Hartley 1955
and Senis; Centrone 1955 and Plewes 1956) using a variety of techniques. Conversely,
Mayfield and Devine (1945), Holden (1948) and more recently Doury et al. (1981) could
not demonstrate any consistent abnormality in the circulation and they describe a
clinical picture of intermittent vasodilation and vasoconstriction. Doupe et al. (1944)
and Nathan (1947) discounted vascular changes as the cause of the pain because the
production of vasodilation by means other than sympathectomy did not relieve the pain.
For these reasons the vascular instability seen in algodystrophy have not been
considered the cause but the result of the pathological process.
The efficacy of sympathectomy as a treatment has led to the proposal that a
variety of neural mechanisms are responsible for the development of symptoms. Indeed
any neuro-physiological explanation of the propagation of pain must take into account
the unusual features seen in algodystrophy such as the onset and character of the pain
and the ease with which pain is aggravated by activity elsewhere in the nervous system.
There are two possible sites for the origin of the pain impulses: peripherally at the site
of the original stimulus and the central nervous system.
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A. Peripheral origin of pain
The essential feature of the peripheral hypothesis is that the cutaneous area in
which the pain is felt is the source of the pain-producing impulse. These impulses
could arise in several ways.
1) Ischaemia and nutritional disturbances causing artificial synapses between
the sympathetic and sensory fibres at their termination.
2) The release of pain-producing substances into the tissues of the skin as a
result of chronic irritation of the injured sensory fibres.
3) From the accumulation of pain-producing substances in the tissues as a
result of vasoconstriction and ischaemia secondary to the irritation of vasomotor nerve
fibres.
There are a number of possible objections to these theories. The sensation of
pain in these instances relies upon an intact sensory input from the periphery.
Algodystrophy may occur after complete division of a nerve or the symptoms may
persist after blocking the nerve thus preventing the central transmission of sensation.
Similarly the causalgic pain in phantom limbs occurs where the peripheral component
is missing. The immediate onset of pain seen in some cases cannot be explained by a
process which takes some time to develop, in particular the production of artificial
synapses. The relief obtained by sympathectomy is unlikely to be due to the removal of
pain-producing substances because vasodilation may already be present prior to
operation.
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B. Central origin of pain
Leriche (1949) believed the sympathetic system to be fundamental in the role of
pain sensitivity. He thought it acted in three main ways: (1) by afferent transmission of
pain impulses; (2) by a vasoconstrictor action, which provoked painful conditions; and
(3) by a metabolic action, which induced an alteration of the state of sensitivity of pain.
He stressed that the afferent component of the sympathetic system was due not only to
impulses in sensory fibres passing through the ganglia to reach the dorsal roots, but
also to true sympathetic afferent impulses which reached the sympathetic ganglia and
were reflected by efferent fibres to the periphery, where they induced painful conditions.
This concept of a reflex arc, although modified, remains a fundamental component of
the current theories of it's pathophysiology.
Leriche's explanation depends upon there being an afferent component to the
sympathetic system which the French and German schools have long held to be true
(Francois-Franck 1899, Pette 1927, Doring 1946 and Leriche 1949). The English
schools have been strongly influenced by the work of Langley (1898, 1903 and 1921)
who introduced the term "autonomic nervous system". Although he recognised afferent
fibres in the sympathetic system he thought they were somatic in nature. In fact, he
wrote that "the afferent nerves of the sympathetic system are indistinguishable in form
and position from those of the somatic system" (1898). This difference of opinion is still
in evidence today but there is increasing evidence in the English literature that visceral
sensation is transmitted by sympathetic afferents (Malliani 1984, Paintal 1986, and
Widdicombe 1986).
There is some clinical evidence that afferent somatic fibres are present in
sympathetic nerves. Some patients with complete spinal transection at the level L1-L2
report pain in the lower limbs which disappeared after sympathectomy (Foester et al.
1929). Other patients with complete spinal transections, who felt burning pain in the
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lower limbs, had anterolateral tractotomy performed immediately above the level of the
transection; this only caused a reduction in the intensity of the pain. A trachtotomy at
the T1-T2 level brought about a complete disappearance of the pain (Freeman and
Watts 1951). It is interesting to note that the afferent fibres found in the sympathetic
system contain small diameter unmyelinated C axons. These are identical to the axons
found in somatic nerves which are thought to be responsible for the transmission of a
burning, persisting and spreading pain.
Although the presence of true somatic afferents in the sympathetic system is
still open to debate, it has been known for years that the sympathetic system does
modulate pain sensation. In Claude Bernard's original studies (1858 and 1879) he
observed that sympathectomy in cats and rabbits affected their response to painful
stimuli.
Livingstone in 1943 developed Leriche's reflex arc theory. He thought that the
dystrophy and pain was due to a vicious circle of impulses "periphery-spinal cord-
sympathetic efferents-periphery". This vicious circle could be maintained and enlarged
both by dystrophic conditions in the periphery and by the activation of internuncial
pools of neurones. This concept was further stressed by De Takats (1965) and Bonica
(1979). There has been recent controversy as to whether the efferent arc is purely
sympathetic. Moruzzi (1968) and Zimmerman (1979) among others feel that it is
Impossible to distinguish a purely sympathetic action from a somatic component in the
reflex arc. As Moruzzi wrote "sympathetic and somatic neurones are often at the end of
the final common pathways and that in the periphery it is well known that the
sympathetic action can modulate the somatic action".
A further theory along the lines of a vicious circle was proposed by Doupe et al.
and Granit et al. in 1944. They proposed that an artificial synapse, or ephapse, is
produced between the efferent sympathetic fibres and the afferent somatic fibres after
nerve injury. Sympathetic outflow being directly transmitted to the spinal cord and
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higher centres and interpreted as pain. This theory does not explain how the ephapses
which occur rarely and late account for causalgic pain which can occur within hours.
Also it presupposes that some form of trauma has occurred which is not always the
case, particularly in variants such as the shoulder-hand syndrome.
Walker and Nulsen in 1948 made some clinical observations which are thought
to support the ephapse theory. Stimulation of de-centralised sympathetic nerves in
patients suffering from causalgia following nerve injury reproduced their characteristic
pain. This was not the case in patients who had undergone sympathectomy without
causalgia. It was thought that the stimulated sympathetic fibres caused direct
stimulation of the somatic fibres due to the presence of an ephapse. This same effect
however could be caused by modulation of the somatic action in the periphery (Moruzzi
1968 and Zimmerman 1979), particularly in an individual in whom the causalgic pain
Is centralised.
Melzack and Wall in 1965 produced the gate-control theory of pain sensation.
They proposed that there are facilitatory and inhibitory mechanisms in the substantia
gelatinosa of the spinal cord in which fine and large sensory fibres play opposing roles
In influencing onward transmission through the dorsal horn. The lesion in causalgia is
postulated to be one which selectively damages the large myelinated sensory fibres.
This disturbs the balance in favour of fine fibre activity which, now unopposed, opens
the gate. Small fibre activity through the system is thereby increased and pain results.
This does not explain the pain found in algodystrophy where there is no evidence of
trauma. The afferent fibres within the sympathetic system are the same small
unmyelinated fibres that are required to open the gate and they may therefore play a
role in pain transmission.
Conversely, stimulating large fibres "closes the gate" and reduces or stops the
pain. This is the basis of the therapeutic use of large fibre stimulation for the relief of
intractable pain. In a later paper Melzack (1971) elaborated on a central control
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mechanism in the brain stem reticular system which could modify the perception of
pain by influencing the transmission of impulses through the gate.
Although the original painful lesion in algodystrophy is peripheral in most cases,
and the perception of pain may well be due to a selective processing of impulses as
proposed by the gate theory, there must therefore be a central mechanism responsible
for the characteristic features seen in algodystrophic pain. These include the character
of the pain, it's spread to adjacent areas, the ease with which the pain is aggravated by
activity elsewhere in the nervous system, the failure of sympathectomy in late cases and
Its eventual resolution in the majority of cases.
Livingstone in 1943 proposed that the chronic afferent impulses stimulated an
internuncial pool of neurones. As Lorent de No had shown in 1938 this pool consists of
two systems. A so-called multiple system, in which the stimulations successively reach
the neurons of the second and then of the third order in the higher centres, and a
closed system around which an impulse circulates. These internuncial neurons carry
the influx not only to the lateral column of the same medulla level and to several over
and underlying levels, but also to the contralateral side. This could account for the
spread of the pain to adjacent areas or even to the opposite limb. The increase in
internuncial pool activity may then cause a continuous and increased stimulation of the
efferent motor and sympathetic neurones.
This has been confirmed in a series of experiments by Procacci et al. (1974 and
1979) and Francini et al. (1979). In controls and patients with algodystrophy, they
measured cutaneous sensory thresholds, in order to assess the afferent activity,
examined the galvanic skin reflex by measuring the reflex variations of cutaneous
potentials (Wang 1985), in order to assess the efferent sympathetic activity, and the
EMG, in order to assess the efferent motor activity. They found that in patients with
algodystrophy there was an abnormal difference in cutaneous sensory thresholds
between the affected limb and the contralateral one in basal conditions, and an
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abnormal pattern of skin potential and EMG variations induced by cutaneous
stimulation both in the effected limb and in the contralateral one. After blocking the
sympathetic chain ipsilateral to the affected limb with local anaesthetics, the sensory
thresholds of both limbs changed and tended to the same value, and the pattern of skin
potential and EMG responses became similar to the pattern found in normal subjects.
They concluded that both the sensory thresholds and cutaneous and muscular reflexes
are controlled by a loop "periphery - afferent discharge - efferent somatic and
sympathetic discharge - periphery" and that this loop through a mechanism of central
transfer affects a similar loop on the contralateral side.
Sunderland (1976) claims that the characteristic features of causalgic pain are
caused by a hyperactive focus of abnormal activity in the cord caused by retrograde cell
death due to peripheral nerve injury. Transynaptic changes, including cell
degeneration, may then affect second and third order neurones. This theory does not
explain the pain of non-traumatic aetiology.
Recent work by Roberts (1986) and Cook et al. (1987) has reinforced the
classical view expressed by Livingston. Prolonged abnormal stimulation of the
internuncial pool may cause a resetting of the sensory thresholds which persists after
the initial stimulus has been removed. Both workers agree that primary afferent C-
fibres can clearly modify the response properties of the dorsal horn neurones, including
projecting neurones, for prolonged periods. This may include the afferent C-fibres
found in the sympathetic system.
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C. Local factors
Although the sympathetic system undoubtedly plays a fundamental role in the
development of algodystrophy, this does not adequately explain the disturbance in the
microvasculature or the articular stiffness.
The microcirculation is composed of arterioles which divide into smaller muscle-
walled vessels, sometimes called metarterioles, and these in turn feed into capillaries.
In some of the vascular beds that have been studied in detail, a metarteriole is
connected directly with a venule by a capillary thoroughfare vessel which has thick,
muscular walls. The true capillaries are an anastamosing network of side branches of
this thoroughfare vessel. The openings of the true capillaries are surrounded on the
upstream side by minute smooth muscle precapillary sphincters. It is unsettled
whether the metarterioles are innervated, and it appears that the precapillary
sphincters are not. They can however respond to local or circulating vasoconstrictor
substances (Table 3.1). The walls of the venules are only slightly thicker than those of
the capillaries. They contain relatively little smooth muscle, but considerable
venoconstriction is produced by activity in the sympathetic nerves to the veins and by
agents such as noradrenaline.
Belenger (1956) maintains that microvascular changes occur in three phases in
algodystrophy:
1)vasodilation of short duration.
2) vasoconstriction during which the metarterioles close; the blood passes via
the thoroughfare channels to the veins which are in spasm. This results in a reflux of
blood into the caplillaries causing exudation into the interstitial space.
3) vasomotor atony
According to Ficat (1968), the vicious circle of events is dominated by the
capillary stasis, which is responsible for hyperpressure and hyperpermeability of the
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capillaries with plasma exudation, microthrombosis and increased blood viscosity. This
has been confirmed by Renter et al. (1979) who conducted extensive dynamic isotope
studies on 20 patients with algodystrophy examining the local blood flow, vascular
volume and interstitial fluid volume. They demonstrated an increase in the vascular
volume and interstitial fluid volume combined with a decrease in blood flow on the
affected side resulting in a local stasis as proposed by Belanger (1956). These findings
also substantiate the histlological findings of capillary dilatation and blood stasis
(Rutishauser et aL 1956), and the high intramedullary pressure measurements found
using intraosseous phlebography (Arlet et al. 1981).
These vascular phenomenon cause tissue anoxia and acidosis which also
contributes to the increased capillary permeability thus completing the cycle of events.
After the oedema has regressed, fibrosis develops, diminishing the capillary
permeability and hindering metabolic exchanges resulting in the atrophic changes seen
in the late stages of algodystrophy.
Chemical factors which affect the microcirculation include histamine,
bradykinin, noradrenaline, adrenaline, angiotensin II and serotonin. There are also
local agents produced from the tissues during episodes of ischaemia. Their actions on
arterioles are summarised in Table 3.1. The exact role of these agents either as final
chemical mediators of the sympathetic dysfunction or normal physiological responses to
the local effects of the sympathetic dysfunction is unknown.
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Table 3.1. Summary of local and systemic factors which affect vascular tone in the
arterioles and pre-capillary sphincters.
CONSTRICTION	 DILATION
Increased noradrenaline discharge
Circulating catecholamines (except
adrenaline in skeletal muscle and liver)
Circulating angiotensin II
Locally released serotonin
Decreased noradrenaline discharge
Circulating adrenaline in skeletal muscle
and liver
Activation of cholinergic dilators in
skeletal muscle
Decreased local temperature
Histamine
Kinins
"Axon reflex"
Decreased 02 tension
Increased CO2 tension
Decreased pH
Lactic acid, potassium, adenosine
Increased local temperature 
Serotonin has a number of interesting pharmacological effects which may
Implicate it as the final chemical mediator. It produces arteriolar and venous
contraction, dilatation and stasis in the capillaries, increased capillary permeability
and, perhaps, dilatation in the arteriovenous anastomosis. Moreover it is found in
abundance in capillary pericytes and platelets and is released in response to tissue
trauma.
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Serotonin is also thought to have a sclerogenic action shown both clinically and
experimentally.
1)In carcinoid syndrome, where there is tumoural hypersecretion of serotonin,
there is endocardial and retroperitoneal fibrosis.
2) Intra-articular injection of serotonin in the monkey provokes an articular
fibrosis, which is accentuated in animals treated by isoniazid (Good et al. 1965).
It is of interest that isoniazid and phenobarbitol, known predisposing factors for
the development of algodystrophy, induce increased levels of serotonin.
Besides it's vasomotor effects, the sympathetic system may have a direct trophic
effect on the tissue. According to Lequesne and Auquier (1968), serotonin could be the
natural sympathetic mediator between the sympathetic influx and the retraction of the
joint capsules and aponeuroses.
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D. Summary
Most evidence would suggest that an initial painful stimulus is transferred to
the spinal column by way of both somatic and sympathetic afferents. The C-fibres in
the sympathetic system along with the somatic C-fibres "open the gate" as described by
Melzack and Wall, or cause direct stimulation of dorsal horn neurones. This results in
stimulation of the internuncial pool neurones which induces overactivity which is
dependant upon prolonged stimulation and modification of the afferent impulse by the
higher centres. This modification is likely to depend upon many factors including
environmental or emotional circumstances and accounts for the spontaneous pain and
vascular instability associated with seemingly unrelated instances such as a cold
weather, a loud noise, or fear.
The intemuncial pool neurones convey impulses not only to the higher centres
but other ipsilateral and contralateral medullary levels resulting in signs and symptoms
distant to the initiating lesion. If the internuncial pool remains hyperactive then the
efferent stimulus to the periphery and higher centres will become self-perpetuating
resulting in symptoms and signs long after the initial stimulus has disappeared.
Continuing impulses to the higher centres will also account for the perpetuation of
perceived pain despite sympathectomy or dorsal horn neurotomy which should
eliminate the afferent stimulation.
To complete the loop to the periphery, there is somatic efferent and sympathetic
efferent stimulation. In the periphery, the sympathetic efferent discharge modulates
the somatic action affecting afferent impulses. Moreover the sympathetic vasomotor
and sudomotor actions, in themselves, increase the original peripheral stimulus.
The exact role of local agents either as final chemical mediators is unknown. It
may be that the sympathetic system releases factors such as serotonin that have both
vasomotor and trophic effects on the tissue. It is more likely that sympathetic
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dysfunction induces the normal physiological response to trauma, this perpetuates
capillary hypertension and exudation resulting in the clinical features of algodystrophy.
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CHAPTER 4: CLINICAL FEATURES OF ALGODYSTROPHY
A. Presentation
Algodystrophy commonly follows a discernable precipitating factor (see chapter
2), most commonly trauma, although some present for no obvious reason. The most
frequently affected site is in the distal limb with the lower limb more commonly involved
than the upper limb (Doury et al. 1981). Although involvement of the shoulder is well
recognised in the shoulder-hand syndrome described by Steinbrocker, isolated
Involvement of the shoulder (commonly termed "frozen shoulder" in the English
literature) is recognised by a number of authors (de Seze et aL 1964; Doury et al.
1981). The condition is also well described in the knee (Renier 1958; de Seze et al.
1960; Blauth 1962; Doury et a/. 1978), hip (Duncan et a/. 1967; Hunder and Kelly
1968; Lequesne 1968), elbow (Ravault 1951; Schiano et al. 1976) and more rarely the
spine (Serre et aL 1968 and 1974).
The age of presentation varies widely but most frequently occurs in later
adulthood; 40-60 years of age (Table 4.1). These large reviews report very few patients
under 20 years of age. In 1978, Bernstein reported 23 cases in children between the
ages 9-16 years and Aftimos (1986) reported a further six. They emphasised that the
condition is often overlooked in children and consequently under-reported. Although
classically the condition is thought to occur predominantly in males, this has not been
confirmed by all workers (Table 4.1.).
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Table 4.1. Age and sex distribution in algodystrophy. Algodystrophy occurs most
commonly between 40 and 60 years of age. Although less common, the condition has
been reported in children.
Number of cases Age range (vrs) M:F ratio
Bouvier et al. (1973) 100 40-70; mean 55 1.2
Kleinert et al.
	 (1973) 506 15-80; mainly 30-60 1.2
Renier et at. (1973) 66 20-80; mainly 35-65 1.8
Patman et al. (1973) 113 11-80; mainly 40-60 0.8
Louyot et aL (1967) 140 15-80; mainly 30-65 2.0
Acquaviva et al. (1976) 90 20-80; mean 53 1.2
Doury et al. (1981) 250 19-81; mean 52 1.4
Subbarao et aL (1981) 123 16-80; median 54 0.4
_
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B. Clinical features 
Despite the variation in aetiology there are number of clinical features that are
consistently found in algodystrophy. These comprise:-
1) pain
Ii) swelling
vasomotor and/or sudomotor instability
iv) articular stiffness
and have been well described in a number of clinical reports (Schiano et aL 1976;
Doury et al. 1981).
1) Pain
The character of the pain varies both between patients and within the evolution
of the condition in an individual patient. It is usually described as a "nagging" or
"tearing" pain and, less commonly, as the classical causalgic "burning" pain. It is
usually made worse by attempts at passive or active mobilisation such that the patient
may involuntarily splint the affected part to prevent initiating the pain. Painful
paraesthesia to light touch may occur though less commonly. The pain may also be
aggravated by emotional or environmental factors such as anger or changes in
temperature. The intensity of the pain varies from a moderate and tolerable one, well
relieved by rest, to a severe, persistent pain, interfering with sleep and considerably
affecting the individuals lifestyle. Initially the pain may be localised to the affected area
but may spread to include adjacent areas.
II) Swelling
Swelling is the most constant physical finding which, like the pain, is greater
and more persistent than expected. It is particularly noticeable when the distal
40
extremities are affected. The oedema is diffuse and pitting in nature resulting in the
loss of skin folds, particularly over the dorsum of the hand. The oedema is most
marked in the earlier stages of the disease and gradually resolves.
ill) Vascular and sudomotor instability
Vascular instability occurs frequently but varies with the evolution of the
condition. Initially the extremity is red and warm. As the condition progresses, and the
oedema settles this is replaced by a blue, cyanotic, mottled appearance with the hand
feeling abnormally cold. Again, these features may be modified by environmental or
emotional factors. The sudomotor instability is less common resulting in excessive
sweating, particularly in the earlier stages.
iv) Articular stiffness
This is probably the most distressing feature for the patient, particularly when
the pain is less severe. It is present from an early stage, initially appearing to be
secondary to the oedematous changes in the soft tissues but becoming fixed
contractures as the oedema settles. The stiffness may persist long after the pain and
vascular changes have subsided.
Despite the often pseudo-inflammatory appearance of the limb, there is an
absence of systemic signs. The patient does not appear toxic with a tachycardia,
pyrexia or regional lymphadenopathy. They have a normal white cell count and
erythrocyte sedimentation rate (Serre et aL 1967; Doury et at. 1981).
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C. Evolution
These features, although characteristic of algodystrophy, are modified depending
upon the site affected and precipitating factors. As this thesis is principally concerned
with algodystrophy of the upper limb following trauma, the evolution of the condition
will be described with particular reference to these features.
In 1946 Ravault described neurotrophic rheumatism of the upper limb" dividing
the condition into two stages. Steinbrocker one year later described the shoulder-hand
syndrome, dividing it into three stages. This method of staging was used by Lee
Lankford and Thompson (1977) in their description of the condition and was later
modified by Doury et al. in 1981. All the authors stress the variable nature of the
evolution particularly in the time span of the various stages. The following is based on
Steinbrocker's original description.
1) Stage 1 
(Ravault's stage 1, Doury's stages 1 and 2)
This stage may run from the time of onset for a few weeks to three months. The
time span between the initial trauma and the appearance first signs varies from a few
days to a months (five months according to May et aL (1973), two months according to
Schiano et ca (1976)). This large variation is most likely due to the retrospective
nature of most studies. The features described largely concern the hand. The stage is
characterised by the appearance of pain which is worse on movement, the intensity
varying from patient to patient. There is tenderness to palpation or pressure on the
joints and phalanges of the fingers. The swelling is initially marked and more
responsive to elevation than in the later stages. The skin takes a pink, red or
sometimes purplish colour and feels warm to touch. This may be associated with
Increased sweating, particularly in the palm. There is limitation in flexion and
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particularly extension of the fingers. The thumb is usually only minimally affected.
Pain and limitation in movement are the overriding features when the shoulder is
involved (Fig 4.1).
Stage 2 
(Ravault's stage 2, Doury's stage 3)
In this stage the pain gradually begins to subside though in certain, more severe
cases it may become more constant in nature and radiates proximally. The pitting
oedema resolves to be replaced by a more brawny oedema and the appearance of fixed
Joint contractures. This is associated with a change in the vascular instability with the
skin becoming cooler and more cyanotic in appearance. The loss of skin folds,
particularly over the dorsum of the hand, associated with the brawny oedema results in
a glossy appearance to the skin.
ill) Stage 3 
(Ravault's stage 2, Doury's stage 3)
This stage is dominated by the onset of trophic changes. The pain and vascular
instability has usually completely subsided. The hand looks atrophic with muscle
wasting and prominence of the interphalangeal joints of the hand. The overriding
feature is the articular stiffness, particularly of the proximal interphalangeal joints of
the fingers. There may be lack of both full extension and curl-up of the fingers (Fig 4.2).
The eventual evolution of the condition is favourable with complete recovery
within several months to two years. There may be sequelae, particularly in the hand,
such as mild trophic changes in the skin and limitation in the range of movement of the
fingers.
4 3
Fig 4.1. Stage I algodystrophy. The hand is classically swollen with pink or red
discolouration of the skin. There is stiffness of the fingers which are held in slight
flexion at the interphalangeal joints.
Fig 4.2. Stage III algodystrophy. The hand has taken on a dystrophic appearance with
wasting which is most prominent in the fingers. This accentuates the interphalangeal
joints which were also stiff.
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CHAPTER 5: TREATMENT
"Diseases desperate grown
By desperate appliance are cured
Or not at all"
Anon
Over the past one hundred and twenty years, a wide variety of therapies have
been recommended for the treatment of algodystrophy. The first documented cure of a
patient with causalgia was reported in 1930 by Spurling, a neurosurgeon, who
performed a successful cervicothoracic sympathectomy. Prior to this event, patients
with severe algodystrophy endured drug addiction, mental deterioration and chronic
invalidism.
Fortunately, although the optimum method of management is still being
debated, the prospects for these patients has become more encouraging particularly
with the use of calcitonin. There is, however, a consensus that early treatment will
achieve the best results regardless of the method employed (Eisinger et al. 1974; Doury
et al. 1981; Schutzer and Gossling 1984; Wang et al. 1985). Despite this, long-term
cures have been reported in some late-stage patients.
The approaches to treatment are summarised in Table 5.1 and discussed below.
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Table 5.1. Treatments used in algodystrophy.
Conservative:
Physiotherapy
Transcutaneous nerve stimulation
Miscellaneous
Sympathetic interruption:
Regional sympathetic blockade
Surgical sympathectomy
Chemical sympathectomy
Drug treatment:
Corticosteroids
Beta-blockers
Calcitonin
Miscellaneous 
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A. Conservative Treatment
I) Physiotherapy
Physiotherapy is often the initial treatment of choice, either solely or in
combination with other treatments. However, the role of physiotherapy remains an
area of controversy replete with anecdotal comments (Schumacker and Abramson 1949;
Queneau et al. 1956; Johnson and Pannozzo 1966; Samuel 1970; Kim et al. 1979).
This is largely because of the variety of therapeutic protocols and the lack of clinical
documentation in the literature. This is illustrated in the general belief that early
mobilisation of an injured extremity prevents the development of algodystrophy.
Although this would appear sound in theory, no one has demonstrated it's value in a
controlled prospective and double blind study.
Physiotherapy is aimed initially at improving the active range of movement.
Passive mobilisation should be avoided, at least initially, as forcing motion to the point
of discomfort may aggravate the condition resulting in more intense pain, swelling and
stiffness (Savin 1974). Similarly the use of heat or ice-packs should be avoided as
extremes of temperature may increase afferent transmission and exacerbate the
condition.
ii) Transcutaneous nerve stimulation (rNs) 
During the past decade numerous reports of the favourable results obtained
with different kinds of TNS in acute and chronic pain disorders have been published
(Long 1974; Melzack 1975; Long 1977; Rosenberg et al. 1978), including algodystrophy
(Goodman 1971; Stilz et aL 1977; Richlin et al. 1978). Although the mechanism of
action is unknown, Melzack (1975) speculated that TNS, at levels capable of producing
cutaneous tingling, could activate transmission in large fibres. According to the gate-
control theory of pain (Melzack and Wall 1965), this would decrease the transmission of
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pain to higher centres. One study demonstrated it's effect in altering sympathetic tone
by raising skin temperature in normal subjects (Owens et aL 1979). Another study
found no alteration in skin temperature, blood flow, or other autonomic functions either
in normal subjects or in patients with intractable pain, although some of these patients
experienced pain relief (Ebersold et aL 1977). While some patients have been afforded
long-term pain relief with a single treatment, most patients require multiple sessions
over several days. A series of eight patients found that TNS provided long-lasting relief
in 25%, transient relief in 50% and no relief in 25% of those observed (Meyer and Fields
1972). TNS has also been used successfully in two isolated cases in children (Stiltz et
aL 1977; Richlin et aL 1978).
ill) Miscellaneous
Other treatments include direct peripheral nerve stimulation (Nashold et aL
1982), radiotherapy (Edeilcen and Wolferh 1936; Munford 1938), electro-acupuncture
(Chan and Chow 1981; Leo 1983), active-stress loading (Watson et a/. 1986) and
ultrasound to the stellate ganglion (Goodman 1971). None have been adequately
investigated in prospective controlled studies.
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B. Sympathetic Interruption
The rationale for sympathetic blockade in patients with sympathetic dystrophy
is the interruption of the abnormal reflex mediated by the autonomic nervous system.
Regardless of the inciting event, successful blockade is nearly always of value in the
early stages. The blockade can be achieved by regional sympathetic block or surgical
sympathectomy. Alternatively, intravenous infusion of reserpine or guanethedine have
been used, which effectively produce a transient chemical sympathectomy,.
i) Regional sympathetic block
Sympathetic blocks were first used by Leriche (1939) and later by Homans
(1940) and Livingstone (1943). The use of regional sympathetic blockade in a patient
serves as both a diagnostic and therapeutic function. Patients who do not experience
any pain relief from a technically successful block should be suspected of having a
problem other than algodystrophy. In it's early stage, a prolonged remission may be
obtained from a single stellate or lumbar sympathetic block. Far more commonly,
however, multiple blocks are required for pain control. While some authors have
described the use of as many as ten to fifteen blocks (Steinbrocker 1968), the more
commonly accepted practice is to limit the number to a maximum of three or four
(Kleinert et aL 1973; Lankford and Thompson 1977). If a patient demonstrates a
clinical response, but requires more than four blocks, consideration should be given to
surgical sympathectomy.
In a series of 69 patients, Steinbrocker et al. (1946), using serial ganglionic
blocks achieved excellent results in 32%, some benefit in 49% and no benefit in 19%.
The same study compared these with another group of 13 patients treated with
corticosteroids, finding the blocks more effective. Duration of follow-up was not
reported. Another series of 32 patients found that 63% had a definite improvement
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although the effects were permanent in only a third (Schumacker and Abramson 1949).
In a series of 26 patients undergoing follow-up for a period of three years, excellent
results were noted in 32% and good results in 50%; two recurrences were reported
(Steinbrocker and Argyros 1958). Kleinert et a/. (1973) in a series of 183, reported an
Improvement in 144 (79%) patients. The improvement was permanent in 121(66%); a
further 23 (13%) underwent surgical sympathectomy after a temporary response and 39
(21%) showed no improvement. More recently Wang et al. (1985) reported a three year
follow-up on 71 patients, 27 treated conservatively and 43 with sympathetic blocks. Of
those treated conservatively, 11(41%) showed signs of improvement at three years
compared with 28 (65%) in the group treated by sympathetic blocks.
Infusions of local anaesthetic by an indwelling catheter have been utilized to
achieve prolonged paravertebral sympathetic blockade. In a series of 160 patients, 57%
were noted to have an excellent response, and 27% were noted to have a good response
but, in the more severe cases, local anaesthesia yielded only temporary palliation
(Betcher et al. 1953). Another series of 25 patients reported improvement in 90% but
with a 25% relapse rate over the subsequent three years (Linson et al. 1983).
ii) Surgical sympathectomy
Periarterial sympathectomy, described in a case report by Heymann in 1924, is
the first mention of surgical sympathectomy. Leriche (1926) was so impressed by it's
effects that it became the treatment of choice for osteoporotic syndromes in Strasbourg
in the 1920's. It has now been superseded by paravertebral sympathectomy which has
been shown to be more effective (Herrmann et a/. 1942; Rasmussen and Freedman
1946).
The current indication for surgical sympathectomy is a diagnosis of
algodystrophy in any patient who has obtained even partial, short-lived, relief from
regional sympathetic blockade, but who has had four such blocks without a permanent
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cure. Several large series have examined the results of paravertebral sympathectomy,
and 58% to 100% of the patients observed (mean 84%) had complete relief of symptoms
(Echlin et al. 1945; Evans 1946; Rasmussen and Freedman 1946; Holden 1948;
Schumacker and Abramson 1949; Barnes 1953; Hardy et a/. 1958; Wirth and
Rutherford 1970; Kleinert et al. 1973; Patrnan et a/. 1973; Lankford and Thompson
1977). The follow-up period in these series ranged from six months to 17 years. Those
patients in whom pain was not relieved by ganglionectomy usually had incomplete
sympathetic denervation or severe, long-standing disease.
ill) Chemical syrnoathectomy
a) Guanethedine
In 1974 Hannington-Kiff introduced intravenous regional sympathetic block
with guanethedine as an alternative to traditional sympathetic neural blockade. The
procedure is essentially the same as for intravenous regional neural blockade to induce
local anaesthesia, using a modification of the technique described by Bier in 1908, but
substituting guanethedine for local anaesthetic. Pharmacologically, the false
transmitter guanethedine, is actively taken up by the sympathetic nerve-endings and
then displaces noradrenaline from it's storage sites (Harmington-Kiff 1982).
Excellent results for pain relief utilizing this technique have been reported by
many authors (Loh et aL 1980; Glynn et al. 1981; Tabira et al. 1983). The pain relief
usually lasts from 12 to 36 hours, but it can be as long as six months (Loh et al 1980).
Thomsen et al. (1982) have documented a threefold rise in total blood flow in the
forearm following sympathetic block with intravenous guanethedine, and the changes
persisted for 48 to 72 hours. Since no associated increase in muscular blood flow was
reported, they concluded that the rise was secondary to augmented skin flow, as
confirmed by concomitant elevation of the skin temperature. In a series of 20 patients
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who were followed-up for three months, guanethedine administered by Bier's block was
compared with stellate ganglion blockade (Bonnelli et al. 1983). Guanethedine was
equally effective for pain relief and was slightly longer lasting. In another series of 47
patients however, 21% of those observed received no benefit, 51% had less than 24
hours pain relief and in only 13% did the pain relief last more than six months (Loh et
al. 1980). The greatest effect was noted in patients with marked hyperaesthesia. Glynn
et a/. (1981) in a double-blind study involving 31 patients demonstrated significant pain
reduction following a block with intravenous guanethedine compared with physiological
saline. However, several patients who were treated with intravenous saline also
experienced amelioration of pain, suggesting a strong placebo effect. There was no
effect on palmar sweating.
b) Reserpine
Reserpine injected intra-arterially is effective in the pain relief of pain and
vasospasm associated with Raynaud's phenomenon and frostbite (Romeo et a/. 1970;
Tindall et al. 1974; Porter et al. 1976). Successful treatment of algodystrophy with
intravenous reserpine has also been reported (Benzon et a/. 1980; Chuinnard et al.
1980). Reserpine, like guanethedine, can produce a sympathetic block when
administered by Bier's technique. Its mechanism of action is the reduction of storage-
vesicle re-uptake of catecholamines, thereby slowly depleting noradrenalin stores in
sympathetic nerve-endings.
McKain et aL (1983), in a prospective, randomised double-blind study, evaluated
the sympatholytic effects of intravenous guanethedine and reserpine in asymptomatic
volunteers. Saline or 0.25% lignocaine was used as a control solution. Sympathetic
adrenergic and cholinergic activity was specifically and independently investigated.
Reserpine had no effect, in comparison with the pre-study baseline or control solutions,
on either adrenergic or cholinergic function. Guanethedine, however, consistently
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produced selective adrenergic blockade with resultant peripheral vasodilation, at the
same time having no effect on the sympathetic cholinergic functions such as sweating.
It appears that guanethedine may be useful in the treatment of pure vasospastic
conditions. The absence of any effect on sympathetic cholinergic activity, however, may
make it inferior to the more global action of conventional sympathetic blocks or
sympathectomy in the treatment of algodystrophy. Although the reported complications
with the use of guanethedine and reserpine have been few, prolonged othostatic
hypotension, dizziness, somnolence, and nausea and vomiting can occur.
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C. Drug Treatment
I) Corticosteroids
The results of treatment with systemic corticosteroids have been examined in
several studies since they were first used in 1958 by Steinbrocker and Argyros (Rosen
and Graham 1957; Glick 1973; Flatt 1974; Kozin et al. 1976; Bulgen et al. 1978; Kozin
eta!. 1981; Christensen et al. 1982). Their effectiveness however still remains
controversial as many of the trials were uncontrolled. Consequently, some authors
claim it has no role in the management of algodystrophy (Serre et a/. 1967; Schiano et
al. 1976).
Corticosteroids are typically given in short courses, being initially used in high
doses (60 to 80 mg of Prednisoline per day) and then quickly tapered off. In a series of
53 patients, Kozin et al. (1976 and 1981) obtained encouraging results using this
regime in the treatment of patients suspected of having algodystrophy. In a subset of
patients who met all the criteria for definite algodystrophy, 82% had a good or excellent
subjective response to the steroid regime. This fell to 76% when all patients with a
probable or possible diagnosis of algodystrophy are included. Although the results did
not appear to be related to the duration of existing symptoms before steroid treatment,
several patients who achieved good responses later required re-treatment. No placebo
treated controls were included in the investigation. In a smaller series using much
larger doses (100 to 200 mg daily for two weeks). Rosen and Graham (1957) reported a
good or excellent result in 67% of patients. There was no long-term follow-up.
In one of the few randomised, controlled studies, Christensen et a!. (1982)
investigated the response of 23 patients to either prednisolone or placebo. Ten
milligrams, three times a day, was given until there was a clinical response, upto a
maximum of 12 weeks. They observed that in all 13 patients treated with prednisolone
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the pre-treatment score improved by 75%, whereas only 20% of the patients who
received placebo experienced relief.
The mechanism of action of corticosteroids in this condition remains unknown.
Kozin et aL (1976 and 1981) demonstrated a chronic perivascular infiltrate on synovial
biopsy specimens from involved sites. The potent anti-inflammatory properties of
prednisolone may account for it's therapeutic effect.
Poplawski et al. (1983) recently reported their results with a new method of
treatment based on a further modification of the Bier block. Intravenous regional
blocks of 1% lignocaine combined with Solu-Medrol (80 mg methylprednisolone sodium
succinate) were administered to 28 patients with algodystrophy. There was significant
Improvement in 21 of the patients usually after several treatments. Local steroid
injection has also been used with some effect, particularly in the treatment of the
shoulder-hand-syndrome (Berger 1954; Serre et al. 1967; May et aL 1973).
The side-effects of steroid therapy are rarely mentioned. Glick (1973), however,
found unacceptable weight gain and moon fades in two patients and dyspepsia in three
patients. Schiano et al. (1976) also found it illogical to prescribe steroids for a condition
which includes a regional osteoporosis as one of it's features.
It would appear therefore that, although steroids may have an effect, their use is
purely empirical and should only be considered for patients who either refuse or cannot
tolerate the more recognised therapeutic regimes.
II) Beta-Blockers
There have been conflicting results of the use of beta-blockers in isolated cases
of algodystrophy. Several recent larger series have suggested however that they may be
effective. Schiano et al. (1976), in a small study of seven patients obtained promising
results. May et al. (1977) reported 30 "good or very good" results out of 34 patients
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with improvement as early as the seventh day. In another study 72% had an excellent
and 13% a good result (Ziegler et al. 1979). Neither of these studies were controlled.
Propranolol is the agent most often used though it's mode of action is poorly
understood. It has a central action, reducing anxiety and regulating the preganglionic
sympathetic tone; and a peripheral action, slowing down nerve conduction in the reflex
arc and blocking the sympathetic affects on the microcirculation.
ill) Calcitonin
This will be dealt with in detail in the next chapter.
iv) Miscellaneous
Other drug treatments include griseofulvin (Cohen et al. 1960; Cherot and Amor
1983), nifedepine (Prough et aL 1985), alpha-blockers (David-Chausse et aL 1957).
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CHAPTER 6: CALCITONIN
A. Introduction
Since its discovery by Copp et al. in 1962, calcitonin has been widely studied
and most of it's actions elucidated. Nevertheless, calcitonin's role is still under
discussion both in physiological and in pathological conditions, so that it has been
refered to as "a hormone in search of a function".
Cakitonin is a peptide hormone secreted by the parafollicular or C-cells of the
thyroid gland (Foster et al. 1964; Pearce 1966). It is composed of 32 amino acids with a
1-7 disulphide bridge and a prolineamide at the carboxy-terminus. It is initially
synthesised as a larger precursor form and may be present in the blood stream in
various forms of different molecular weight.
The amino acid sequence of many species of calcitonin have been determined to
date, and four have been used therapeutically; extracted porcine and synthetic salmon,
eel and human. In spite of the similarity between the various calcitonins, there are
considerable differences in half life, metabolic clearance and some biological activities,
especially between mammalian and non-mammalian calcitonins.
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B. Mode of Action of Calcitonin in Algodystrophy
Calcitonin has been widely used in the treatment of bone disease characterised
by active bone turnover, such as Paget's disease of bone and hypercalcaemia due to
malignancy. In these conditions, the beneficial effect of calcitonin is due to its ability to
block bone resorption (Freidman and Raisz 1965).
As one of the major features of algodystrophy is the marked bone resorption, it
therefore seemed logical to use an agent with an anti-osteolytic action. In January
1973, Eisinger et al. reported the first ten cases of algodystrophy to be treated with
calcitonin, seven of whom had a rapid clinical response. The rapid resolution of pain
and vascular instability in these early studies indicated however, that calcitonin had
effects other than preventing bone resorption.
These effects will now be considered in more detail.
1) Pain
Several lines of evidence suggest that calcitonin is both a peripheral and a
central modulator of the neural activity evoked by painful stimuli.
a) Peripheral
One reasonable hypothesis about the analgesic action of calcitonin is that it
influences the production of pain-inducing or pain-exacerbating substances. Indeed, in
skeletal diseases in which there is intensified bone resorption, local increases of H+,
kinins and prostaglandins appear to contribute to pain in the bone as well as in other
tissues. In particular, arachidonic acid metabolites may be important in hyperalgesia,
since they are known to be general pain amplifiers (Ferreira et al. 1973)
That calcitonin may interfere with the prostaglandin system has been suggested
indirectly by its anti-inflammatory action in carragenin-induced oedema of the foot
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(Abdullahi et al. 1975) and directly by its inhibition of prostaglandin and thromboxane
synthesis in vitro (Ceserani et al. 1979). Evidence for a direct anti-inflammatory action
of calcitonin has been obtained by Strettle et al. (1980), who have shown a potent
Inhibition of histamine-induced vascular leakage, which would appear not to be
dependant on the effect of calcitonin on plasma calcium concentration. This action of
calcitonin could account partially or fully for the resolution of the acute inflammatory
appearance seen in algodystrophy
This peripheral action of calcitonin would account for the success in early
treatment of algodystrophy, before the pain in the spinal or higher centres becomes self-
propagating.
b) Central
Calcitonin has been found in inframammalian species lacking a bony skeleton
(Copp 1962); this finding suggests the possibility of a new role for the hormone.
Recently, the presence of irnrnunoreactive calcitonin has been demonstrated in the
human pituitary gland and cerebrospinal fluid (Cooper et a/. 1980; Pavlinac et al. 1980).
and the presence of binding sites for calcitonin in the human brain (Pecile 1983). The
most striking feature of this work was the dense clustering of calcitonin binding sites in
some of the brain stem and cord structures that participate in the regulation of pain
perception. It is of interest that a primary condition of high calcitonin levels in
cerebrospinal fluid has been found to accompany a syndrome of congenital insensitivity
to pain (Fabri et al. 1983).
The intracerebroventricular administration of calcitonin in animals (Pecile et aL
1975) and the subarachnoid injection of calcitonin in man (Fraioli et aL 1982) result in
analgesia. Since similarities have been observed between morphine- and calcitonin -
induced analgesia, it has been thought that the hormone's analgesic effect may involve
the endogenous opiate system, in particular Beta-endorphins. Recent data have shown
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a rapid increase in circulating Beta-endorphin like immunoreactivity in man after
intravenous infusion of salmon calcitonin (Gennari 1983). Nevertheless, the role of
endogenous opiates in mediating the analgesic effect of the hormone is still debated.
Some authors report that calcitonin-induced analgesia is not reversed by naloxone, the
opiate antagonist (Braga et al. 1978); others claim that the analgesic effect of calcitonin
can be reversed by the use of naloxone at doses 10 to 1000 times greater than those
required to antagonize the effects of morphine (Bates et al. 1981). At such high doses of
naloxone however, the effects of the drug on the opiate receptors might well be non-
specific. A possible resolution of this paradox may lie in studies suggesting the
existence of different mechanisms and receptors for analgesia specific to calcitonin
(Pecile 1983).
It is difficult however to envisage a direct central action fron calcitonin
administered in it's parenteral form, as in algodystrophy, because their is no evidence
to suggest that calcitonin crosses the blood brain barrier.
ii) Vascular instability
Calcitonin has been shown experimentally to have a vaso-active effect on
vascular smooth muscle. Driessens et a/. (1981), studying isolated blood vessels in
canine tibia, believed that some of the skeletal effects of calcitonin may be due to it's
direct action on the vascular smooth muscle cell of bone blood vessels. They showed
that calcitonin caused a dose-dependant increase in perfusion pressure indicating that
it caused constriction of bone blood vessels. In a clinical context, medullary carcinoma
of the thyoid secretes excess calcitonin which results in symptoms of flushing. This
may be due in part to another peptide encoded by the human calcitonin gene, calcitonin
gene related peptide (CGRP), which is found in the circulation and is the most powerful
vaso-dilator known to man (Struthers et al. 1986).
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Renter et a/. (1979) demonstrated vascular stasis in patients with algodystrophy
using dynamic isotope studies, one feature of which was an increase in the vascular
volume. Following treatment with calcitonin the vascular volume was decreased
without entailing a decrease in the bone uptake. This led them to think that the
therapeutic efficiency of calcitonin was derived from it's vascular effect rather than from
an action on bone. Calcitonin has also been used in other conditions where there is an
abnormality of the micro-circulation such as migraine and Raynaud's disease with
some effect (Schiano and Acquaviva 1976; Vayssairat et al. 1980).
Increased bone resorption
Milhaud et al. (1965) was the first to suggest that calcitonin acted by inhibiting
bone resorption. In vitro studies by Freidman and Raisz (1965) using bone cultures
confirmed this finding. A direct action of calcitonin on bone was also demonstrated by
perfusion studies using the isolated cat tibia (MacIntyre et al. 1967). They showed that
infusion of porcine calcitonin caused an arteriovenous difference in calcium
concentration of upto 5%, corresponding to a net retention of calcium in bone. In
addition, when calcitonin was infused into rats there was a marked reduction in urinary
hydroxyproline (Martin et at. 1966). These results indicated that calcitonin acted by
inhibiting bone resorption, thereby decreasing the circulating levels of the products of
resorption; calcium, phosphate and hydroxyproline-containing peptides.
It was subsequently established that this inhibition of bone resorption was
brought about by an inhibitory effect of calcitonin on the osteoclast (loss of ruffled
borders, reduction in cell size and numbers). The hypocalcaemic effect is not.seen
normally in the adult as bone turnover is relatively low. Even pharmacological doses of
cakitonin cause only a transient fall in serum calcium in normal adults (Foster et al.
1966; Singer et al. 1969). When bone turnover is high however, such as in childhood or
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conditions such as Paget's disease, calcitonin causes a sharp decrease in serum
calcium (Woodhouse et al. 1970; MacCredie et al. 1971).
Although a stimulatory effect of calcitonin on bone formation cannot be
excluded, experiments both in vivo and in vitro, have failed to establish any increase in
osteoblast formation (Milhaud et al. 1965; Raisz 1965; Robinson et a/.. 1967; Reynolds
et al. 1968).
Thus in algodystrophy, where there is a regional increase in bone turnover,
calcitonin will prevent excessive resorption and may speed skeletal recovery as the
condition subsides. It is unlikely however that this effect on bone is related to the
alleviation of symptoms seen following treatment with calcitonin.
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C. The Use of Calcitonin in Algodvstrophy.
Since the report by Eisinger et a/. in 1973, the beneficial effects of calcitonin
have been confirmed (Acquaviva et al. 1976; De Bastiani et a/. 1978; Ginsberg et al.
1978; Doury et al. 1981; Martin 1985; Gobelet et al. 1986). Calcitonin appears to have
a dramatic effect, particularly in the early stages, but unfortunately only one
randomised double-blind study has been published (Doury et a/. 1981). They used 100
units of salmon calcitonin or placebo intramuscularly per day for four weeks in 28
patients suffering from stage I algodystrophy of the lower limbs. At 14 days there was
an appreciable improvement of their pain in 64% of those receiving calcitonin compared
with 25% in the placebo group (p<0.001). At 28 days both groups had improved such
that there was no significant difference in their pain. Although this study demonstrates
the rapid effect of calcitonin, it also confirms the spontaneous resolution of symptoms
that can occur in algodystrophy. Open studies evaluating the use of calcitonin should
therefore be interpreted with caution. This criticism is true of most studies on the
treatment of algodystrophy and highlights the need for more information on the early
natural history of the condition.
Martin in 1985 published the results of a multicentre study involving 432
patients using 80 units of salmon calcitonin intramuscularly six days a week for three
weeks followed by three injections a week for a further two weeks. Pain had
disappeared at one week in 58% and in 75% by three weeks. The rapid resolution of
pain was also reported by Ginsberg et al. (1978) with an 80% good or very good
response in 14 patients. There is a similar resolution seen in the vasomotor symptoms,
swelling and stiffness.
At present, the dose of calcitonin used appears to be purely empirical. Most
studies use 80-100 units of salmon calcitonin by daily intramuscular or subcutaneous
Injection daily for four weeks which is equivalent to 160 units of porcine calcitonin (De
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Bastiani et al. 1978). Only one study has looked at the effect of a smaller dose.
Acquaviva et a/. (1976) in an open study involving 90 patients compared the effect of
100 units of salmon calcitonin with a control dose of 1 unit. Of the 79 (88%) patients
who received the larger dose, 54 (60%) derived benefit, whereas none of the 11 (12%) in
the other group improved. Although the lack of any improvement in the control group
is surprising considering the presumed incidence of spontaneous improvement, it
indicates that doses as small as 1 unit have no effect. More controlled studies are
needed to define the optimum dose.
Side-effects following treatment with injected calcitonin are common. Doury et
al. (1981) observed intolerance in 20-35% though the incidence may be as high as 60%
(Gennari et al. 1983). The symptoms however, were seldom intense enough to interrupt
treatment. The side-effects are usually only troublesome; consisting of vasomotor
symptoms such as hot flushes, nausea and vomiting or lethargy. They appear rapidly
within minutes and upto an hour after the injection and last several hours. Over the
course of the treatment period, the side-effects often become less troublesome or can be
controlled with symptomatic therapy. An advantage of a smaller dose of cakitonin, if it
can be shown to be effective, may be a lower incidence of side-effects.
Antibody formation may be a problem with non-human calcitonins; it has
recently been shown that up to 57% of patients treated with salmon calcitonin may
develop antibodies to the hormone. Furthermore, clinical resistance may occur in upto
23% of patients (Singer 1980). The human hormone is thought to be non-antigenic
(Dietrich and Fischer 1977) but may be associated with more side-effects than salmon
or eel calcitonin at equivalent doses (Gennari et al. 1985). The short duration of
treatments used in algodystrophy makes antibody formation a theoretical rather than
practical problem.
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D. Nasal Calcitonin
The administration of peptide hormones (insulin, calcitonin) is restricted to the
parenteral route as proteolytic digestion prevents administration by mouth (Stevenson
et al. 1981). This is one of the major drawbacks to the use of calcitonin in conditions
such as algodystrophy where a regimen of regular daily injections is required. For this
reason other non-parenteral routes have been sought. Various substances, including
vasopressin, leuteinising hormone releasing hormone, insulin and glucagon are
absorbed by the mucosa of the respiratory system.
In 1984, Reginster et al., reported the results of nasally administered calcitonin
In Paget's disease with encouraging results. There have since been a number of studies
confirming the use of nasally administered calcitonin in conditions with increased bone
resorption though with conflicting data concerning it's efficacy compared with
subcutaneous administration (Eisinger 1985; Benjamin et al. 1986; Elomaa et aL 1986;
Nagent de Deuxchaisnes et al. 1987). This is largely because there are few dose-
response data for the parenteral route and it is therefore difficult to assess the
bioequivalence of intranasal calcitonin. However in the doses used intranasally (upto
400 units), the decrease in bone turnover in both the acute and long-term appear to be
less marked than with the subcutaneous administration of calcitonin. These findings
suggest a lower bioequivalence.
This reduced absorption may also account for the lack of systemic side-effects
seen. It has been argued however, that steady absorption from the nasal mucosa
avoids the peak to peak variation in absorption from a subcutaneous site. The high
calcitonin levels in circulation at each peak accounting for the side-effects. Of the 100
patients studied (Eisinger 1985; Benjamin et al. 1986; Elomaa et al. 1986; Nagent de
Deuxchaisnes et al. 1987) none developed systemic side-effects and only 17 developed
local side-effects with 3 withdrawing from treatment.
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Pontiroli et a/. (1985) compared the acute effects of human calcitonin using the
same dose given intravenously and intranasally but with the addition of sodium
glycholate as a surfactant to increase absorption via the nasal route. They found no
difference in the hypocalcaemic response or the incidence and severity of side-effects
between the two groups.
It would appear therefore that calcitonin is absorbed through the nasal mucosa
In sufficient quantity to have some effect on bone turnover though the magnitude of this
effect is not known. Further studies are needed to confirm that the addition of a
surfactant to the nasal spray will improve the efficacy. If so this may be at the expense
of systemic side-effects similar to those seen with parenterally administered calcitonin.
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CHAPTER 7: AIMS OF THESIS
Although there is a great deal of disagreement about the incidence of
algodystrophy, it is becoming increasingly recognized that the condition is far more
common than originally thought. A high incidence has been recognized in the French
literature for many years perhaps because in Britain and North America the less severe
forms of the condition have been ignored.
Even though the condition was described over a century ago, little is known
about the early natural history of the condition and the degree of morbidity it causes,
particularly in it's less severe form. This is due to a number of reasons, not least of all
the confusion over the nomenclature of the syndrome. The reported studies are almost
universally retrospective and poorly constructed incorporating patients with a variety of
aetiological factors, sites of involvement and stages of disease into one group. The
results are consequently difficult to analyze. There is also a lack of quantitative
methods of assessment to accurately follow the progression of the disease. The same
criticisms can also be levelled at the various therapeutic trials described.
The first aim of this thesis was to document the incidence and natural history of
algodystrophy following Colles' fracture. Colles' fracture appeared to be a reasonable
model of post-traumatic algodystrophy since it is common, occurs in a fairly
homogeneous population (post-menopausal women) and follows a reasonably constant
type of trauma. Even so, the reported incidence in the literature ranges from 2 - 30%,
probably related to non-uniform criteria for the selection, evaluation and diagnosis of
the disorder.
A second aim was to define the early natural history of the condition following
Colles' fracture in a controlled fashion using quantitative methods of assessment which
include clinical observations, radiographs, Technetium isotope scans, single photon
absorption scans, laser Doppler angiography and serum and urine biochemistry. These
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methods were used to identify the various features of the disease and follow their
development with time. From this it was hoped to identify certain features at
presentation which would accurately predict the course and severity of the condition.
This would enable the most appropriate form of treatment to commence at an earlier
and probably more effective stage. I also aimed to document the morbidity caused by
the various degrees of severity found in the condition to determine whether it's
increasing recognition was of clinical significance.
A sound knowledge of the natural history of the condition is necessary for the
evaluation of therapeutic regimes, particularly since there may be a high incidence of
spontaneous resolution. It was intended to use the quantitative methods of assessment
as a method to determine the effects of therapeutic intervention. The use of calcitonin
has gained favour in the treatment of algodystrophy with particular interest in the nasal
form of administration which improves patient compliance. The rationale for the use of
cakitonin was that it had analgesic properties, affected the microcirculation and
prevented bone resorption, all of which might have been beneficial in algodystrophy.
The results of therapeutic intervention are however difficult to evaluate because of the
lack of controlled trials and the subjective method of assessment. For this reason the
final aim was to thesis examine the role of nasal calcitonin in a double blind controlled
clinical trial.
6 8
METHODOLOGY
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CHAPTER 8: STUDY DESIGN
A. Introduction
A criticism of many previous studies of algodystrophy has been the variable
nature of the study group with regard to aetiology, site of involvement and stage of
disease. In an effort to avoid these pitfalls, we attempted to select a uniform population
for study.
Colles' fracture was considered an appropriate clinical model for a number of
reasons. The fracture is one of the most frequent fractures in man: only fractures of the
fingers and ribs are more frequent (Conwell 1970) and accounts for 8-15% of all bony
injuries (Golden 1963; Sturm 1969). Before the age of forty, the incidence of CoIles'
fractures is about equal in males and females. In men, the incidence rises slightly from
forty to eighty years of age, whereas in women the incidence rises 8-10 times from forty
to sixty after which it remains constant (Alffram and Bauer 1962; Newton-John and
Morgan 1970; Falch 1983). This difference is associated with the higher incidence of
osteoporosis after the menopause in women (Reifenstein 1957; Bate 1969; Newton-John
and Morgan 1970). The fracture is usually caused by a simple fall on the outstretched
hand with the wrist in dorsiflexion (Bacorn and Kurtzke 1953; Frykrnan 1967). Thus
the degree and type of trauma required to produce a Colles' fracture is fairly uniform.
This may not be true in younger patients as the amount of energy required to produce
the fracture is greater (Alffram and Bauer 1962), indeed describing these fractures as
CoIles' fractures may be misleading. Also, the method of treatment, which has been
implicated as a factor in the development of algodystrophy, is identical within the
orthopaedic department from which the patients in this study were collected.
In summary we chose to study algodystrophy in a fracture which is common,
which occurs in a relatively uniform population (post-menopausal females), arises in a
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comparable manner with regard to type and degree of trauma and is treated in a
standardised manner.
Despite numerous papers on CoIles' fractures in the English literature, the
Incidence of algodystrophy has only been reported in upto 2% cases (Bacon and Kurtzke
1953; Plewes 1956; LidstrOm 1959; Frykman 1967; Poole 1973; Stewart et al. 1984).
The studies are generally retrospective and the presence of algodystrophy is usually
considered an incidental finding to the main topic of the paper. Thus the 2% may
reflect the incidence of algodystrophy in its fully established and most severe form. In
contrast, in a study designed specifically to investigate algodystrophy, Aubert (1980)
recorded an incidence of 29%. The increase in incidence is probably accounted for by
the detection of a greater number of milder cases. This was confirmed recently by
Atkins et al. (1990).
Patients who have sustained a CoIles' fracture appear to be suitable for both an
Investigation into the natural history of algodystrophy and as a therapeutic model.
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B. Study Design for Natural History
Between December 1987 and April 1989, 274 patients were reviewed personally
after attending the Accident and Emergency Department at the Royal Hallamshire
Hospital with a Colles' fracture. No attempt was made to influence their initial
management. An undisplaced fracture was immobilised in a moulded plaster of Paris
radial slab over a single layer of plaster wool with the hand held in radial deviation and
slight flexion to prevent displacement. A displaced fracture was reduced under regional
(Bier's block) or general anaesthesia and the position held in a radial slab in the
position described above. Rarely the fracture was immobilised in a below elbow cast.
All patients were given a broad arm sling to elevate the fracture for two to three days
and encouraged to mobilise fingers, elbow and shoulder. They were also instructed to
return if concerned about pain or swelling and discolouration of the fingers. They were
then reviewed the following day to ensure that there was no impairment of circulation
or neurology and to check the adequacy of the plaster. A radiograph was taken at one
week to ensure there had been no loss in position in which event a further
manipulation of the fracture was performed.
The plaster was removed at four to five weeks when details concerning the type
of fracture, their management or problems while in plaster were recorded (Table 8.1).
The fracture was described using Frylanan's classification (Frykrnan 1967) based on the
postero-anterior and lateral radiographs taken at initial presentation. This description
is dependant upon involvement of the distal radio-carpal or radio-ulna joint with or
without avulsion of the ulna styloid and consists of a scale of 8 different types with an
increasingly unfavourable prognosis (Table 8.2). No attempt was made at this stage to
evaluate the presence of the various features of algodystrophy because the patients
were understandably anxious and any data gained might not accurately reflect the true
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clinical state. The patients were given general advice regarding mobilising fingers, wrist
and forearm and asked to return in two weeks.
The main features of algodystrophy, namely pain, vascular instability, swelling
and stiffness, were evaluated with a variety of clinical and laboratory techniques. These
Included serum and urine biochemistry, bone scintigraphy, radiology, photon
absorptiometry and laser Doppler angiography and will be referred to in detail later.
For logistic reasons, not all patients were fully investigated (excluding clinical
evaluation), particularly those patients who had no evidence of algodystrophy (Appendix
I). Sufficient patients without algodystrophy were enrolled however, to act as
representative controls for each of the techniques described (excluding laser Doppler
angiography), details of which are given in the subsequent sections of this chapter.
At two weeks out plaster, the patients were first fully clinically assessed. They
were then reviewed monthly, initially upto 6 months in those with no evidence of
algodystrophy, or until they were asymptomatic in those with algodystrophy. The
investigations were performed at two weeks and subsequently at varying intervals
during the progression and resolution of the disease process (Table 8.3). Patients were
rarely offered formal physiotherapy but were instructed in the mobilisation of their
upper limb, particularly fingers and wrist. Ten patients, none with algodystrophy, who
were young and required a higher degree of function from their hand were referred for
more intensive treatment.
The patients who developed algodystrophy were a ready source of clinical
material for the investigation of the effect of nasal calcitonin. Details of this study
design and it's links with the larger study into the natural history of algodystrophy are
given later.
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Table 8.1. Data recorded on entry to the study.
NAME:
ADDRESS:
DATE OF BIRTH.:
SEX:
DATE OF ENTRY TO STUDY:
HOSPITAL NO:
INITIAL ASSESSMENT
DATE OF FRACTURE:
SIDE FRACTURED:
FRYKMAN TYPE:
? MANIPULATION:	 YES NO
IF YES - HOW 01 .-ihN	 DAYS
TIME FROM # TO M.U.A.	 HRS.
TYPE OF ANAESTHETIC (SPECIFY)
TYPE OF PLASTER APPLIED: 	 RADIAL SLAB
HALF ARM P.O.P.
OTHER (SPECIFY)
TIME IN PLASTER	 DAYS
PHYSIOTHERAPY:
	
YES NO
IF YES - FOR HOW LONG:
HANDEDNESS:
PROBLEMS IN PLASTER (SPECIFY):
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Table 8.2. Frykmans classification of Colles fracture. The classification depends upon
the fracture of the distal radius involving the radio-carpal or distal radio-ulna joint with
or without avulsion of the ulna styloid.
Frykman type
	 Radio-carpal joint
involvement
Radio-ulna joint	 Avulsion ulna
involvement
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CHAPTER 9: CLINICAL METHODS OF ASSESSMENT
A. Pain and tenderness
Two different approaches are generally used in the assessment of pain in clinical
studies. These are semi-quantitative assessments based on visual analogue scales
(VAS) or questionnaires, or the application of a quantifiable noxious stimulus to a
tender region. The VAS has been demonstrated to be a reliable and reproducible
evaluation of pain intensity for patients with chronic pain (Huskinsson 1974). However,
It is generally considered limited by Its unidimentional character of pain assessment.
The McGill Pain Questionnaire (MPQ) (Melzack 1975) was developed to overcome this
problem by generating information concerning affective, sensory and evaluative aspects
of pain.
Although the VAS was originally used as a component of the pain assessment in
this study, it quickly became apparent that patients had difficulty in differentiating the
pain due to algodystrophy from that of their fracture. Whilst the MPQ may have
overcome these problems, it was considered too time consuming to be used on an
essentially elderly population and, as Davidoff et al. (1988) found, appeared to be
Inferior to the VAS as a brief clinical assessment of patient progress. In these studies
the patients were asked if they had any pain in the hand, specifically excluding the
wrist, or in the shoulder. Their reply was recorded as a simple yes or no. No attempt
was made to quantify the degree or type of pain.
The importance attached to tests for pain sensitivity may be gauged by the
numerous methods designed for ascertaining it. In 1943, Goetzl et al. noted 82
different methods involving the application of mechanical, chemical, electrical and
thermal stimulation. The simplest mechanical test was described by Libman (1934)
which involved a semi-quantiative assessment of thumb pressure applied to the styloid
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process. The simplest modification of this method, to allow an accurate measurement
of the stimulus, is the pressure algometer or dolorimeter. This instrument was used as
far back as the Victorian days for assessment of analgesia in tabetics. It has been used
recently in rheumatoid arthritis (McCarty et ca. 1965 and 1968), algodystrophy (Kozin et
ca. 1976) and exhaustively investigated by Atkins et al. (1989). This instrument
therefore appeared the most appropriate to assess pain and tenderness in
algodystrophy.
1) Dolorimetry technique
The dolorimeter used was a modification of a compresion-extension gauge
provided by a small engineering company (Salter Bros., Sheffield) (Fig 9.1). It consisted
of a hollow metal cylinder, open at one end, containing a spring. One end of the spring
was attached to the closed end of the cylinder and the other end attached to a metal rod
which protruded from the cylinder. There was a slit in the side of the metal casing
alongside which was a graduated scale measuring kilograms of pressure upto 11 kg. A
pointer was attached to the junction of the spring and rod which, when the spring was
at its normal length, registered zero on the scale. A small plastic button tipped with felt
was attached to the free end of the rod to prevent damage to the patients skin.
To maximise reproducibility, the technique used in each examination was
identical. The normal hand was always examined first to gain the patient's confidence
and allow them to become accustomed to the technique before the affected hand was
measured. All the joints and the proximal and middle phalanx of the fingers were
examined sequentially starting with the distal interphalangeal joint (DIPJ) of the index
finger and working towards the little finger. Then the middle phalanx was measured,
again starting with the index finger.
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Fig 9.1. The dolorimeter used to quantify the degree of tenderness in the bones and
joints of the hand. It was a modification of a compression-extension guage with a scale
in Kg upto a maximum of 11 on the side of the cylinder.
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Fig 9.2. The tip of the dolorimeter applied to the area of measurement and steadied
with the examiners left hand. The cylinder was then depressed until the patient
indicated the first perception of pain at which point no further pressure was applied.
The maximum deflection was recorded from the Kg scale on the barrel.
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As the examination by necessity produces a noxious stimulus, the technique
was fully explained to the patient beforehand. The intention was to identify the point at
which the pressure applied was first perceived as pain. When the threshold was
reached, the patient was instructed to give a pre-arranged signal so that no further
pressure was applied and a reading could be taken from the scale on the dolorimeter. It
was stressed that the signal should be made at the point the sensation first changed to
pain and not when the pain became intolerable.
The hand was placed flat on the table and the felt-covered plastic button was
placed on the skin and steadied between the index finger and thumb of the examiners
left hand (Fig 9.2). The barrel of the dolorimeter was then gripped in the fingers of the
right hand and held perpendicular to the table, allowing full view of the scale, and a
steady downward pressure applied. This pressure was transferred through the spring
to the patients finger. At the pre-arranged signal the pressure ceased and the reading
was made. A low reading indicated a more tender area. This was then repeated in the
sequence described above. The pressure was applied at approximately 3 kg per second,
as recommended by Atkins et al. (1989). If the rate was increased, the pain threshold
was perceived earlier and an abnormally low reading was recorded. Examination of
both hands rarely exceeded five minutes.
Patients with algodystrophy commonly had fixed flexion deformities and were
unable to lay their hands flat on the table. Pressure then applied to the arched finger
was abnormally painful and a falsely low reading was recorded. This was overcome by
placing the hand over a purpose built arch providing contact with all the fingers. The
dolorimeter was then held perpendicular to the surface of the arch beneath the joint or
phalanx being examined, pressure applied as before, and a reading taken.
The technique is mildly uncomfortable provided that the dolorimeter is only
applied upto the threshold from pressure to pain. No patients refused either an initial
or subsequent examination. Problems did arise occasionally with stoical patients,
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usually male, who maintained that they could have withstood far more pressure.
Careful explanation that the test was meant to find when pain first appeared and not
when it became intolerable usually sufficed. At the end of the examination, there were
skin dimples at the sites measured which disappeared within ten minutes and on no
occasion was the skin damaged.
Another potential pitfall was the anxious patient who at the beginning of the
examination recorded abnormally low pressures. This was immediately obvious as the
remaining readings were at a higher and steady level. This was overcome by careful
explanation of the technique and beginning on the distal inter-phalangeal Joint of the
index finger on the unaffected hand which Atkins et al. (1989) had demonstrated to be
the least painful site. On the rare occasions this problem arose, the examination was
repeated and in no instance did it recur in subsequent examinations.
a) Reproducibility and Normal range
In order to assess the reproducibility and calculate the normal range, 24 female
and 2 male patients with a mean age of 64 + 3.5 years were studied. The age range and
sex ratio were selected so as to resemble the population of CoIles' fracture to be studied.
They were all hospital in-patients with no recent history of a distal radial fracture and
no evidence of algodystrophy in the upper limb. The dolorimetry was performed as
described above and repeated the following day with no reference to the previous day's
score.
The distribution of the dolorimetry readings was investigated using Probit
analysis and the significance of the difference between dolorimetry readings assessed
using Student's t test or analysis of variance. The coefficient of variation for paired
measurements was computed as:
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CV (%) = standard deviation of the difference 	 x 100
mean value
The normal range (mean + 2 standard deviations (SD)) was then calculated for the most
reproducible technique.
ii) Results
There was no significant difference in the dolorimetry score between the two
hands at any anatomical site or with the hand taken as a whole (Table 9.1). Also, when
comparing sites within a hand, the joints were no more tender than the phalanges.
Similarly there was no difference between the dominant and non dominant hand.
Coefficients of variation (Table 9.1) were calculated for both the absolute values
and the ratio of scores between the two hands (calculated as second hand/first hand).
They were greater for the absolute measurements rather than the ratios and decreased
the greater the number of recordings made (ie. whole hand < all joints < all phalanx).
Therefore the most reproducible measurement was for the ratio between the two hands
which involved 20 measurements per hand.
The values for the ratio of the dolorimetry scores were normally distributed (Fig
9.3; Probit analysis; r = 0.97). The range of dolorimetry scores expected in normal
subjects at the 95% confidence interval was 0.92 - 1.08.
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Fig 9.3. Probit analysis was performed on the dolorimetry ratios in 26 patients
who had no evidence of algodystrophy or recent distal radial fracture. Since
the ratios, which were expressed as the score for the second hand examined
divided by the first, were normally distributed, the 95% confidence interval was
used to calculate the normal range for finger tenderness.
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iii) Discussion
In the normal population examined in this study, there was no increased
tenderness over the joints, unlike that described by Atkins et aL (1989). Kozin et al.
(1976) suggested however that the algodystrophic process was associated with a specific
Increase in tenderness of the joints rather as compared with the bones. Therefore
measurement of the joints alone would be sufficient to provide adequate data on the
amount of tenderness. In making these conclusions however, they may have
misinterpreted their data since the joints on the unaffected side were also more tender.
This was confirmed by Atkins et aL (1989) who showed that in patients with
algodystrophy, although the joints were more tender than the phalanx, there was
increased tenderness throughout the affected side when compared with the normal
side.
The reproducibility of the technique could also be further improved if all sites on
the hand were used and increased further still if the ratio of the scores rather than the
absolute measurements were used. This contrasts McCarty et aL (1965) who suggested
that the absolute dolorimetry reading alone was highly reproducible. This latter study
however was undertaken on rheumatoid patients with bilateral involvement of the
hands. Clearly a relapse in the condition would not alter the ratio of the scores but the
absolute score for each hand would decrease uniformly.
The precision of the technique using the ratio of scores for both hands is clearly
sufficient to enable the sequential evaluation of patients in a study of the natural
history of algodystrophy and their response to treatment with nasal calcitonin. It is
likely to be more precise than the semi-quantitative method described by Davidoff et al.
(1988).
As the distribution of the dolorimetry scores in the present study was normal,
the range of values for unaffected subjects was calculated as 0.92-1.08 using the 95%
confidence interval. This is not dissimilar to Atkins et at. (1989). Therefore one of the
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clinical criteria used to assess the presence of algodystrophy was a dolorimetry score of
less than 0.92.
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B. Vascular and Sudomotor Instability
Techniques such as thermography (Perelman et aL 1987), oscillometry (Scheibe
1969; Renier et aL 1973), ultrasonic (Doury et aL 1981) and laser Doppler angiography
(Cochrane et aL 1986), and galvanic skin reflex (Wang 1985) have been used to
investigate alterations in the microcirculation or sweating and may be of use therefore
to investigate the natural history of algodystrophy and it's response to treatment. They
are of little value however, for screening a population for evidence of algodystrophy as
they are too time consuming.
In the absence of a rapid, objective method of assessing vascular or sudomotor
instability, a modification of the questionnaire described by Atkins et al. (1990) was
used to define the presence of an abnormality.
I) Method
Vascular instability in algodystrophy manifests itself as a change in skin colour,
a temperature change, or an abnormal response to changes in environmental
temperature. Sudomotor instability presents as increased or decreased sweating in the
affected limb. The questionnaire was designed to record features in the affected hand
which did not occur on the opposite side or before the Cones' fracture. To decrease
observer bias as much as possible, the same standard questions were read out to the
patients before any other clinical information was sought. The questions asked were as
follows:
1) Have you noticed any change in the colour of your hand since the accident?
If yes - red or blue?
2) Has the temperature of your hand felt in any way different from the other since
the accident?
If yes - hot or cold?
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3) Has your hand responded differently to changes in the temperature since your
accident?
4) Has your hand sweated more than it used to since the accident?
5) Has your hand felt clammy since the accident?
Originally the patients were asked lithe features they described were getting
better or worse on subsequent visits. It quickly became apparent however that they
found it difficult to recall this information and it would have been of negligible
statistical value.
The hands were also examined for clinical evidence of vascular instability in
addition to swelling, dysthesia and shiny skin. The examination took place immediately
after the questionnaire, ensuring that the techniques used to measure tenderness or
hand volume did not affect the clinical signs. The features were recorded as follows:
1) Dysthaesthesia	 Yes	 No
2) Oedema	 Yes	 No
3) Shiny skin	 Yes	 No
4) Altered colour	 Yes	 No
If yes:	 Red	 Blue.
5) Altered temperature 	 Yes	 No
If yes:	 Warmer	 Cooler
ii) Discussion
Other than using the more invasive techniques described earlier, there have
been no attempts in the literature to quantify vascular instability on purely clinical
grounds. Indeed some studies of treatment efficacy disregard it completely. Although
subjective, the standardised questions and the simple yes or no answers used in this
study were designed to limit the observer's influence on the results. The questions also
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gave information concerning the different features of vascular instability and not simply
it's presence or absence.
Although it is difficult to prove the validity of such an examination there were
certain indications that it was of value. All patients who had other features of
algodystrophy such as pain, abnormal tenderness, swelling and stiffness replied
positively to at least part of the questionnaire, indicating the presence of vascular
Instability. This contrasts with the majority of patients following a Colles' fracture with
no evidence of algodystrophy who denied any problem. These findings will be described
in more detail in chapter 15. Occasionally patients with algodystrophy were relieved
they had been questioned on signs and symptoms that they did not understand and
were grateful to discuss them.
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C. Swelling
As with the assessment of vascular instability, a rapid and reproducible method
of recording changes in hand volume was sought. Two previously described methods;
hand volume measurement (Stenberg et al. 1980; Davidoff et aL 1988) and digital
circumference (Wilkins et al. 1974; Kozin et al. 1974) were further investigated.
i Method
The presence or absence of swelling on questioning the patient and on
examination were recorded in addition to a quantitative method of assessment.
a) Hand volume
A two litre perspex cylinder with a centimeter scale on the side was used for the
measurement of hand volume (Fig 9.4). The cylinder was sufficiently spacious to
comfortably immerse the hand in the position of rest. The cylinder was half-filled with
warm water and the level of water recorded before each examination. Extremes of
temperature were avoided as this might have exacerbated the symptoms due to
algodystrophy in those affected. The patient was asked to stand and place their
unaffected hand in the water keeping the hand completely relaxed. The observer
steadied the hand by gripping the distal forearm and lowered the hand until the water-
level reached the distal wrist crease (Fig 9.5). A reading was then made from the
centimeter scale on the cylinder. The same procedure was then performed with the
affected hand. The volume of each hand was then calculated as the volume of water
displaced, the whole procedure took 1-2 minutes.
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Fig 9.4. A two litre perspex cylinder, half filled with water, was used to measure hand
volume. The hand was immersed in the water and the amount of displacement
measured off a centimeter scale.
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Fig 9.5. The hand was immersed until the water level reached the distal wrist crease.
This anatomical landmark was constant and distal to the fracture site therefore
avoiding swelling of the fracture site itself.
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b) Digital circumference
The instrument used to measure digital circumference was similar in principal
to that described by (Wilkins et al. 1974) but measured three sites rather than one Fig
9.6). At the upper end of the instrument there is a groove where the finger is placed
over which are three aluminium strips. The strips are incorporated into a scale
measuring arbitrary units which runs down the length of the instrument. At the end of
each strip is a marker indicating the point on the scale at which to take the reading.
Attached to each of the markers is a lightly coiled spring which, at rest, maintains the
markers at zero. At the base of the three markers traversing the scale is a bar which
when pushed moves the markers along the scale, tenses the spring and loops the
aluminium strips over the groove for the finger. The finger is then inserted into the
groove with the instrument held on it's dorso-medial aspect (Fig. 9.7) preventing flexion
of the finger. The springs are then relaxed which applies tension in the three
aluminium strips over the finger. A reading can then be made off the scale for each
aluminium strip. Difficulty was encountered when centering the strips over the distal
interphalangeal joint as the distal phalanx was often too narrow to register on the
instrument. Similar difficulties were also encountered when measuring the little finger
even with the strips centered over the proximal interphalangeal joint (PIPJ). It was
therefore decided to measure the diameters of the proximal and middle phalanx and
PIPJ of the index, middle and ring fingers of each hand with the middle strip centered
accurately over the PIPJ. The normal hand was measured first.
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Fig 9.6. The arthrocircometer was used to measure digit circumference at the proximal
phalanx, proximal inter-phalangeal joint and middle phalanx of the index, middle and
ring fingers.
"446111116-
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Fig 9.7. The finger was inserted into the groove on the instrument and the aluminium
strips tightened over the three measurement sites. The degree of swelling at the three
sites was measured in arbitrary units off a scale on the body of the instrument.
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c) Patients
The reproducibility of hand volume measurement was studied in 24 female and
2 male patients with a mean age of 64 + 3.5 years. They were the same patients used to
assess dolorimetry. The age range and sex ratio were similar to those expected in
patients with Colles' fracture. They were all hospital in-patients with no recent history
of a distal radial fracture and no evidence of algodystrophy in the upper limb.
Hand volume and digital circumference measurements were repeated after an
interval of 24 hours without reference to the previous days score. As the dominant side
may have conceivably been larger, this was recorded for later evaluation. The statistical
methods were the same as those used in the reproducibility studies on dolorirnetry.
ii) Results
a) Hand volume
The measurement of hand volumes for both the absolute measurements and
ratios were highly reproducible (Table 9.2). Not surprisingly there was a large
population variation in the absolute measurement of hand volume for both the
dominant and non-dominant hand (standard deviation (SD) 62.3 and 60.7 respectively).
This population variation was reduced considerably if the ratio of dominant to non-
dominant hand was used (SD 0.03). The dominant hand was neither consistently nor
significantly larger than the non-dominant hand, and in order to avoid any spurious
but statistically significant swelling, two ratios were calculated for each pair of
measurements, dominant to non-dominant and non-dominant to dominant. All the
ratios were then summed which gave a mean of 1.00, as expected, and SD of 0.05
which was slightly greater than the SD based solely on the dominant to non-dominant
ratio (Table 9.2). Probit analysis of the ratios showed them to be normally distributed
(Fig 9.8). The normal range for dominant to non-dominant, using the 95% confidence
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interval, was calculated as 0.90 to 1.10 (mean +2 SD). From the reproducability of the
measurement (5%), a 10% change in hand volume in an individual would therefore be
likely to be a significant (p < 0.05) change.
4-01
.5
0
2
0
g
.g	 In	 11)	 Cn 	 CV
O >	 a).	 .41	 ,c14	 6	 0TS	 0	 co	 ,—,	 ,—,	 r-4	 r-I
0
O 0,	 10	 N.*	 CO	 CD
O 0	 r-(	 rl	 cq	 —1
.....	 al
ci	 c:5	 0i	 c:i-pm;	 a u)
@
-0	 . if)as q	
—1N.
r-4 	 r-I	
rlCCO
v-I
O r-I	 .1	 r-;	 I-I	 r-I10
tid0
4•••A
ig
1.4
ai
'C
g
4
>
C.)
CV
0,
,--i
a)
ri
t!
CO
M.
cl
-1I
(2°.( 0
..5
a)
0
0
0
-a
>
iz,
-N
4-•
g n
co
N.
0
co
t,
lq
•:14
f-4
c0
u,
r-4
N.
cii
r-I
co.
co
t,
a.) g 0' o 0 6 CD CO If). t'
4
''-'0
0
0
as(I) N.CV CtiCO COCO .:NCV
-4
0)
a.)
+4
Z
a)
to_ca)
4-•
a)
a)
a)
E
itA8
co
cc: > CI CI 0.
cl
1:$ 41.)
.5
'0
0
cO
4
4-•
0
0
CO
cf,
csi
N
cl
t;
If)
0.
cD
,--1
cl
CO
co
cc )
CV
Z.'
=
g cr) co
rl r-I .1 Tt,
1:f
a.)
2
a.)
a)
4
C.)
0
.0
o
.00A
0
CI1
cl)
0
CI
•—n
0)
Cs1
Cs!(0
CO
C.
CO01
N.
N.
cl
0)
r-1
0
,--1
a)
Pi
a)1..,
2
a.)
cu
as
(.4
c.)
Q
a)
(I)
as
4
To'
.5
T1
a)
'-'
u.)
cuim.,
V
a)
0
v)
ct
a)
as
g
111
I>
V
g
w
1-4
"g
61
a)
'a
.5
a)
761
TS
"d
11.)
1°
il
E2
•
•
•
•
1	 1.03	 1.06	 1.09	 1.12	 1.15
Hand volume ratio
Fig 9.8. Probit analysis was performed on the hand volume ratios in 26 patients
who had no evidence of algodys trophy or recent distal radial fracture. Since
the ratios, which were expressed as the score for the second hand examined
divided by the first, were normally distributed, the 95% confidence interval was
used to calculate the normal range for hand volume.
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b) Digital circumference
The measurement of digit circumference was a less reproducible than
measurement of hand volume, particularly the ring finger. The most reproducible
measurements were on the absolute values for the middle finger but with a wide
standard deviation of the population (Table 9.2). The most reproducible measurement
for the ratios (where there was less variation between measurements) was for the total
score (coefficient of variation for paired measurements - 10%; Table 9.2). Therefore to
be of value in detecting changes in finger swelling in an individual, there would have to
be a 20% change in size. As with the hand volume measurements the dominant was
not significantly or consistently larger. As the ratios were normally distributed (Fig 9.9),
the normal range for the ratio of dominant to non-dominant hand total scores using the
95% confidence interval (mean 1.00 + 2SD) was calculated as 0.78 - 1.22.
Using simple regression analysis, there was no siginificant correlation between
the hand volume ratio and digital circumference for the index, middle, ring or all three
fingers.
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Fig 9.9. Probit analysis was performed on the grip strength ratios in 26
patients who had no evidence of algodystrophy or recent distal radial fracture.
Since the ratios, which were expressed as the score for the second hand examined
divided by the first, were normally distributed, the 95% confidence interval was
used to calculate the normal range for grip strength.
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iii) Discussion
The requirements of the measurement of hand volume to be faced in the fracture
study were that it should be accurate, simple, painless, convenient, noninvasive,
inexpensive and reproducible. In fulfilling these criteria it would be of value not only as
a research tool but in normal clinical practice.
Water displacement has been used by a number of authors as a method of
assessing changes in hand volume over time (Stenburg et al. 1980; Wilson-MacDonld et
aL 1984; Davidoff et al. 1988) and all claim good reproducibility. Davidoff et al. (1988)
claimed a difference of greater than 5% between the affected and unaffected to be
abnormal. Stenberg eta! (1980) used a modification of a test used to measure changes
in limb oedema in the rat (Kishore et a 1976). This involved filling a container to the
brim, immersing the hand and measuring the amount of water displaced in a separate
container. Although accurate, this method was more time consuming and
inconvenient.
Davidoff et a (1988) used a technique identical to that described in this study
except in the identification of the end-point for the depth of immersion of the hand.
They used the tip of the ulna styloid which can be difficult to accurately identify and
may lead to spurious changes in volume when taking serial measurements. I used the
distal wrist crease as this is easily identified, does not change position with time and is
distal enough to exclude any changes in volume attributable to resolution of fracture
swelling.
Not surprisingly there was a large coefficient of variation in the volume of hands
measured (dominant 21.7%; non-dominant 21.4%) and therefore using the ratio of one
hand to the other (coefficient of variation - 2.9%) would be a more representative
assessment of changes in hand volume with time and for comparison with other
patients. The technique was highly reproducible with a coefficient of variation for
paired measurements of 3.8% using the ratio of dominant to non-dominant hand.
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Although the mean value for the dominant hand was slightly larger, this difference was
not significant. In the fracture study the volume ratio will be expressed as the affected
to unaffected side because the affected hand is not always the dominant hand, the
calculation of the normal range based on the dominant to nondominant may introduce
a spurious difference. It was therefore decided to use two ratios for each pair of
measurements, dominant to non-dominant and non-dominant to dominant, which were
then summed. This provided a mean of 1 but a slightly larger SD due to the wider
distribution of the ratios around this mean and therefore a slightly wider normal range.
The normal range for hand volume ratio lay between 0.90 - 1.10 (mean 1.0 + 2 SD).
The method of measuring digital circumference was a modification of the
arthrocircometer used by Willkens et a/. (1973) which was described for use in
rheumatoid arthritis. These instruments are a development of the jeweler's rings
(Heyman 1974) or jeweler's tape (Kozin et al. 1976). The advantage of the instrument
used in this study is that three measurements can be made at once, theoretically
cutting the time taken for the examination by one third. Technical problems with the
instrument used in this study prevented it's use in measuring the distal interphalangeal
joints and the joints of the little finger.
There was however a larger variation in the digital circumference than hand
volume ratios giving a wider normal range of 0.78 - 1.22. The technique was also less
reproducible than the measurement of hand volume (coefficient of variation of 10%). As
a 20% change in digital circumference was required to be significant in individuals, it
was decided not to use this method of assessment. The measurement of hand volume,
which was more reproducible with a narrower normal range, was selected for use in
subsequent studies.
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D. Function
Although Atkins et a/. (1989) described a syndrome of pain, stiffness, vascular
Instability, and swelling, which would be consistent with a diagnosis of algodystrophy,
there was no formal assessment of hand function. It is also unclear whether the
presence of these features indicate future functional impairment. For this reason the
functional outcome was investigated by measuring grip strength, the presence of finger
stiffness and a functional score.
Method
a) Grip strength
The grip strength was measured using a purpose built instrument measuring in
pounds/inch2 (Fig 9.10). The patient held the bulb of the instrument in the unaffected
hand with the dial facing the observer and, when instructed, made a power grip. The
maximal deflection was then recorded. This was repeated three times and an average
score calculated. The procedure was then repeated on the affected hand.
To test the reproducibility and calculate the normal range, grip strength
measurements were performed on the same population used in the evaluation of
dolorimetry, hand volume and digital circumference. Their grip strength was then
remeasured 24 hours later without reference to the previous results. The normal range
and coefficients of variation were calculated as previously described.
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Fig 9.10. The grip strength was measured on a guage measuring pounds/inch2.
Using a power grip, the patient squeezed the rubber bulb, with the guage facing the
examiner. The maximum deflection on the meter was recorded for three attempts and
the mean value used in further calculations.
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b) Stiffness
At each visit the patients were asked if they experienced any stiffness specifically
In the fingers at any time during the day. Care was taken to avoid confusion with wrist
stiffness. If stiffness was a daily occurrence, even if only transient (ie. early morning)
and occurred only in the affected hand, it was recorded as a positive feature. Originally
a visual analogue scale was used to grade the degree of stiffness but, as with the pain
visual analogue scale, this was abandoned as the patients did not fully understand the
meaning of the request and each examination became too time consuming.
c) Functional score
The scoring system was based on that described by de Brujn (1987) (Table 9.3).
It takes into account complaints, motor function of the hand (including % grip strength
compared with the normal hand) signs and symptoms and the cosmetic result. The
penalty score assigned to the findings was based on the guidelines of the Committee on
Medical Rating of Physical Impairment (1958). The maximum score possible is 132 with
the majority provided by the assessment of the motor function of the hand (72) and
complaints (44); signs and symptoms (11) and cosmetic appearance (5) provide the
remainder. The "subjective judgement of the end result" was scored 5 if the patient
complained of impaired function only during heavy work or excessive movement; and
10 when there was impaired function of daily life activities or if the general way of life
was affected. "Open question for complaints" was the only parameter available for
registering more minor dissatisfaction with the end result which did not include pain or
Impaired function (a, b, c and h). The assessment of the cosmetic appearance took into
account not only features attributable directly to the fracture, such as prominence of
the ulna head or dinner-fork deformity, but also the soft tissue changes seen in
algodystrophy.
MOTOR FUNCTIONS OF THE HAND
grip power
making a fist
finger extension
opposition
opening a door
weight lifting
picking up a pen
crumpling a piece of paper
lifting a cup and saucer
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Table 9.3. Scoring system for the clinical evaluation of the functional result.
score
COMPLAINTS
a. pain while resting	 10
b. pain while moving	 8
c. pain during heavy work/excessive motion (if b=0)
	 4
d. numbness or paraesthesia in the fingers
	 3
e. restricted daily basic life activities	 10
f. pain while wringing out cloths (if b+c=0)
	 3
g. loss of power	 3
h. subjective judgement of the end result
	 5 or 10
I. open question for complaints (if a+b+c=0)
	 1, 2 or 3
0-40% 40-60% 60-80% 80-90%
8 5 3 2
8
8
8
abnormal impossible
5 8
5 8
5 8
5 8
5 8
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SIGNS AND SYMPTOMS
swelling of hand/fingers	 5
abnormal colour	 2
skin atrophy/hyperaesthesia/hyperhidrosis	 4
ulnar compression pain 	 2
Cosmetic appearance
	
2, 3 or 5
This system was used to assess the majority of patients suffering from
algodystrophy and a representative sample of patients without algodystrophy at six
months following their fracture.
Ii) Results
Both the absolute measurements of grip strength for the dominant and non-
dominant hand, and the ratio of dominant to non-dominant hand were highly
reproducible and slightly better for the ratio of measurements (Table 9.4; 8.3%). Not
surprisingly the grip strength of the dominant hand was greater than the non dominant
hand, though not significantly, which accounted for the mean value of the ratio of
measurements being greater than 1 (1.08). As in the calculation of hand volume and
digit circumference, this may lead to spurious differences as the affected hand may not
always be the dominant one. Therefore the ratios of dominant to nondominant and
nondominant to dominant were doubled up to give a mean of 1.0 and slightly larger SD
of 0.12. As this population was normally distributed (Fig 9.11), the normal range using
the 95% confidence limit was calculated as 0.76-1.24 (mean + 2SD).
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Fig 9.11. Probit analysis was performed on the grip strength ratios in 26
patients who had no evidence of algodys trophy or recent distal radial fracture.
Since the ratios, which were expressed as the score for the second hand examined
divided by the first, were normally distributed, the 95% confidence interval was
used to calculate the normal range for grip strength.
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Table 9.4. The grip strength (1b/in2) was measured in 26 control patients and
expressed as the mean, standard deviation (SD) and coefficients of variation (CV) of the
dominant, non-dominant and ratio of dominant to non dominant. Of the three, the
coefficient of variation for the ratio was marginally better.
Mean SD CV (%)
Dominant hand (1b/in2) 16 4.8 8.9
Nondominant hand (1b/in2) 15 4.9 8.4
Ratio 1.08 0.11 8.3
iii) Discussion
The hand and wrist are capable of performing a number of different types of
grips such as pinch grip, key grip, hook grip and power grip, necessary for
manipulating the environment. It is the loss of power grip, however that is most
frequently complained of and most frequently tested in the clinical setting as an
assessment of functional recovery. Previous studies have used a modified
sphygmomanometer (Lansbury 1960; Kozin et al. 1976; Atkins et cd. 1990) to assess
grip strength and were able to show significant differences between the affected and
normal side at presentation (Kozin et al. 1976; Atkins et al. 1990). It is unclear however
whether the technique is reproducible enough to detect serial changes in grip strength
In a longitudinal study. Indeed Atkins (1988), using the sphygmomanometer, found a
coefficient of variation for paired measurements of 17.8%, almost twice the figure in this
study. He also abandoned measurement of pinch grip as it was more time consuming
and even less reproducible than the measurement of power grip. The method used in
this study is therefore rapid and more reproducible than the modified
sphygmomanometer described in the other studies.
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Stiffness was difficult to assess as not all patients with symptoms of stiffness
had measurable clinical evidence of limitation of movement. In addition care was
needed to ensure that wrist stiffness, which may not be solely due to the development of
algodystrophy, was not confused with stiffness of the fingers. Patients found the
concept of a visual analogue scale to assess the degree of stiffness difficult to
understand as the stiffness often varied from day to day or even at different times
throughout the day. They also tended to mark the scale based on a global stiffness of
wrist and fingers rather than fingers in isolation. It was elected therefore not to pursue
this technique as a method of assessing stiffness. In view of these difficulties, no
attempt was made to assess the stiffness quantitatively or develop a scoring system
using a questionnaire. It was felt that similar problems in understanding the questions
would be encountered and the information yielded would not warrant the time spent.
The overall aim, as in the other methods of clinical assessment, was to develop rapid
techniques for use in the clinical setting. Therefore the presence of stiffness of the
fingers was recorded as a positive finding provided the stiffness was a daily occurrence
(even if for only part of the day) and was unilateral in nature.
Many different scoring systems have been developed to assess the functional
end result following a Cones' fracture, often as modifications of LidstrOm's (1959) or
Gartland and Werley's (1951) original descriptions. These systems frequently
concentrate on the range of wrist movement rather than hand function as a marker of
the end result. Hand function after Colles' fracture is seldom mentioned (Lucas and
Sachtjen 1981). For this reason part of de Brujn's (1987) scoring system, specifically
the assessment of motion in the wrist, was excluded to concentrate solely on those
features dealing with the function of the hand.
It is recognised that the functional end result following a Cones' fracture can
only be judged from one year after injury (Flynn 1966; Solund et a/. 1983). Assessment
at one year however, may miss any functional impairment due to the milder forms of
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algodystrophy described by Atkins et cil. (1989). Since a major aim of this thesis was to
study the early natural history, it was decided to assess the patients with algodystrophy
functionally at six months and compare this to a matched group of patients with Cones'
fracture but with no evidence of algodystrophy. It would have been too time consuming
to use the scoring system at every clinical assessment. The measurement of grip
strength and stiffness were used as a crude assessment of function on a longitudinal
basis.
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CHAPTER 10: RADIOGRAPHY
The radiographic changes following algodystrophy were first recognised by
Sudeck in 1900, soon after the development of radiography as a diagnostic technique.
Since then there have been numerous reports on the various radiographic features but
with little attempt to quantify changes. Most reports concentrate on the qualitative
changes that occur and there is therefore only subjective data on the progression of
radiographic changes. Although these changes deal mainly with trabecular bone,
alteration in cortical bone has also been reported (Genant et a/. 1975; Kozin et a/.. 1976).
These radiographic changes are further complicated because the appearance of post-
traumatic algodystrophy may be similar to that of disuse bone atrophy (Steinbach 1964;
Jones 1969; Feist 1970).
A semi-quantitative scoring system was devised and tested from the radiographs
of the hand. The changes scored were based on the appearance of trabecular bone.
The use of metacarpal morphometry was also investigated as a means of assessing
progressive changes in cortical bone.
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A Scoring System
1) Method
Four prominent features were apparent at sites of trabecular bone on
radiographs of patients with post-traumatic algodystrophy. These comprised a
generalised loss of density, patchy radio-translucencies, subchondral radio-
translucencies and a loss of trabecular definition (Fig 10.1a-e). A semi-quantitative
four-point scoring system was then devised based on the presence of each of the four
features:
0	 absent
•
1	 borderline
2	 definite changes
3	 marked changes
The score for each feature was summed, and the final score expressed as the total of
the individual scores giving a maximum possible score of 12.
The system was then applied to the carpus and proximal metacarpal metaphysis
in patients with a Colles' fracture two weeks after removal of plaster. This area of the
wrist was chosen because it avoided the fracture site and would have been irmnobilised
equally in patients with or without features of algodystrophy, and therefore the degree
of bone atrophy due to disuse was likely to have been similar.
Forty-four patients with a Colles' fracture who demonstrated abnormal pain,
tenderness, vascular instability, swelling, and stiffness and were thus considered on
'clinical grounds to have algodystrophy, were included in this study. A postero-anterior
radiograph was then taken of both hands on the same film to allow accurate
comparison of the affected and unaffected hands. An identical procedure was carried
out on 33 patients with Colles' fracture who had no evidence of algodystrophy. The
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radiographs from both groups were then reviewed in a random fashion and scored
without knowledge of the clinical findings.
a) Reproducibility
To assess the intra-observer reproducibility. 36 of the radiographs were picked
at random and re-examined by the same person without reference to clinical details or
the previous score. The inter-observer reproducibility was assessed in a similar fashion
by a different observer. The coefficient of variation (%) for the paired measurements
was calculated as:
standard deviation of the difference x 100
mean
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Fig 10.1a-e. Radiogaphs of the carpus taken approximately seven weeks after Cones'
fracture showing varying degrees of severity of the four features examined in
algodystrophy. Each panel also shows the radiograph of the unaffected carpus taken
on the same plate at the same time. The patients shown in b-e all had clinical evidence
of algodystrophy.
a) This patient had no evidence of algodystrophy and apart from a definite loss
of density (right hand panel; grade - 2), there was no other radiographic features; total
score = 2.
b) In addition to a definite loss of density (left hand panel; grade - 2) there was
some evidence for increased patchy radiotranslucency (grade - 1) and loss of trabecular
pattern (grade - 1); total score = 4.
Fig 10.1a-e (cont.).
c) The right carpus showed loss of density (left hand panel; grade - 2), increased
patchy radiolucency (grade - 2) and loss of trabecular pattern (grade - 1), there was also
a "pencil line" appearance to the articular margin (grade - 1); total score = 6.
d) This radiograph showed a more marked patchy appearance of bone (right
hand panel; grade - 3), with loss of density (grade - 2), subarticular radiolucency (grade
- 2) and loss of trabecular pattern (grade - 3); total score = 10.
e) Radiograph showing the most marked changes with maximum scores for
each feature; total score = 12.
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11) Results
Both groups were matched for age (mean 63 + 7 years), sex (all female) and
period of time immobilised (mean 35 ±5 days). The coefficient of variation for the intra-
observer error was 14% which was slightly lower than the inter-observer error 17%.
The distribution has been represented in the form of a matrix to depict the variation
between the two observers (Table 10.1). On 15 (43%) occasions the radiographic score
was identical; on 18 (51%) there was a difference of one; and in the remaining three
(6%), there a difference of two.
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Table 10.1. Two observers were used to calculate the inter-observer reproducibility of
the radiographic scoring system which is explained in Fig 10.1. In this matrix, the
number of patients for each score is given for each of the individual observers.
Observer 2
Observer 1 0 1 2 3 4 5 6 7 8 9 10 11 12 Total
0 1 0 0 0 0 0 0 0 0 0 0 0 0 1
1 0 3 0 0 0 0 0 0 0 0 0 0 0 3
2 0 2 3 1 0 0 0 0 0 0 0 0 0 6
3 0 0 0 3 0 0 0 0 0 0 0 0 0 3
4 0 0 0 3 1 1 1 0 0 0 0 0 0 6
5 0 0 0 0 0 0 1 0 0 0 0 0 0 1
6 0 0 0 0 0 0 1 0 0 0 0 0 0 1
7 0 0 0 0 0 0 2 0 3 1 0 0 0 6
8 0 0 0 0 0 0 0 1 1 0 1 0 0 2
9 0 0 0 0 0 0 0 0 0 0 2 0 0 2
10 0 0 0 0 0 0 0 0 0 0 1 0 0 1
11 0 0 0 0 0 0 0 0 0 0 1 1 0 2
12 0 0 0 0 0 0 0 0 0 0 0 1 0 1
Total 1 5 3 7 1 1 5 1 4 1 5 2 0 36
119
ill) Discussion
With one observer performing all the measurements, there would have to be a
28% change in the score to be confident (p <0.05) of an apparent difference between
any two radiographs. This difference may appear large but is not unexpected
considering the semi-quantitative nature of the scoring system. A difference of one
point between any two radiographs immediately accounts for an 8% difference.
Therefore a difference of only three points between two scores would yield a statistically
significant disparity.
Genant et al. (1975) and Kozin et al. (1976) describe a patchy osteopaenic
appearance in algodystrophy which they define as generalised or juxta-articular and
quantify in a similar manner to this study. No attempt is made to examine the features
which contribute towards this patchy appearance. After personally reviewing
radiographs of disuse atrophy alone or combined with algodystrophy, it appeared that
the patchy appearance in algodystrophy was due to well defined radio-translucencies
and a subchondral radio-translucency which along with the generalised osteopenia
accounted for the alteration in trabecular architecture. An attempt was therefore made
to further quantify these features.
Originally this took the form of counting the number, or measuring the size of
the radio-translucent areas but this proved to be too imprecise a technique. It was
therefore elected to simply grade the appearance. Similarly the subchondral radio-
translucencies were difficult to quantify other than semi-quantitatively using a standard
radiographic technique. Even with the use of fine detail radiography, both Genant et al.
(1975) and Kozin et al. (1976) found similar difficulties and used a subjective method of
assessment. The osteopaenic appearance, radio-translucent areas and subchondral
radiotranslucency combine to alter the trabecular architecture which again was
assessed in a semi-quantitative manner.
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A critical analysis of the part played by each of the four individual features is
detailed, along with the scoring systems ability to discriminate between algodystrophy
and disuse atrophy, in Chapter 19.
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B. Metacarpal Morphometry
i Method
Metacarpal morphometry was performed on the same radiographs used in
evaluating the scoring system. As both hands were included on the same film, there
was no difference in magnification and therefore the affected hand could be directly
compared with the unaffected.
The technique used was based on Horsman and Simpson's (1975) six
metacarpal hand index used in quantifying osteoporosis. This is based on manually
measuring the combined cortical width of the index, middle and ring finger metacarpal
bones of both hands. The total width of the metacarpal and the width of the medulla
was measured at the mid-point of the metacarpal (Fig 10.2). The cortical width of the
metacarpal was then calculated by subtracting the total width from the medullary
width. This is then repeated on all six metacarpals and the cortical widths totalled to
give a six metacarpal hand index. The modifications used in this study relate to both
the method of measurement and the calculation of the final score.
The calculations of the mid-point of the metacarpal, the diameter, and radial
and ulna cortical widths were performed by computer soft-ware specifically designed for
this purpose with an Omega 2000 computer. The software also collected all the patient
data which could be exported to a data-base for further analysis. A further advantage
of the system was that it corrected for changes in magnification of the radiograph when
comparing sequential changes. The system stored the length of the metacarpal and
then compared this with subsequent measurements, correcting the measurement of
cortical width for changes in metacarpal length.
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Fig 10.2. Metacarpal morphometry was based on the measurement of cortical width at
the mid-point of the metacarpal. This was performed on the index, middle and ring
finger metacarpals.
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The radiograph was attached to an illuminated digitising tablet. Information on
the measurement points was transmitted to the computer by a handset which consisted
of an optical system with mounted cross-hairs and five buttons to relay the differing
information (Fig 10.3). The cross-hairs were used to accurately position the hand-set
and the position marked by pressing the appropriate button. After entering patient
information, the computer then prompted the user for the data required in a set order.
Initially the length of the metacarpal was measured by marking the distal and proximal
ends by appropriately positioning the cross-hairs. It then automatically calculated the
position of the midpoint of the metacarpal. It then prompted the user to trace the
outline of the outer edge of the radial cortex followed by the inner edge of the same
cortex. The distinction between the compact cortical bone and cancellous bone on the
endosteal surface was less obvious, particularly on the affected hand, due to the
irregularity of the surface (Fig 10.4). A consistent attempt was made however to
measure the edge of the cortex at the base of the irregularities, thus excluding the
apices of the saw-tooth appearance. Both cortical edges were then measured on the
ulnar aspect of the metacarpal. From this input the program then calculated the
diameter of the mid-point of the metacarpal and the width of the radial and ulna cortex.
The whole procedure was then repeated to include the index, middle and ring finger
metacarpals of both hands.
The original use of this technique was to provide a measurement of generalised
osteoporosis. Its use in this study was somewhat different in that it was attempting to
show a change in cortical width affecting one hand only. Therefore the calculations
were expressed to demonstrate the difference between the two sides. Rather than a
total six metacarpal hand score, the ratios of combined cortical width and the
percentage cortical width ([combined cortical width/combined diameter] x 100) of the
affected to unaffected hand were calculated. In addition the absolute values of cortical
and metacarpal width were also presented.
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Fig 10.3. The metacarpal morphometry was performed by a semi-quantitative
technique. The radiographs were mounted on an illuminated digitising tablet and a
hand set with mounted cross-hairs was used to record the position of either end of the
metacarpal and to trace the periosteal and endosteal border of each cortex. This
information was transmitted to a computer where the mid-metacarpal diameter and
cortical widths were calculated. This data was then stored for later analysis.
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Fig 10.4. In patients with algodystrophy, the endosteal border appeared particularly
Irregular. An attempt was therefore made to measure width at the base of the
Irregularities to represent the edge of the endosteal surface.
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a) Reproducibility
The reproducibility of the technique was based on sequential measurements at
the unaffected hand in patients with algodystrophy. These were taken at presentation
and at 12 weeks. The coefficient of variation for the paired measurements of combined
cortical width was calculated as previously described. The measurements were
expressed as + one SEM and any difference between groups assessed using an unpaired
Student's t-test.
in Results
There were 44 radiographs of patients with algodystrophy and 33 with no
evidence of algodystrophy (Appendix I). The combined cortical width, percentage
cortical width and metacarpal diameter of the unaffected hand in patients with
algodystrophy were almost identical to those of the unaffected hand in those with no
evidence of algodystrophy (Table 10.2). Because there was no difference in
measurement between these populations, it was assumed that measurements on the
unaffected hand were not influenced by the presence or absence of algodystrophy in the
contralateral hand. Indeed, though not significant, the combined cortical width and
percentage cortical width were slightly less in the group with no evidence of
algodystrophy. Therefore the measurements on the unaffected hands in both groups
were combined and the coefficient of variation calculated on the difference between the
measurements initially and 12 weeks later (Table 10.3). The techniques were highly
reproducible with coefficients of variation of 1.6% for the measurement of combined
cortical width and 1.7% for percentage cortical width.
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Table 10.2. Cortical measurements in the unfractured side in algodystrophic and
control patients. There was no significant difference between the mean (± SEM)
combined cortical width and mean a SEM) % cortical width in the unaffected hand on
the initial radiographs between patients with algodystrophy and the control population.
Algodystrophy Control
UNAFFECTED HAND Mean SEM Mean SEM
Combined Cortical Width (mm) 9.48 0.30 9.41 0.37
% Cortical Width 40.91 8.74 39.69 9.06
Metacarpal diameter (mm) 23.2 0.33 23.8 0.31
Number 44 33
Table 10.3. Mean and standard deviation of combined cortical width and percentage
cortical width for the initial radiograph and that at 12 weeks. Since there was no
difference between the algodystrophy and control group, they were combined and used
to calculate the reproducibility of the technique.
UNAFFECTED HAND
INITIAL
Mean SD
12 WEEKS
Mean	 SD
CV
0/0
Combined Cortical Width (mm)
% Cortical Width
9.90
41.44
2.27
9.73
9.80
40.66
2.04
8.44
1.6
1.7
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iii) Discussion
There are two main sources of error inherent in this technique. They are
measurement error, and errors associated with the radiographic technique.
Measurement variation arises in the assessment of the width of a cortex to two decimal
places which gives a variation of + 0.005 mm. In practice this is unlikely to be
significant as with the naked eye it is impossible to define such small dimensions. The
use of magnification to identify dimensions as small as 0.01 mm would only increase
the difficulty in identifying the endosteal border. This is a further source of error due to
the irregularity of the surface, particularly in the affected hand. Increased endosteal
resorption has been demonstrated on fine detail radiography by Kozin et al. (1976) in
patients with algodystrophy. Attempts were made to minimise this by taking the base
of the irregularity as the true endosteal border.
Errors in locating the same mid-metacarpal site in sequential radiographs was
minimised by the design of the software which relied on the observer simply identifying
the distal and proximal extent of the metacarpal. The distal end was easily defined as it
was the smooth articular surface of the metacarpo-phalangeal joint. The proximal end
was less easily identified due to the superimposition of the carpo-metacarpal joint lines.
In practice the most distal of the different articular margins was taken as the true
proximal extent. Even when measured by hand, the degree of error only amounted to
3% of total metacarpal length (Naor et a 1972) and is thus negligible. This error is
likely to be further reduced as the calculation of the mid-point is not directly operator
dependant.
Possible errors in radiography fall into three groups. Underexposed films may
make the cortical margins difficult to identify, an incorrect film-focus distance may lead
to errors in magnification and rotation of the hand may spuriously alter the cortical
dimensions. The first two errors are excluded by the standard radiographic technique
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employed in all the subjects. The error in rotation should be minimised by the
standardised manner in which the hand was positioned. With the hand flat on the
radiographic plate and the forearm in neutral rotation, it is difficult to rotate the hand
unless a conscious effort is made. There is a potential source of error however in
patients with algodystrophy who have a fixed flexion deformity of the fingers. This
could cause an increase in the magnification of the image as the palm is lifted off the
plate and a relative shortening of the metacarpal as the distal end is lifted up. This
error is largely negated as the computer soft-ware makes appropriate changes to the
calculation of the cortical widths when there is an apparent alteration in magnification
due to alteration in the length of the metacarpal.
Both Adams et al. (1969) and Naor et al. (1972) pointed out that morphometry
was less reproducible if the measurements were made over a long period of time. This
was probably due to the observer unconsciously altering his criteria of measurement.
In accordance with their recommendations, the measurements of all radiographs in this
study took place over a two week period to minimise this potential hazard.
The standard positioning and radiographic technique, with a computer based
calculation of the cortical widths including correction for magnification (the potentially
greatest cause of error in sequential measurements) considerably minimised sources of
error. The only real source of observer error, the identification of the endosteal border,
was minimised as much as possible by the short time period between measurements. It
Is therefore not surprising that the technique was a highly reproducible.
Metacarpal morphometry, as an indirect measurement of bone mass, was first
developed by Barnett and Nordin in 1960. The combined cortical thickness of the
second metacarpal was expressed as a percentage of metacarpal diameter at the same
site. It has since been used in a number of cross-sectional studies (Fujita et al. 1966;
Garn 1970) but due to poor reproducibility, little valuable information is available in
longitudinal studies. Adams et al. (1969) studied two replicate measurements of the
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2nd metacarpal on 86 films and found the coefficient of variation for the intra-observer
error to be 8-10% for the cortical width. A similar degree of measurement error for a
single estimation of cortical width was demonstrated by Naor et a/. (1972) but a
reduction in variation was obtained (6%) using the average of two independent
determinations rather than a single assessment. The technique was further refined by
Horsman and Simpson in 1975, measuring the middle three metacarpals on each had
in a rigidly standardised manner using needle-tipped Vernier calipers measuring to
within 0.05 mm. They calculated the cortical width of the six metacarpals and
expressed the metacarpal index as the mean of these six measurements. This
technique proved to be highly reproducible in their hands with a measurement error of
0.072 mm (2 SD). This allowed changes in cortical width of 1.5% to be detected with
95% confidence in a population of pre-menopausal women. As they pointed out, this
compared favourably with the precision of other methods such as photon
absorptiometry.
The reproducibility of the technique in this study (coefficient of variation - 1.6%)
is comparable to that of Horsman, using only the three metacarpals of the unaffected
hand. As one might expect, the reproducibility of the percentage cortical width was
slightly worse (1.7%), since another potential variable (metacarpal diameter) is involved
in the calculation. Using Horsman's method of measurement, Aitken (1984) also found
the percentage cortical width less reproducible (3%) so there would therefore appear to
be little potential benefit in this method of calculation.
There was no difference in the cortical width of the unaffected hand between
patients with algodystrophy and the control population. This suggests that the
algodystrophic process does not result in changes in cortical bone measurable by this
technique on the unaffected side. This finding is contrary to that of Genant et aL (1975)
who used the 2nd metacarpal index in a study of 7 patients. They maintained that
there was a decrease in the cortical width of the unaffected side of the contralateral
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limb by comparing their values to those quoted by Garn et al. (1971) for the normal
population. Their numbers were small and they should have used their own control
population to make a more valid comparison.
Metacarpal morphometry appears therefore to be a reproducible method of
assessing cortical bone. A 3% change in combined cortical width would be sufficient to
show a significant (p < 0.05) change in an individual. When used with the scoring
system previously described, it was hoped to describe the natural history of the
radiographic changes in both cortical and trabecular bone due to algodystrophy
(Chapter 24).
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CHAPTER 11: SCINTIGRAPHY
Bone scintigraphy is a valuable diagnostic tool for the early diagnosis and follow-
up of several articular disorders. It's use in the early diagnosis of algodystrophy has
been demonstrated by a number of authors (Doury et al 1979; Renier et al. 1979; Kozin
et a!
 1981; Mackinnon and Holder 1984; Constantinesco et al 1986) but without
standardising the population studied nor time from the initiating event. We have
shown, in a study examining the uptake following a Colles' fracture in patients with and
without evidence of algodystrophy, that there is still increased isotope uptake in the
control group three months after the fracture (Atkins et a/. 1990). It is questionable
therefore to what extent increased isotope uptake in algodystrophy is due to fracture,
simple disuse atrophy or to a factor inherent to the algodystrophic process. Accordingly
there may be a source of confusion in the diagnosis of post-traumatic algodystrophy
based on scintigraphy.
Scintigraphy not only analyses the bone fixation but includes the study of early
bone scans which can be termed the "vascular phase". Conventionally, the interest of
bone images is essentially diagnostic while the interest of the vascular images are more
specifically pathophysiologic. In our own studies we intended to examine both images,
to test their ability to differentiate between disuse and post-traumatic algodystrophy at
an earlier stage in the disease than has been previously attempted, and to study the
resolution of the scintigraphic uptake with time. Patients with hemiplegia were also
studied to further delineate the part played by disuse atrophy in the scintigraphic
findings of post-traumatic algodystrophy.
i Method
An intravenous cannula was inserted into the unaffected ante-cubital fossa
without the use of a tourniquet. The isotope scan was performed using a large field of
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view gamma camera equipped with a high resolution parallel hole collimator. Each
scan was carried out as a two stage procedure as mentioned previously. The early
Image or "vascular phase" consisted of four sequential 100 second images of the hands
and forearms in anterior view, obtained immediately after a rapid bolus injection of 400
MBq of technetium 99 labelled methylene diphosphonate into the intra-venous cannula.
The delayed image was taken of the hands, wrist, elbow and shoulder of both the
affected and unaffected limb four hours after injection. In addition to analogue display
on radiographic film, each image was stored in digitised form in a 128 x 128 array using
a Nova series minicomputer equipped with colour display and facilities for region of
interest analysis.
Quantitative analysis of the digitised anterior view of the hands on the delayed
image was undertaken to assess the relative uptake of the isotope into the metacarpo-
phalangeal joints (MCPJ) on the affected and unaffected sides (Fig 11.1). The isotope
uptake, or metacarpal score, was then expressed as the ratio of the counts in the
affected ROI over the unaffected:
ratio =  counts affected 
counts unaffected
To standardise the areas measured a grid was made over the ROI using the
computer soft-ware. It was not possible to use a fixed grid size on all scans due to the
variation in the size of the image from patient to patient. Also, in cases with markedly
Increased uptake, there appeared to be a "spill-over" of tracer uptake outside what
would be considered the region of interest. Ignoring this "spill-over" would
underestimate the magnitude of the isotope uptake. Therefore the size of the ROI to be
measured was defined manually for each individual patient, and an attempt was made
to use the same sized grid on the unaffected hand. To exclude any small variation in
the size of the ROT between the affected and unaffected side, a scaled ratio was then
calculated taking into account the size of the (ROT):
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• scaled ratio = counts affected
	
x	 ROI size unaffected 
ROI size affected
	 counts unaffected
lithe areas of interest are identical, they automatically cancel themselves out, leaving
the calculation for the ratio.
Scintigraphic examinations were performed on 43 algodystrophy patients and 10
patients with a Colles' fracture but no evidence of algodystrophy who were also age and
sex matched (Appendix I) two weeks after removal of plaster, at the same time as the
other initial assessments. The examination was then repeated after a 12 weeks interval
in those patients with algodystrophy.
Patients with a dense hemiplegia after a cerebro-vascular accident (CVA), such
that there was no active movement in the affected limb, were asked to participate in a
study examining the scintigraphic findings following complete disuse. As there is a
recognised high incidence of algodystrophy following CVA (Chapter 2), every effort was
made to exclude patients with the appropriate symptoms or signs bearing in mind their
altered perception of pain. Those patients who appeared not to have algodystrophy
were scanned at approximately 7 weeks after the CVA, an identical time to the fracture
study group. Only the delayed scans were performed in these patients.
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Fig 11.1. The activity on the delayed phase of the isotope scan was calculated as the
ratio of counts in the affected metacarpo-phalangeal joints over the unaffected and
expressed as the metacarpal score.
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ii) Results
To identify to what extent the size of the region of interest was affecting the
results, the scaled ratio was divided by the ratio:
counts affected	 x	 ROT size unaffected 
ROT size affected
	 counts unaffected
counts affected 
counts unaffected
which resolves to:
ROT size unaffected.
ROI size affected
If the size of the ROI was the same for the affected and unaffected side, the result
should be 1.0 and therefore the calculation for the ratio would be as valid as the scaled
ratio. As a difference in the range of interest was only likely to be introduced in
conditions where there was markedly high uptake, this was only calculated for the
patients with algodystrophy. Including the Colles' control patients would have masked
any true discrepancy in the size of the ROT.
The mean of the scaled ratio/ratio was 0.97 (SD - 0.11). Therefore the size of
the ROI was on average estimated as 3% larger on the affected side. This was by no
means consistent however in view of the relatively large standard deviation (0.11). The
difference in the ROI therefore accounted for only a 3% disparity between the scaled
ratio and the ratio. Therefore as the underestimation of the degree of "spill-over"
described earlier was negligible, the metacarpal score was based on only the absolute
ratio of the uptake in the affected to unaffected hand.
Ten patients with a Colles' fracture but no evidence of algodystrophy underwent
Isotope examination. The mean metacarpal score was 1.14 + 0.04 with a range from
1.02 - 1.35.
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iii) Discussion
Attempting to standardise the ROI does not confer any benefit as there is little
difference (3%) between the counts ratio with and without correction for the area
Involved. The metacarpal score was therefore calculated on the basis of the number of
counts alone. Theoretically this may have been influenced by a "spill-over" from the
fracture site on the affected side making the metacarpal score spuriously high.
In an earlier study using a similar patient group and method of quantitation
(Atkins et aL 1990), the mean score for the control population was 1.08 + 0.11, 14
weeks after fracture and included scores ranging from 0.7 - 1.6. In some patients, the
uptake in the affected side was therefore less than the unaffected side. In this study
the mean ratio was higher (1.14 + 0.04) and in all patients the uptake in the affected
side was always greater than 1. This is likely to be due to the earlier time after fracture
In the present study and therefore the increased scintigraphic uptake due to disuse
atrophy would be more marked. This highlights the difficulty in relying solely on the
delayed scan in the early diagnosis of post-traumatic algodystrophy. Between 7 and 14
weeks the ratio improved by an increment of approximately 0.01 per week. At that rate
of improvement, there would be no detectable difference between the affected and
unaffected sides at approximately 23 weeks after fracture provided the recovery was
linear (Fig 11.2).
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CHAPTER 12: DENSITOMETRY
Apparent loss of bone density is a notable feature of algodystrophy on
radiographs, but this does not provide a quantitative assessment of bone mass which is
needed in evaluating the natural history of the condition or it's response to treatment.
A variety of noninvasive techniques are currently available for the assessment and
measurement of bone mass or bone mineral content. Some of these, such as
radiogrammetry and radiographic photodensitometry, while well established and
technically straightforward, have significant methodological problems that are reflected
in poor measurement precision. Others, such as neutron activation analysis, have been
developed and performed in research centres for many years, but are unlikely to be
widely implemented because of their high cost and technical complexity. Recent
advances in technology however, have presented accurate bone mass measurements in
a clinical setting. These techniques include single and dual photon absorptiometry. As
single photon absorptiometry is routinely used in appendicular sites it seemed
appropriate to investigate the use of this technique to measure changes in bone mineral
density due to algodystrophy.
i Method
The single photon absorptiometry (SPA) scanner used was the Nuclear Data ND
1100. This instrument uses a low photon energy of 27.5 key from it's 131 1 photon
source. The low energy provides maximum contrast between bone and soft tissue,
although the high attenuation produced by all materials at these energies effectively
limits usefulness of this technique to appendicular body sites such as the distal radius.
The bone mineral content was measured directly by determining the attenuation
of the photon energy as it passed through bone. The changes in transmittance, which
are proportional to the mineral mass in the scan path, were measured by a scintillation
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detector. Difference in soft-tissue thickness alone produce transmitted-beam intensity
variations, hence the total thickness of tissue traversed by the beam must be
standardised. This was done by positioning the arm in an acrylic reservoir filled with
water so that the only remaining variable at each measurement point was the bone
mass present in the beam path. The data from each scan was automatically transferred
to a Hewlett-Packard computer with standardised software. This permitted
communication between the instrument and the operator via the keyboard, automatic
calculation of bone mineral content and density, graphical display of the data on the
monitor and a hard copy of the data on a print-out.
The scanner we employed was usually used for measurements at the distal
forearm and therefore this standard technique will be described first to highlight the
modifications made for this study. To prevent errors in repositioning, the patient
grasped a handle in the reservoir using a power grip which automatically positioned the
arm (Fig 12.1). An 8 mm gap between the radius and ulna was then identified
automatically by the computer software and subsequent scans, proximal and distal,
were started from this point. After the scanner had located the start position it moved 8
mm distally from the start position. It then performed four scans, 2 mm apart, moving
In a proximal direction (distal; scans 1-4), followed by a further six scans 4 mm apart
(proximal; scans 5-10) giving a total of 10 scans. Based on the degree of attenuation of
the beam, the software calculated the bone mineral content (BMC; corrected for fat in
the forearm) and the bone mineral density (BMD; BMC/bone width) for both the
proximal and distal scan sites.
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Fig 12.1. The single-photon scanner as usually used to measure bone mineral content
at the distal radius and ulna. As a means of standardising the position of the wrist, the
patient grasps a handle within the water bath.
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Fig 12.2. The water bath on the single-photon scanner was altered for the purpose of
this study. Grasping the handle, as is standard in distal forearm measurement, would
have obscured the metacarpals and therefore the bath was lengthened and the handle
moved distally. The patient could then hook their fingers around the handle which
allowed free access to the metacarpals.
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The forearm was unsuitable in this study due to the site of the fracture. Any
data reflecting demineralisation due to algodystrophy may have been masked by
fracture callus giving spuriously high results. The standard measurement technique
described above was therefore altered to measure the 4th and 5th metacarpals.
Grasping the handle in the reservoir as described above would obscure the
metacarpals and prevent their accurate measurement. The reservoir therefore, was
adapted to allow the fingers to hook over the handle (Fig 12.2) maintaining the hand,
and therefore the metacarpals, in the photon beam. When the hand was scanned in
this position, the computer automatically interpreted the 4th and 5th metacarpals as
the ulna and radius respectively. It also searched for an 8 mm inter-osseous gap
which, if found at all, was mid way along the diaphysis of the bone and not at the
Junction of the metaphysis/diaphysis as was intended. Therefore a method of
accurately repositioning the hand was sought. Scans of the proximal metacarpal would
have been ideal as, similar to the reasoning with the radiographic assessment of
trabecular bone, this area is immobilised equally in patients with or without
algodystrophy. Unfortunately no reproducible starting point to scan this area seemed
apparent. The distal palmar crease did however provide an anatomical landmark which
could be used as a starting point to scan the distal metacarpal. This was a constant
anatomical feature (Fig 12.3) over the distal metaphyseal/diaphyseal junction (Fig
12.4). The scanner was therefore aligned optically over this flexor crease for it's first
scan. Although the inter-osseous gap at this point is less than 8 mm, the computer
soft-ware was overridden to accept this position. Subsequent scans were performed
both distally (through mainly trabecular bone in the metaphysis) and proximally
(through mainly cortical bone in the diaphysis) from the skin crease to provide data on
the BMC and BMD of the 4th and 5th distal metacarpal.
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Fig 12.3. The distal palmar crease on the ulna aspect of the hand was the anatomical
landmark used as the starting point for the distal and proximal single-photon scans.
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Fig 12.4. A marker was placed on the distal palmar crease prior to the radiograph
being taken. The marker lies over the junction of the distal metaphysis/diaphysis.
Therefore single-photon scans distal to this point were through trabecular bone and
proximal scans through cortical.
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The scans were performed, as in the other initial assessments, 2 weeks after the
plaster had been removed. The scans were then performed at monthly intervals (Table
8.3). Twenty-nine patients with algodystrophy and 23 control patients were assessed,
all of whom also had radiographs taken at the same time and were used in the
radiographic assessment (Chapter 10).
a) Reproducibility and Normal ranges
In order to assess the reproducibility and calculate the normal range of BMC
and BMD, 18 female and 3 male patients with a mean age of 61 + 5 years were studied.
They had no evidence of algodystrophy in the hand and no recent fracture of the distal
radius. A single photon scan was performed on both hands as described above. This
gave a value for the BMD and the BMC for both the distal (trabecular bone) and
proximal (cortical bone) scans, a total of four measurements on each hand. The scan of
the dominant hand was then repeated a day later without reference to the previous
day's scores. To prevent errors due to deterioration in the source or operator error, the
ratio of the dominant hand to nondominant was also calculated and used to calculate
normal ranges rather than the absolute values. This has a further advantage in the
fracture study as the unaffected hand is used as an automatic control.
The coefficient of variation of the paired measurements was used to assess the
reproducibility of the technique. The distribution of the ratios at each site were
investigated using Probit analysis and the significance of the difference between ratios
assessed using Students' t test. The normal range (mean ±2 SD) was then calculated
for the most reproducible technique at each site.
ii) Results
Coefficients of variation were calculated for the BMD and BMC at each of the two
sites (Table 12.1). Although there was little difference, maximal reproducibility was
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achieved measuring BMD at both the proximal (4.2%) and distal (4.4%) sites and
therefore the BMD measurement was used in the further analyses.
The mean measurement were slightly greater at the dominant hand for all
measurements except the BMD distally, but given the relatively large standard
deviations (Table 12.1), the dominant hand was not consistently the most dense. Not
surprisingly there was no significant difference between the dominant and nondominant
hand (p > 0.05). In order to avoid any spurious but statistically significant difference in
BMD in the fracture study, it was decided to double up the ratio of both dominant to
nondominant and nondominant to dominant sides to remove any misleading, slightly
skewed distribution. As the values for the BMD ratios at the distal (Fig 12.5; Probit
analysis r = 0.96) and proximal (Fig 12.6; Probit analysis r = 0.97) sites were normally
distributed the normal ranges at each of these sites were calculated as 0.70 - 1.30
distally and 0.76 - 1.24 proximally.
.d
0
h)
LO	 CO
3-I
a a	 ad
8 8	 8
a 4	 ci
Tt, 	 Ni
CO
	 N.	 c0
a tri	 a
-.
CO	 Cr)
1.4	 CO
a 4	 a
0
5
-4
0(1.)
g Z
co
P. go0
	
.cr	 ,-.	 cu
g Ni
.5	
4..:).,
c..)
-ti
a.)	
0
'0
O lei	
oi..,
o o,
,.....	
'5
	
a.)	 c.)
	5	 a)i.
	.5	
c.) o
5
a)
	
a)	 a)
	
1...	 s...
O Cl,	 a)
	
cn	 .0
al
	
a)	 g A
IiiIII
III
v g 
t.0
	
3	 0
	1-13	 •H	 -ea'0	 a.)
	al	 lis	 Ecu0	 1-,
	
.'	
0
0 00
	
2	 1:1	
ct4.)
	
4.)	 E1:1
	
'R	 4g.	 c4
.00	
oi6.
0 1:$ Z
0
	
0	 (1 ,:0,r3
1.4
CL)
.5
5
'00
cd
0
-4
'0
o 0
a) al lo.0 c.)0 a) al 0
.0
a)
-I
a)
g
0
a.)
'.
g
.
c.)0
a) 1.4
14 1
'0 pii
Ci
1-1
A)
as
Eli
03
c.)
ctl
I,
E
o0
'0
g
..4.1
a)
0
E-1 E 'W 4
g'	 c7
0	 0
,z	3 _g	 .
▪
	.)
z0 00	 -RC A U
-,..
A	 01	 III	 It PI	 0:1
••
•
•
•
99.9 -
99 -
0.1 -
I	 I	 I	 1	 i
0.69	 0.89
	
1.09	 1.29	 1.49
Distal BMD ratio
Fig 12.5. Probit analysis was performed on the distal BMD ratios in 21 patients
who had no evidence of algodystrophy or recent distal radial fracture. Since
the ratio, which was expressed as the score for the dominant divided by the non-
dominant hand, were normally distributed, the 95% confidence interval was used
to calculate the normal range.
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Fig 12.6. Probit analysis was performed on the proximal BMD ratios in 21
patients who had no evidence of algodystrophy or recent distal radial fracture.
Since the ratios, which were expressed as the dominant divided by the non-
dominant hand, were normally distributed, the 95% confidence interval was used
to calculate the normal range.
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ili) Discussion
This technique was developed to study the decrease in bone mineral that occurs
following algodystrophy and it's evolution with time. In longitudinal studies however,
the measurement precision is critical lithe method is to be sensitive enough to monitor
clinically significant rates of change of bone density. The consequences of poor
precision are that individuals must be studied over longer periods to establish a true
change, or that larger numbers of subjects must be studied in order to demonstrate a
given change (Kanis et al. 1983).
The short-term reproducibility of this technique is approximately 4% which is
greater than the 1-3% described by Christiansen et aL (1975) at the forearm. This 4%
reproducibility applies to measurement of BMD which was only slightly less than
measurements based on BMC. The better reproducibility with BMD was unexpected
however as this measurement relies on two variables, BMC and bone width, rather than
BMC alone. The difference in reproducibility between the technique described and
forearm scanning and that described to measure metacarpal density was probably due
to positioning errors since the width of the metacarpal varies markedly at the site
measured. The hook grip used in this technique when positioning the hand is less
replicable and is more likely to allow slight rotation of the hand than the full grip used
in measurements of the distal forearm. Changes in orientation are unlikely however to
cause major problems with reproducibility (Christiansen et at. 1975). The main source
of error was probably variation in the starting point of the scans. In distal radial scans,
the starting point is found automatically by the computer soft-ware and is therefore not
operator dependant. It was not possible to program the scanner to find a smaller
interosseous gap and therefore the starting point relied on optically aligning the
scanning arm on the distal palmar crease.
SPA is usually used to evaluate changes in mineralisation due to generalised
osteoporosis which occurs slowly over a long time period rather than the rapid onset of
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demineralisation apparent radiographically in algodystrophy. Although this technique
needs to detect an 8% change in BMD to be significant (mean +2SD), it may still be
sufficiently reproducible to detect the more marked changes seen in algodystrophy.
The radiographic scoring system described in Chapter 10 was based on changes
seen in trabecular bone which change markedly in algodystrophy. Trabecular bone has
a higher rate of turnover than cortical bone due principally to the greater surface area
available for active resorption and formation. For this reason the results of increased
resorption in algodystrophy are more likely to be apparent and seen at an earlier stage
in trabecular bone rather than at a cortical site. In the forearm 85% of bone mass is
trabecular in both bones at 1 cm from the ulna styloid tip; this proportion falls to 10%
within the next 2 cm proximally (Sclenker and VonSeggen 1976). The distal and
proximal scan sites at the forearm are mainly through trabecular and cortical bone
respectively. Although these proportions will not be identical for metacarpals, in view of
the starting point for the scans at the metaphyseal/diaphyseal junction, the distal scan
is through the mainly trabecular metaphysis and the proximal scan through the mainly
cortical diaphysis. Indeed, BMD was 24% less at the distal site. Consequently
differential losses and recovery in BMD in the two different areas scanned are likely to
reflect in part the differing response of trabecular and cortical bone.
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CHAPTER 13: BIOCHEMISTRY
Radiographically there is a generalised loss of bone which is indicative of a net
increase in bone resorption. No comment can be made of the change, if any, in bone
formation. These changes however occur locally and consequently may not markedly
influence the overall rate of skeletal bone turnover. There have been reports however,
claiming that systemic indices of bone resorption and formation change, particularly in
the early stages of the disease (Eisinger et al. 1974; Schiano et al. 1976).
In this section the techniques used for the biochemical assessment are
described and the laboratory normal ranges defined. The findings in algodystrophy are
described in chapters 21 and 25.
Methods and Normal ranges. 
Serum and urine samples were taken after an overnight fast. The serum was
used to measure calcium, phosphate, alkaline phosphatase, creatinine, urea and
electrolytes using a Technicon SMAC. Serum calcium was adjusted for variations in
serum albumin by the addition or subtraction of 0.02 mmol/lfor each g/1 that albumin
was above or below 42 mg/l. A portion of the serum was also frozen for later
determination of parathyroid hormone (PTH), using chicken antiserum directed at the
mid portion of the PTH molecule (Immuninuclear Corporation), and osteocalcin, using a
radioimmunoassay (Hauschka et cr/.. 1989). To minimise interassay variability in the
PTH and osteocalcin assays, the stored serum samples were analysed over a three week
period.
After voiding the bladder following an overnight fast, urine was collected over a 2
hour period before breakfast. Urinary calcium and hydroxyproline were expressed as
ratios of urinary creatinine, which in the fasting state provided indices of net calcium
release from bone and bone resorption (Paterson et al. 1983). Urinary hydroxyproline
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was measured using a modification of Stegemann's method (Stegemann and Stalder
1967). The laboratory reference ranges are shown below.
Measurement	 Laboratory normal range
Serum calcium (mmo1/1)	 2.26 - 2.63
Alkaline phosphatase (IU/1) 	 35 - 105
Parathyroid hormone (pg/l)	 30 - 130
Osteocalcin (ng/ml)	 8 - 32
Urinary calcium mol/mol	 <0.30
creatinine
Urinary hydroxyproline mmol/mol 	 <30.0
creatinine
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CHAPTER 14: PREDISPOSING CHARACTERISATION OF ALGODYSTROPHY
Despite numerous studies, the aetiology of post-traumatic algodystrophy
remains unknown. Although Kleinert et al. (1973) in their large series of 506 cases did
not comment on the severity of the trauma preceding algodystrophy, Serre et al_ (1973)
thought that 50% suffered only minimal trauma and that there was no correlation
between the severity of trauma and the subsequent severity of algodystrophy. A
number of authors ((Herrman et al. 1942; Well and Gerard-Marchant 1954; Fontaine et
al 1957; Beasley 1964; Ivins et cd. 1969; Serre et a/. 1973; Bernstein et al. 1978; Kim et
al 1979; Goldner 1980; Fam and Stein 1981) have claimed that immobilisation rather
than the initial trauma may precipitate algodystrophy or aggravate the condition. The
aim of this study was to examine the predisposing features attributable to the patient or
the fracture management and their bearing on the development of algodystrophy.
Methods. 
Two hundred and seventy-four patients with Colles' fractures were reviewed
prospectively over an 18 month period begining in December 1987 upon completion of
their period of immobilisation. All presented to the orthopaedic fracture clinics at the
Royal Hallamshire Hospital, Sheffield. As will be shown in Chapter 15 discrete
populations were identified based on the presence of abnormal pain or tenderness,
vascular instability, swelling or stiffness. Any patient with all these symptoms and
signs was assumed to be suffering from algodystrophy. The data collected (including
age, sex, side fractured, time from fracture to manipulation etc.) on the 274 CoIles'
fracture patients has been explained in Chapter 8 and is detailed in Table 8.1.
The results were expressed as mean + one standard error of the mean (SEM).
Differences between groups were calculated using Student's t test for unpaired data and
the Chi-squared test (with Yates correction for 2 x 2 contingency tables) for frequency of
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observations.
Results
There was a peak prevalence of Colles' fractures during the winter months
(October - March; Fig 14.1b), reaching a peak in December and January.
Algodystrophy however, appeared to be more prevalent during Spring and, to a lesser
extent, Autumn (Fig 14.1a).
aJ Patient characteristics
Of the 274 patients studied, 77 (28.1%) had features of pain/tenderness,
vascular instability, stiffness and swelling. The mean age at presentation of the
population as a whole was 63.7 years (SD 14.2) with a female to male ratio of 4.5:1
(Table 14.1). The mean age of female patients sustaining a Colles' fracture was 65.8
years + 0.9 compared with 54.2 years + 2.3 in males (Fig 14.2a; p <0.0001). From 40
years, the age prevalence rose steadily to it's peak at 65 years in female patients, no
such increase in incidence was seen in the male patients (Fig 14.2a). This post-
menopausal peak in Cones' fractures was confirmed by estimating the incidence based
on the population statistics for Sheffield Area Health Authority (HMSO 1987; Table
14.2). As there were two hospitals with emergency services serving this area, the
population was divided by two to give an approximate estimate of the number served by
each hospital. There was no significant difference between the mean age of the
algodystrophy and control patients (Table 14.1; Fig 14.2b). Similarly there was no age
difference in male (algodystrophy 54.3 years + 3.4; control 54.2 years + 2.9) and female
(algodystrophy 66.3 years + 1.09; control 65.6 years + 1.1) patients.
Fracture of the left side (58.8%) was significantly more common than the right
(41.2%) (X2 = 16.12; p < 0.0001) with the overwhelming majority of patients being right
handed (95.3%). There was no significant differences in the side fractured or the hand
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dominance between those patients who developed algodystrophy and the remainder
(Table 14.1).
Table 14.1. Mean (± SEM) and ratios of sex distribution, handedness and side affected
in 274 patients with a CoIles' fracture. Those in the algodystrophy group had
symptoms of abnormal pain/tenderness, vascular instability, swelling and stiffness.
ALGODYSTROPHY CONTROL TOTAL (SD)
Age (years) 64.7k 1.3 63.5 + 1.1 63.7 (14.2)
Sex(F:M) 62:11 162:39 224:50
Handed (R:L) 71:2 190:11 261:13
Side (R:L) 28:45 85:119 113:161
Time from fracture (hrs) 7.4 + 0.8 6.8 + 0.4 7.02 + 0.4
Time in plaster (days) 38.9 +0.9 37.1 + 0.6 37.5 + 0.5
Table 14.2. The apparent incidence of Cones' fractures were calculated for male and
female patients based on the 1977 population census for Sheffield Area Health
Authority. Above the age of 45 years, there is approximately a 10 fold increase in the
incidence of Colles' fracture.
Age	 Incidence of Colles' fractures (per 1,000 population)
Male Female
15 - 29 years 0.00005 0.00006
30 - 44 years 0.0002 0.0002
45 - 59 years 0.0003 0.001
60 - 74 years 0.0003 0.002
>75 years 0.0006 0.002
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b) Fracture type and management.
Frykman type. The distribution of Frykman types showed peaks at the upper and
lower ends of the scale (Fig 14.3). Thus fractures usually occurred without joint
involvement or, if there was joint involvement, both the radio-carpal and distal radio-
ulna joints were affected (Table 8.2). In general the more severe fractures occurred in
the algodystrophy group ((Fig 14.4; compare Frykman I with Frykman VIII).
Involvement of the ulna styloid (Frykrnan II, IV, VI and VIII), was also associated with a
higher incidence of algodystrophy (X2 = 29.03; p <0.0001). The only fracture type
which was associated with a higher incidence of algodystrophy but did not involve
fracture of the ulna styloid was the Frykrnan VII. This fracture however is inherently
severe with fracture lines extending into the radio-carpal and distal radio-ulna joints.
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Fracture management. One hundred and sixty-six fractures (61.0.%) required
manipulation. This included 62/73 (85%) patients with algodystrophy and 104/201
(52%) without algodystrophy, which was significantly different (X2 = 4.70; p = 0.03).
The majority (86.2%) of the fractures, however required only one manipulation (Table
14.2). In those patients who needed manipulation, there was no significant difference
In the number of manipulations required between the two groups
Table 14.2. Manipulations of Cones' fracture in patients divided by the presence or
absence of algodystrophy. There was a significantly greater proportion requiring
manipulation in the algodystrophy group (X2 = 4.70; p <0.03).
Number of Manipulations
0	 1	 2	 3	 One or more
Algodystrophy 11	 54	 8	 62
Control	 97	 89	 13	 2	 104
Although the time interval from fracture to manipulation was slightly greater in
the algodystrophy group (algodystrophy 7.4 + 0.84 hours; control 6.8 + 0.40 hours;
Table 14.1), the difference was not significant with the majority of patients treated
within 10 hours from the time of injury (Fig 14.5). Most patients were immobilised in a
radial slab (81.8%), with the remainder in half-arm plasters or full-arm plasters (Table
14.3). There was no significant difference in the method of immobilisation between the
two groups. Similarly there was no difference in the period of immobilisation
(algodystrophy 38.9 + 0.9; control 37.1 + 0.6; Fig 14.6; Table 14.11.
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Table 14.3. The majority of patients in both groups were immobilised in a plaster back
slab.
Radial slab Half-arm cast Full-arm cast Total
Algodystrophy
Control
61
163
11
37
1
4
73
204
Discussion,
The distribution of Colles' fracture recorded over a one year period (1988)
demonstrated a higher incidence in winter. Although not recorded, it was my
Impression that most of the injuries took place outside, contrary to fractures of the
femoral neck which usually occur after falls in the home. This may explain the higher
incidence in winter with falls due to icy or wet conditions. The higher prevalence of
algodystrophy during Spring, and to a lesser extent, Autumn was surprising and
contrary to Aubert's (1980) findings of an increased prevalence during winter.
The higher incidence of Coas t fracture following menopause in females is well
known and was reflected in these data (Fig 14.2a). There was no similar increase in
incidence in males with advancing age. Indeed the incidence of Cones' fractures
remained relatively constant between 30 years upto retirement age at 65 years (Fig
14.2a). Therefore in males, rather than the ageing process, which results in more
porotic bones and poorer coordination, leading to Cones' fracture, it appears that
trauma sustained during the working years may be as important in the aetiology of this
fracture in men. From an epidemiological point of view, these fractures in men
therefore appear discrete and it has been suggested (McMurtry, personal
communication) that their treatment should also differ from that of the post-
menopausal Cones' fracture. He recommends more aggressive treatment with open
reduction and internal fixation of the fracture.
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The left side was fractured more often despite the majority of patients being right
handed. It is unlikely that this is due to a conscious effort to protect the dominant
hand. Therefore, if one assumes that falls should at least occur equally on either side,
there must be another factor which results in the non-dominant hand fracturing more
frequently. In an age and sex matched population of patients without fracture or
algodystrophy there is no difference in bone mineral between the dominant and non-
dominant hand (Chapter 12). Therefore there is no inherent weakness in the non-
dominant hand to account for a higher fracture rate.
The Frykrnan classification of Colles' fractures determines the presence of joint
involvement, and consequently increasing force expended at the time of injury, with or
without fracture of the ulna styloid. Although the classification does not directly assess
the degree of fracture corru-ninution, with a higher Frykman grade, it is more likely that
comminution would ensue as the degree of energy being expended increased. The data
on the Frykman classification indicate that the more severe the fracture, the higher is
the probability of developing algodystrophy. The incidence of algodystrophy was low a
Frykman I fracture and became higher with a Frykman VIII fracture. Involvement of the
ulna styloid is also a measure of the force expended at the time of injury. Therefore in
the Frylanan classification, for a given joint involvement, more force is involved if the
ulna styloid is fractured. Although the association between fracture of the ulna styloid
and algodystrophy reached significance only in the Frykman VIII fractures, in all grades
where the styloid was involved (Frykman II, IV, VI and VIII), there were more patients
with algodystrophy (Fig 14.4). This difference became highly significant when they were
compared as a group without fracture of the ulna styloid (p <0.0001).
The main disadvantage of the classification is that it provides no information
about the degree of angulation or displacement. Although there was no direct evidence
of displacement or angulation, manipulation of the fracture, and consequently the
degree of displacement, was associated with a higher incidence of algodystrophy (p =
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0.03). It is unlikely that the act of manipulating the fracture itself resulted in the
higher incidence of algodystrophy as multiple manipulations did not increase this
further (Table 14.2). Other features of the treatment such as time to manipulation, type
of immobilisation and period of immobilisation were not related to the development of
algodystrophy.
Algodystrophy following minimal trauma is well recognised (Bouvier et a/. 1973:
Kleinert et a/. 1973: Patman et al. 1973 and Doury et al. 1981). Indeed seven of our
patients developed algodystrophy following a Frykrnan I fracture. Nevertheless, these
data suggest that the increased force involved at the time of fracture resulting in distal
radial comminution, fracture of the ulna styloid and displacement were associated with
the increased likelihood of developing algodystrophy.
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DIAGNOSTIC FEATURES
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CHAPTER 15: CLINICAL FEATURES AND THEIR ASSOCIATION
Atkins et a/. (1990) demonstrated the presence of a discrete population of
patients with abnormal tenderness, stiffness and vascular instability based on a study
of 60 patients with Colles' fracture seen two to six weeks after removal of plaster. They
found a significant association between these features (p <0.0001). The aim of this
study was to investigate the nature and distribution of the four classical clinical
features of algodystrophy, namely pain and tenderness, vascular instability, swelling
and stiffness. In addition, it was intended to confirm Atkins et aL (1990) previous work
that the presence or absence of these features occurs in discrete populations.
Methods
All 274 patients were reviewed clinically following Colles' fracture (Appendix I).
The clinical techniques used to assess the four features of algodystrophy have been
described in detail (Chapter 9). They were the subjective presence of pain, vascular
instability, swelling and stiffness. In addition, dolorimetry was used as an assessment
of tenderness.
The same method of statistical analysis was used in this and subsequent
chapters. The values were expressed as mean + one standard error of the mean (SEM)
and normality of distribution assessed using Probit analysis. The significance of the
difference between means was calculated using Student's t test or one way analysis of
variance (ANOVA) for unpaired data. Wilcoxin's paired or unpaired test was used for
non-parametric data and Chi-squared (with Yates' correction for 2 by 2 contingency
tables) for frequencies. Correlations between data were identified using simple
regression analysis for parametric data and Spearman's rank correlation for non-
parametric data.
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Results
a) Features.
Pain and tenderness. The mean dolorimetry score for all the patients was 0.91 (SD
0.14) but with a large range from 0.34 to 1.08. Probit analysis demonstrated that the
population was not normally distributed (Fig 15.1a). If however, the total population
was split into two groups based on the lower limit of the 95% confidence interval (0.92)
for dolorimetry scores in the control population, each population became normally
distributed (Fig. 15.1b and c) which suggests the presence of two populations based on
the presence or absence of abnormal tenderness in the fingers.
Eighty-two patients (30%) complained of pain in their hands, 65 of whom also
had abnormal tenderness. There were 54 patients who complained of shoulder pain
which was not related to trauma at the time of injury, 45 of whom also had abnormal
tenderness. The relationship of hand and shoulder pain to the algodystrophy group will
be dealt with later.
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Fig 15.1. Dolorimetry was used to assess finger tenderness in 274 patients with
Colles' fracture and their distribution plotted using Probit analysis (a). This
demonstrated that the population was abnormally distributed. When Probit
analysis was performed in patients with abnormal (b) or normal (c) dolorimetry
ratios, the distribution for each group became normal.
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Vascular instability. One hundred and twenty out of the 274 patients studied (43.8%)
exhibited signs of vascular instability in the fractured hand. Of these 120 patients, 101
(84%) had alteration in temperature and 88 (73%) alteration in colour of the hand.
Sixty-nine (58%) patients complained of both. Ninety of the patients with an alteration
in temperature complained of warmth (89%), the remainder claiming their affected hand
felt cool. Of the 88 patient who complained of a change in colour of their hand, 66
(75%) thought it was red and 22 (25%) blue. Table 15.1. depicts the inter-relationship
between the patients with temperature and colour changes. There was a statistically
significant difference in the distribution of temperature and colour change between the
groups (X2 = 16.25: p <0.003) suggesting that the hand tended to feel warm regardless
of the colour.
Thirty-three (27.5%) of the patients who had an alteration in temperature or
colour thought that, although the there was always a difference, the intensity altered
with changes in the environmental temperature. In cold weather the hand would be
abnormally cold and blue and in hot weather warm and red. In addition 5 of these
patients noticed a difference dependant on mood. Two notable examples were patients
who, having returned to work later in the course of the disease, noticed alteration in
colour, temperature and pain in stressful situations.
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Table 15.1. Vascular instability, based on the presence of abnormal colour or
temperature, was present in 120 of the 274 CoIles' fracture patients studied. The
number of patients with alteration in colour have been cross-tabulated with alteration
in temperature. The majority of patients have hot hands regardless of the colour
change.
TEMPERATURE COLOUR
Blue Red No change Total
Cold 5 4 2 11
Hot 11 49 30 90
No change 6 13 0 19
Total 22 66 32 120
There were some differences between the history of temperature and colour
changes and clinical examination. In 73 of the 101 patients who reported a difference
In temperature, an increase in skin temperature was clinically apparent (Table 15.2). A
further six patients had a warm hand unnoticed by the patient. Twenty-eight patients
who reported a change in temperature had no change on clinical examination. Ninety-
one patients had clinical evidence of a change in colour of the affected hand but only 80
gave a history of colour change, the remaining 11 gave no such history (Table 15.2).
There were also 8 patients who reported a colour change which was not evident on
examination.
Change in colour 80	 8
No change in colour 11	 175
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Table 15.2. Of the 274 Cones' fracture patients studied, 101 reported or had clinical
evidence of a change in temperature of the hand with 99 reporting a change in colour
providing a total of 120 patients with evidence of vascular instability. A proportion of
patients reported vascular instability without any clinical evidence which may support
evidence for a sub-clinical form of algodystrophy.
History
	
Clinical evidence	 No clinical	 evidence
Change in temperature
	
73	 28
No change in temperature
	 6	 167
The reports of temperature and colour change with no clinical features may
reflect the variable nature of the instability in that it was not evident at the time of
examination. More importantly however, it may provide evidence for a trend towards a
sub-clinical form of algodystrophy. Using dolorimetry as a measure of disease activity,
patients with and without clinical evidence of temperature and colour changes were
compared. There were significantly lower dolorimetry scores in the patients with
clinical and historical evidence of a change in colour or temperature but, even in the
absence of clinical evidence, the dolorimetry scores were still below the lower limit of
normal (0.92; Table 15.3) This lends support to the presence of a sub-clinical form of
algodystrophy.
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Table 15.3. Dolorimetry scores (mean + SEM) in patients with and without clinical
evidence of temperature or colour change but who claim such changes on questioning.
Clinical evidence	 No clinical evidence
Temperature change 0.76 + 0.02 0.90 + 0.02 p <0.0001
Colour change 0.77 + 0.02 0.91 + 0.05 D < 0.03
Forty-three patients complained of hyperhidrosis, all of whom exhibited other
features of vascular instability. Although the majority complained of increased
temperature and warmth (90%), 10% had cool, blue, clammy hands. As with the
changes in temperature and colour, sweating also seemed to related to external factors.
Thirty of the 43 patients with hyperhidrosis exhibited an increase in sweating as
compared to the unaffected hand when undergoing dolorimetry. This was never seen in
patients who had not complained of hyperhidrosis.
Finger stiffness. One hundred (36.5.%) of the patients complained of stiffness in the
fingers with or without clinical evidence of loss of movement. In none of the cases was
this attributable to concomitant trauma to the fingers at the time of injury.
Swelling. One hundred and twenty four patients (45.3%) complained of swelling in
their fingers and hand regardless of clinical evidence of swelling. Of the 124 patients
with a history of swelling, 106 also had clinical evidence of oedema in the hand. Only
12 had evidence of oedema but denied swelling. This leaves 18 people who claim to
have swelling which was not clinically evident. This may indicate a sub-clinical form of
algodystrophy which is supported by the difference in dolorimetry scores between the
two groups:
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Clinical evidence of swelling 	 0.80 + 0.16
No clinical evidence of swelling	 0.94 + 0.08
p <0.002
b) Association offeatures.
In total there were 77 (28.1%) patients with a dolorimetry score lower than 0.92
(control population 95% confidence interval; 0.92-1.08) and evidence of vascular
instability, finger stiffness and hand swelling, 125 (45.6%) patients without any features
and a borderline group of 71(26.3%) with a variety of features (Table 15.4; Fig 15.2).
If the probability of each of the features being displayed was independent of the
occurrence of any of the other features, and occurred randomly with a probability level
of 0.5, then the distribution of the number of features, between 0 and 4, displayed by
the patients would follow a binomial distribution. On this assumption, the expected
frequencies were calculated and compared in relation to the observed frequencies:
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Table 15.4. The observed incidence of patients with all, some or none of the features of
pain/tenderness, vascular instability, swelling and stiffness were compared with the
expected binomial distribution.
Feature
	 Observed	 Expected 
0	 125	 17.12
1	 36	 68.50
2	 14	 102.75
3	 22	 68.50
4	 77	 17.12 
Total	 274	 273.99
By looking at the frequencies in Table 15.4 it can be seen that the frequencies
observed do not follow the distribution expected. This was confirmed by testing the
goodness-of-fit using Chi-squared techniques (X 2
 = 1012.88; p <0.0001). There was an
excess number of patients observed displaying either none or all four of the features,
and much smaller numbers of patients displaying one, two or three of the features.
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Discussion, 
Analysis of the distribution of the features demonstrated that if a patient
displayed one of the features there was a high probability that all four would be
displayed, and similarly, if a patient did not display one of the features it is unlikely
that others would be seen. Consequently there was a discrete population of patients
who exhibited all the classical signs and symptoms of algodystrophy, pain and
tenderness, vascular instability, swelling and stiffness, amounting to 28% of patients
following a Colles' fracture in this study. The presence of two distinct populations was
further confirmed by the normal distribution of dolorimetry ratios in those patients with
ratios above or below 0.92, the lower limit of normal. Therefore there were two
populations, one with and one without abnormally tender fingers.
Patients predominantly presented with a warm, red hand. Indeed, the hand felt
warm even in the presence of blue skin discolouration in the majority of patients. This
Is keeping with the classically described features of stage I algodystrophy (Chapter 4).
Thirty-three percent of patients who had evidence of vascular instability claimed that
the type or intensity of the changes was affected by changes in environmental
temperature or mood. In addition 70% of those with hyperhidrosis had a further
increase in sweating in the affected hand when undergoing dolorimetry. These
environmentally dependant changes in vascular instability and hyperhidrosis
demonstrate the influence of cerebral function on the spinal levels involved in the
algodystrophic process and consequently on the clinical presentation of the condition.
There was a discrepancy in the number of patients with a history of vascular
instability or swelling and the clinical signs they displayed. As mentioned in the
methodology, the wording of the questions concerning the presence of features such as
vascular instability and swelling were structured to avoid suggesting changes to the
patient. Therefore, the reports of temperature and colour change and the presence of
hand swelling with no clinical features may reflect the variable nature of the condition
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In that it was not evident at the time of examination. More importantly however it may
provide evidence for a trend towards a sub-clinical form of algodystrophy. This was
suggested by the significant difference in the dolorimetry scores between those with and
without clinical evidence of vascular instability or hand swelling. The question of sub-
clinical algodystrophy will be dealt with in more detail in a later chapter. This includes
an analysis of the 72 patients who had some but not all of the features of algodystrophy
and may represent a sub-clinical group.
Despite numerous papers on Cones' fracture in the English literature, the
incidence of algodystrophy is generally regarded to be low (upto 2%; Bacorn and
Kurtzke 1953; Plewes 1956; LidstrOm 1959; Frykman 1967; Pool 1973; Stewart et a/.
1984). In contrast, in a study designed specifically to investigate algodystrophy, Aubert
(1980) recorded an incidence of 29%. This was recently confirmed by Atkins et a/.
(1990) using similar diagnostic criteria to those used in this study. The high incidence
is probably accounted for by the detection of a greater number of milder cases which
may nevertheless cause morbidity.
In conclusion there is statistically significant evidence for the presence of two
distinct patient populations following Colles' fracture, one of which displays all the
clinical features of algodystrophy and amounts to 28% of patients studied. It is
therefore valid to use this population for further studies into the natural history of the
condition.
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CHAPTER 16: QUANTITATIVE CLINICAL MEASUREMENTS. 
Having confirmed the presence of two discrete population based on the presence
or absence of abnormal pain and tenderness, vascular instability, swelling and
stiffness, it was appropriate to extend the analysis to examine the differences in the
quantitative clinical measurements between the two groups and to what extent these
measurements might contribute to a diagnosis of algodystrophy.
Methods. 
The quantitative measurements used to assess the 274 Colles fracture patients
have been described in Chapter 9. They were measurements of tenderness
(dolorimetry), hand volume and grip strength. In addition the subjective presence or
absence of pain in the hand and shoulder was examined further in relation to the
presence of the four features of algodystrophy; abnormal tenderness, vascular
Instability, swelling and stiffness. In the dolorimetry assessment the presence of the
latter three were used as criteria for the diagnosis of algodystrophy.
The statistical analysis used was the same as described in the previous chapter.
Results
Dolorimetry. Using Probit analysis, the distribution of dolorimetry scores was studied
in patients with or without evidence of vascular instability, stiffness and swelling. In
the population without any of these features, the dolorimetry score was 0.99 + 0.002
which was not significantly different from the control population 1.00 + 0.008 but was
normally distributed (Fig 16.1b). Similarly the dolorimetry scores for patients with all
the features (mean 0.77 + 0.02) were normally distributed (Fig 16.1a). In addition,
there was a highly significant difference between these two populations (Fig 16.2; p <
184
0.0001). It is interesting to note that the distribution of dolorimetry scores in the group
of patients who displayed some of the features was not normally distributed (Fig 16.1c),.
and indeed the pattern of distribution is similar to that seen in the population as a
whole (Fig 15.1a). In addition, the mean dolorimetry score for the borderline group
(0.94 + 0.01) lies in between, and is significantly different from the group with no
features (p <0.0001) and those with all three features (p < 0.0001) (Fig 16.2).
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Fig 16.1. Dolorimetry was used to assess finger tenderness in 274 patients with
Colles' fracture and there distribution plotted using Probit analysis. The
distribution was normal in those patients with (a) and without (b) the presence
of vascular instability, swelling and stiffness. In those patients who
displayed one or two of the features (c), the distribution was abnormal. This
implies the existence of two distinct populations based on the presence or
absence of these three features.
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Fig 16.2. The dolorimetry ratios (+A SEM) were calculated in three groups of
patients. Those with all the features of vascular instability, swelling and
stiffness were considered to be suffering from algodystrophy. The normal group
had none of the features and the borderline either one or two. The mean ratio
in the algodystrophy group was significantly different from the normal group
(p <0.0001). In addition, the mean ratio for the borderline group lay between
the algodystrophy and normal ggroups and was significantly different from both
(p < 0.0001).
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There was a significant association (X2
 = 105.3; p <0.00001) between the
presence of pain in the hand and the presence of the four features (Table 16.1). If the
patients in the borderline and normal groups are considered in isolation, this
significance disappears confirming there is an abnormally increased proportion of
patients with hand pain in the algodystrophy group. In the borderline group, 7 also
had abnormally tender fingers. Therefore 65 (79%) patients with pain in their hands
also had abnormal tenderness. Of the 77 patients with all the features of
algodystrophy, all but 19 had pain in their hand. There was also a significant
association (X2 = 67.7; p < 0.00001) between the presence of pain in the shoulder and
inclusion into one of the three groups (Table 16.1). Again this was due to a higher
incidence of shoulder pain in the algodystrophy group. Six patients developed the
classical features of "frozen shoulder". There were a further 12 patients excluded from
this analysis who reported pain in the shoulder but who also gave a history of trauma
to the shoulder at the time of the Cones' fracture.
Table 16.1. Distribution of patients with hand or shoulder pain based on the presence
of abnormal tenderness, vascular instability, swelling and stiffness.
Algodystrophy Normal	 Borderline	 Total
Hand pain 58 8 16 82
Shoulder pain 40 5 9 54
Hand volume. Probit analysis of the distribution of hand volume ratios showed that
they were not normally distributed (Fig 16.3a). If, however the population was
subdivided into patients with and without the four features associated with the
diagnosis of algodystrophy, the distributions were normal (Fig 16.3b and c), again
suggesting two distinct populations of fracture patients. Also a highly significant
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difference in hand volume was found between the algodystrophy (1.09 + 0.009) and the
normal group (1.007 + 0.003; p < 0.00001; Fig 16.4). There was no significant
difference between the normal group and the control population or borderline group.
Grip strength. The distribution of grip strength measurement also conformed to the
pattern seen with the dolorimetry score and hand volume ratios. The distribution of
data became normal when patients were divided based on the presence or absence of
the four features (Fig 16.5). The patients with algodystrophy were significantly weaker
(0.20 + 0.02) than the normal population (0.42 + 0.03; p < 0.00001; Fig 16.6) but there
was no difference between the latter and the borderline group (0.34 + 0.03).
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Fig 16.4. The volume ratio mean (+/- SEM) was calculated in those patients
with all the features of tenderness, vascular instability, swelling and
stiffness (algodystrophy), none of the features (normal) and the presence of
one to three of the features (borderline). The volume ratio was significantly
greater in the algodystrophy group (p <0.0001).
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features of tenderness, vascular instability, swelling and stiffness. This
implies the presence of two distinct populations.
I
i
1
0.55 -
0.45 -
0
17.3'
_c
4-6)
a 0.35 -
112
Q.
0
0.25 -
0.15 -
I	 I	 I
algodystrophy normal 	 borderline
Fig 16.6. The grip strength ratio (+/- SEM) was calculated in those patients
with all the features of tenderness, vascular instability, swelling and
stiffness (algodystrophy), none of the features (normal) and the presence of
one to three of the features (borderline). The grip strength ratio was
significantly less than the algodystrophy group (p < 0.0001).
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Due to the non-uniform distribution of dolorimetry score, hand volume and grip
strength, correlations between these parameters were performed using the Spearman
Rank test for non-parametric data. There were significant correlations between the
dolorimetry score and hand volume (Rs = -0.54; p <0.00001) and dolorimetry score and
grip strength (Rs = 0.46; p < 0.00001). Although the correlation between hand volume
and grip strength was poor, there was still a significant association (Rs = -0.29; p <
0.00001). In this three way analysis however, it is not clear to what extent the
parameter that was excluded from the calculation influenced the correlation between
the remaining two. For example, to what extent does a change in volume of the hand
affect the correlation between tenderness (dolorimetry) and grip strength. To investigate
this, partial correlations were calculated which take into account this factor. This
showed that the correlations, though slightly reduced, still existed between dolorimetry
and hand volume (Rs = -0.41) and dolorimetry and grip strength (Rs = 0.38). The weak
correlation between hand volume and grip strength however, completely disappeared
(Rs = -0.02).
Discussion. 
This study has shown that the three quantitative clinical measurements,
dolorirnetry, hand volume and grip strength, are capable of differentiating between
groups of patients with and without algodystrophy following a Colles' fracture.
In the previous chapter, two distinct populations were identified on the basis of
a dolorimetry score greater or less than 0.92, the lower limit of normal. This analysis
was carried further with the distribution of the dolorimetry scores calculated on the
presence of all, some or none of the features of algodystrophy. Again, in those patients
with all or none of the features, the dolorimetry scores were normally distributed. In
addition, patients who exhibited all three features had significantly greater tenderness
in their fingers than those with none of the features. In those with no features of
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algodystrophy, their dolorimetry scores were no different from a control population who
had no previous fracture. Therefore finger tenderness is likely to be solely related to the
presence of algodystrophy.
The presence of pain in the hand and shoulder was significantly associated with
algodystrophy. There were however 19 of the 77 patients who displayed all the features
of algodystrophy who did not complain of hand pain. The presence of pain in the hand
was on occasions difficult to assess as the patient concentrated on the fracture site
rather than distally in the hand. It was my impression that patients who exhibited the
features of algodystrophy also complained of abnormally increased pain from the
fracture site but this was not specifically recorded. Excessive pain from the fracture
site may well have masked pain in the hand in some cases and accounted for the 19
patients who reported no pain but were abnormally tender. Nevertheless, there were a
significantly greater number of patients with tender hands in the algodystrophy group.
The presence of a greater number of patients with shoulder pain in the
algodystrophy group, with no history of trauma to the shoulder at the time of injury, is
of interest. They may represent patients with mild forms of shoulder-hand syndrome,
indeed six of them went on to develop the classical features of a "frozen shoulder". The
spread of symptoms to sites distant to that originally injured demonstrates the patho-
physiological concept of involvement of spinal levels above or below those serving the
dermatomes of the injured part.
As with the dolorimetry scores, Probit analysis of the hand volume and grip
strength demonstrated non-gaussian distributions. When the distributions were
calculated on the presence or absence of the four features of algodystrophy, they were
normal. Furthermore there was a significant difference in the mean values for the two
measurements between the algodystrophy and normal group. These investigations are
able therefore to identify, on a population basis, those patients with algodystrophy.
Although originally there seemed to be a correlation between hand volume and
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grip strength, this disappeared when the influence of tenderness in the hand was
excluded. The loss of grip strength therefore was not secondary to the hand swelling
but was associated with the degree of tenderness in the hand. The change in grip
strength however, did not influence the correlation between hand volume and
tenderness which suggested that the latter two may be causally related.
This study has demonstrated that in the absence of any of the features of
algodystrophy, there was no difference in the degree of tenderness or hand volume
compared with a control population with no recent fracture. The use of these
measurements with the addition of grip strength were able to identify a population of
patients with algodystrophy.
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CHAPTER 17: THE DIAGNOSTIC POWER OF QUANTITATIVE
MEASUREMENTS.
The diagnosis of algodystrophy in the previous chapters was based on the
presence of abnormal tenderness (dolorimetry), vascular instability, swelling and
stiffness. The only quantitative measurement was dolorimetry, and although this test
in isolation is able to differentiate between populations of patients, it's ability to
diagnose algodystrophy on an individual basis was unknown. Although the
measurement of hand volume and grip strength are not fundamental to the diagnosis of
algodystrophy, it was of interest to compare the diagnostic accuracy of these
measurements with dolorimetry. For these reasons estimations of diagnostic precision
were performed on the three quantitative measurements.
Methods
The dolorimetry, hand volume and grip strength techniques used to assess the
274 Cones' fracture patients have been described in Chapter 9. The diagnosis of
algodystrophy was based, as in previous chapters, on the presence of abnormal
tenderness, vascular instability, swelling and stiffness. In the dolorimetry assessment
the presence of the latter three were used as criteria for the diagnosis of algodystrophy.
The ability of the quantitative measurements to discriminate between
algodystrophy and disuse was evaluated by categorising patients according to the
presence or absence of clinical evidence of algodystrophy and a measurement value
greater or less than a chosen cut-off value. Thus patients fell into four categories for
any chosen cut-off value:
a: algodystrophy with an abnormal score (true positive)
b: algodystrophy with a normal score (false negative)
c: disuse atrophy with a normal score (true negative)
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d: disuse atrophy with an abnormal score (false positive)
The sensitivity of each feature (ability to detect patients with algodystrophy) was
calculated as a/a+b, and the specificity (ability to exclude patients without disease)
c/c+d. The relative power of the different techniques in the diagnosis of algodystrophy
was evaluated using Receiver Operated Characteristics (ROC) curve analysis which is
based on the relationship between specificity and sensitivity at different cut-off values.
The nearer the curve approaches the ideal curve (Fig 17.1), the more powerful the
technique. The optimal predictive power of each value ({a+c}/(a+b+c+d}) to discriminate
between algodystrophy and disuse was also calculated for each type of measurement.
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Fig 17.1. Two hypothetical ROC curves, one with 100% sensitivity and 100%
specificity, and the other with no discriminant value.
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Results
ROC analysis of the dolorimetry data produced a curve approaching ideal (Fig
17.2). The maximal predictive value of dolorimetry was 90% at a score less than or
equal to 0.91 which corresponds to the cut-off value defined by the control population
(lower limit of normal using the 95% confidence interval - 0.92). At this score there was
a sensitivity of 89% and specificity of 91%. Therefore, of the 87 patients with a
diagnosis of algodystrophy based on the above criteria, 77 would have been diagnosed
by dolorimetry alone, with 10 falsely diagnosed as having no algodystrophy. Of the
remaining 196 patients only 17 were thought to have algodystrophy. Dolorimetry
therefore appears to be a highly discriminating factor in the diagnosis of algodystrophy
and it's inclusion with the other three features seems justified.
ROC analysis on the other two parametric variables, hand volume and grip
strength, demonstrated them to be of less discriminant value. Hand volume performed
better but the curve fell short of ideal (Fig 17.2). The maximal predictive value was only
82% with a low sensitivity of 63% but a reasonably high specificity of 89%, based on a
ratio of 1.06 or greater (affected to unaffected hand). It would appear therefore that the
hand volume ratio was able to accurately categorise those with no algodystrophy (high
specificity) but was less able to identify those with algodystrophy.
Grip strength was of even less diagnostic ability in isolation. The curve was little
better than that expected with no discriminant value (Fig 17.2). The highest predictive
value was only 77% at a grip strength ratio of 0.12 (affected to unaffected hand). At this
value there was a low sensitivity (38%) but again a high specificity (93%). Therefore as
with hand volume measurements, the technique was able to categorise the normal
patients, but was a poor discriminant of those with algodystrophy.
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Fig 17.2. The ability of the dolorimetry, hand volume and grip strength ratios
to identify patients with algodys trophy was analysed by ROC analysis on 274
patients with a CoIles' fracture. Dolorimetry was the most sensitive and
specific technique for diagnosing algodystrophy with the curve approaching
ideal. The measurement of grip strength was of little diagnostic value.
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Discussion. 
Dolorimetry as a measurement of tenderness proved to be an accurate method
of detecting patients with vascular instability, swelling and stiffness. This was further
confirmed by it's maximal predictive value corresponding to a score of less than or equal
to 0.91, a score previously defined in a control population as being the lower limit of
normal (95% confidence interval).
The measurements of the hand volume ratios was not a sensitive method of
identifying patients with algodystrophy. However, although it may be of poor
discriminant value in individual cases, it was still capable of differentiating between the
groups and may therefore be of use in a longitudinal study. The same applies to the
measurement of grip strength which, as a measure of morbidity, may be of use in
defining the degree and rate of recovery of function in the patients with algodystrophy.
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CHAPTER 18: SUB-CLINICAL ALGODYSTROPHY.
Although two distinct patient populations were defined based on the presence or
absence of tenderness, vascular instability, swelling and stiffness (Chapter 15), there
still remained a number of patients who displayed some, but not all, of these features.
These patients therefore occupy a middle ground between no disease and outright
algodystrophy and may represent a sub-clinical form of the condition. To determine
whether they were a discrete group or the features of the condition occurred at random,
the quantitative clinical measurements were used to further characterise this borderline
group.
Methods
There were 72 patients who had either one, two or three of the four features of
algodystrophy (abnormal tenderness, vascular instability, swelling or stiffness). Each
group was assessed using the quantitative clinical techniques (dolorimetry, hand
volume and grip strength) described in the previous two chapters and the presence of
pain in the hand and shoulder. This group was further analysed by dividing it into the
number of features displayed from one to three (Table 15.4). The statistical analysis
used was the same as in previous chapters.
Results
There was a significant difference in the dolorimetry score between those with
one feature (0.98 + 0.01) and those with two features (0.91 + 0.03; p <0.02). Patients
with three features had spuriously high dolorimetry scores (0.92 + 0.02) as a low
dolorimetry score (<0.92) would have automatically excluded them from the borderline
group (Fig 18.1).
The increasing tenderness in the borderline group was mirrored by complaints
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of increasing pain in both the hand and shoulder. Of the 16 patients who complained
of pain in the hand in the borderline group, three had one feature, five had two features
and eight had three features (X2
 = 8.0; p < 0.02). This significant difference
disappeared if the analysis was carried out on those with only one or two features.
There was therefore a significantly greater number of patients with three features who
complained of pain in the hand. Of the 5 patients who complained of shoulder pain in
the borderline group, three were in the group with three features and one in each of the
remaining two groups. Due to the few numbers, no statistical analysis was carried out
on this data.
The hand volume in the borderline group also increased with increasing
numbers of associated features (Fig 18.2). There was however no significant difference
between the groups.
Although there was a decrease in grip strength between patients with one and
two features, this trend was not significant and did not continue when patients with
three features were considered (Fig 18.3).
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Fig 18.1. The mean (+/- SEM) dolorimetry ratio was calculated in 72 patients
who displayed either one, two or three features of abnormal tenderness,
vascular instability, swelling and stiffness. There was a significant
difference (p <0.02) in the dolorimetry ratio between patients displaying
one or two of the features. The value for three features is spuriously high as
a dolorimetry ratio of less than 0.92 would have excluded them from the
borderline group.
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Fig 18.2 The mean (+/- SEM) volume ratio was calculated in the 72 patients who
displayed either one, two or three of the features of abnormal tenderness,
vascular instability, swelling and stiffness. There were no significant
differences between any of the groups but there was a trend towards increasing
hand volume as the number of features increased.
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Fig 18.3. The mean (+/- SEM) grip strength ratio was calculated in 72 patients
who displayed either one, two or three features of abnormal tenderness, vascular
instability, swelling and stiffness. Again there were no significant
differences but the trend in the towards a greater loss in grip strength in the
patients with more features was still apparent though less convincing than with
the measurement of the dolorimetry and hand volume ratio.
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Discussion
Although a discrete population can be identified on the basis of the four main
features, there was a definite trend in the borderline group, particularly with the data
concerning pain and tenderness, towards more morbidity in the patients with three of
the four possible features needed for a diagnosis of algodystrophy. Therefore, there was
a spectrum of morbidity associated with these features which increased as the number
of features increased. In view of this trend, the absence of a feature was unlikely to be
due to inaccuracy inherent in the assessment technique used as these would have been
expected to occur at random. There would accordingly have been no definite trend in
morbidity seen in this borderline group.
These patients therefore represent a sub-group who do not manifest all the
symptoms which have been arbitrarily defined as required for the diagnosis of
algodystrophy. The reason why they failed to develop all the features of the condition
remains unknown.
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CHAPTER 19: SKELETAL ARCHITECTURE
The characteristic radiographic features of algodystrophy, first reported by
Sudeck in 1900, are a general loss in trabecular bone density with a patchy
appearance. Changes in cortical bone, comprising of endosteal, intracortical and
periosteal resorption of bone, have also been reported by Genant et al. (1975) and
Kozin et al. (1976). These reported changes in trabecular and cortical bone, however,
have been largely subjective.
Although the radiographic changes seen in post-traumatic algodystrophy have
been described, it is unclear to what extent they are due to the condition itself, or
disuse atrophy following trauma. This may lead to diagnostic confusion in the early
stages if the clinical picture is equivocal. Also the pathophysiological mechanism
causing disuse atrophy and the extent with which this is altered in algodystrophy is
unknown. A more effective method of differentiating the radiographic changes in
algodystrophy from disuse and more information on the pathophysiology of the changes
would benefit not only the diagnosis, but also the formulation of future treatment
regimes.
For these reasons, having defined algodystrophy on the basis of clinical features,
the radiographic characteristics of bone were examined in patients with algodystrophy
using the scoring system and metacarpal morphometry described in Chapter 10, and
compared with a control group of Colles' fracture patients who did not have
algodystrophy.
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Methods. 
a) Radiographic features.
The radiographic techniques of a scoring system and metacarpal morphometry
have been described in Chapter 10. Radiographs were performed on 77 patients with a
Colles' fracture two weeks after removal of the plaster cast, 44 of whom demonstrated
abnormal pain/tenderness, vascular instability, swelling and stiffness and were thus
considered on clinical grounds to have algodystrophy.
b) Single photon absorption (SPA)
The technique has been described in Chapter 12 and was performed on the
same day the radiographs were taken on 29 patients with algodystrophy and 23
controls.
The statistical methods used were the same as that described in the previous
chapter on clinical features.
Results
There was no difference in the age, sex and duration of immobilisation between
patients with algodystrophy or control. Nor was there any difference in the radiographic
score, combined cortical width (CCW) or bone mineral density (BMD) at the unfractured
side (Table 19.1).
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Table 19.1. Details of patients and findings (mean + SEM) at study entry on the
unfractured side.
ALGODYSTROPHY	 CONTROL	 P<
n = 44	 n = 33
Age (years)	 65± 1	 64± 1	 NS
Sex M:F	 6:38	 3:30	 NS
Duration of	 39± 1	 37± 1	 NS
immobilisation (days)
Combined cortical
	 9.5 + 0.3
	 9.4 + 0.4
	 NS
width (mm)
Metacarpal diameter (mm)23.2 + 0.3
	 23.8 + 0.3
	 NS
Radiographic score
	 0	 0	 NS
*BMDcort (g/cm2)	 0.83 + 0.16	 0.80 + 0.17	 NS
*BMDtrab- (g/c1112)
	
0.60 + 0.11	 0.59 + 0.12	 NS
* measured in 29 algodystrophy patients and 23 controls.
At the affected (fractured) side all the measurements were lower at first review
approximately seven weeks after fracture compared to the unaffected side, with the
exception of the metacarpal diameter which did not change. On the assumption that
these measurements would have been similar before fracture between sides, and that
no bone loss had occurred on the unfractured side, the rate of change was calculated
for each patient with and without algodystrophy (Table 19.2). Bone loss and
radiographic changes occurred in all patients but the changes were more marked in
patients with algodystrophy and more marked at the trabecular (radiographic score and
BMDtrab) rather than cortical sites.
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Table 19.2. Rates of change + SEM in bone measurements at the first assessment 7
weeks after fracture. Values are expressed as the percentage difference between the
affected and unaffected hand.
ALGODYSTROPHY CONTROL 131 <
Metacarpal diameter (mm) 100.6 + 1.2 98.5 + 0.9 NS
Combined cortical width (mm) 96.2 + 1.1 97.2 + 1.7 NS
Radiographic score 59.4 + 3.6 ** 20.7 + 2.9 ** 0.0001
BMDcort 85.8 + 2.8 * 94.3 + 2.5 0.05
BMDtrab	 76.8 + 2.9 ** 89.7 + 1.8 0.001
P 1 signifies the significance of difference between patients with and without
algodystrophy.
Asterisks signify the significance of difference from the control (unfractured side).
* p <0.05; ** p <0.001
The radiographic score for each individual feature was significantly greater in
patients with algodystrophy (Table 19.3). There was no significant difference between
the mean values for each of the four features within the group of patients with
algodystrophy (ANOVA; p >0.05). This was not true of the patients with no evidence of
algodystrophy. The mean value for the density was greater than those of other features
(Table 19.3) and analysis of variance of the four groups confirmed there was a
significant difference in the means (p <0.01). The difference disappeared when the
scores for lucencies, subchondral lysis and loss of trabecular pattern were taken in
isolation (ANOVA; p > 0.05). Therefore, although all the features were apparent with
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disuse, a generalised loss of density was the most prominent.
Table 19.3. Mean score + SEM for each individual feature and the total fcir the groups
with algodystrophy and the control population.
ALGODYSTROPHY CONTROL
Number 44 33
Density 2.0 + 0.1 1.2 + 0.1 p < 0.001
Lucency 1.9 + 0.1 0.6 + 0.2 . p < 0.001
Erosion 1.6 + 0.2 0.4 + 0.1 p < 0.001
Trabeculae 1.7 + 0.2 0.5 + 0.2 p <0.001
Total 7.1 + 0.2 2.6 + 0.5 p < 0.001
Using simple regression analysis there was a significant association between
measurements of trabecular bone (BMD trab
 and radiographic score; R = -0.46, p>
0.05) and measurements of cortical bone (BMDcort
 and CCW; R = 0.47, p <0.05) in
patients with algodystrophy seven weeks after fracture. There was however no
correlation between measurements of cortical and trabecular bone.
ROC analysis.
Radiographic score. ROC analysis of each individual feature produced curves which
overlapped, but indicated that each feature examined could contribute significantly to
the diagnosis. When the total score was used the curve (Fig 19.1) was of more
predictive value than the individual scores taken in isolation. At a score of 4 or greater,
the positive predictive value was ma]dmal (83%), with a sensitivity of 87.5% and
specificity of 75%. The positive predictive value at this score was also greater than for
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any of the features assessed individually. This meant that 39 of the 44 algodystrophy
patients were positively identified with only 8 of 33 controls falsely identified.
Combined cortical width. This proved to be of little discriminant value with a linear ROC
curve (Fig 19.2).
Bone mineral density. There was little difference in discriminant ability between the
proximal (cortical) scan and the distal (trabecular) scan (Fig 19.3). Comparison with Fig
19.1 showed that these techniques were less powerful in discriminating algodystrophy
from disuse than the radiographic score.
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Fig 19.1. The ROC curves for the individual radiographic features and total
score combined. The greatest sensitivity and specificity was achieved using the
combined score.
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Fig 19.2. The combined cortical width ratio was measured in 77 patients with a
Col/es' fracture but proved to be of no value in the diagnosis of algodystrophy
as assessed by ROC analysis.
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Fig 19.3. There was little difference in diagnostic ability between the distal
and proximal BMD ratios assessed by ROC analysis on 52 patients.
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Discussion
This study indicates that the radiographic appearances, as measured by the
radiographic score, of algodystrophy are not specific for the disorder but are
qualitatively similar to those which follow fracture and immobilisation. It is not
possible from the present study to determine to what extent such changes are
secondary to fracture or to the immobilisation. Nevertheless our findings are of some
Importance since traditionally investigators rely on the radiographic changes to
diagnose algodystrophy even in the presence of a fracture. Not withstanding, the
present study also indicates that the radiographic changes in patients with Colles'
fracture are significantly more marked in those patients who developed algodystrophy.
The differences between patients with and without algodystrophy are sufficiently large
to discriminate albeit imperfectly between disuse and the radiographic changes due to
algodystrophy following trauma. Regarding the measurement of cortical width, there
was a greater decrease in the algodystrophy group two weeks after immobilisation but
this did not reach statistical significance.
Kozin et aL (1976) and Genant et al. (1975) demonstrated loss of bone density
and cortical width in both the affected and unaffected hands in patients with
algodystrophy as proof of the bilateral nature of the condition. Unfortunately they had
few patients and did not use a control population for comparison. Within the sensitivity
of our techniques, we were unable to demonstrate any changes in the unaffected hand
in the patients with algodystrophy or control population and consequently cannot
support their findings.
This difference between measurement of cortical and trabecular bone was
reflected in the results of the bone mineral density. Unlike the measurement of cortical
width, there was a significant decrease in the cortical BMD when compared with the
unaffected side (p <0.05), but the rate of change was greater in trabecular bone (p <
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0.001). Thus the semi-quantitative assessment of bone density and increased porosity.
seen on the radiographs was confirmed by a quantitative assessment of trabecular
BMD. This relationship was further confirmed by the significant correlation between
the radiographic score and trabecular BMD. It is interesting to note that, although
there was no significant decrease in cortical width between the two groups, there was a
good correlation between the cortical BMD and measurement of cortical width. This
may suggest that the lack of cortical changes evident on metacarpal morphometry was
due to increased porosity of the cortex due to intracortical resorption of bone from
around the Haversian canals. This feature was examined in more detail relating to the
natural history of the skeletal changes in algodystrophy (Chapter 24).
Regarding the scoring system we devised, the total score provided a more
powerful discrimination than each radiographic feature alone in distinguishing patients
with and without algodystrophy. A cut-off value of four gave the maximal predictive
value (83%) which is nevertheless short of 100%. It is not suggested therefore that
radiography alone can be used to diagnose algodystrophy nor to screen a population,
but it can provide an adjunct to diagnosis alongside other clinical and investigative
Indices. There was no difference in the predictive capabilities of cortical and trabecular
BMD but they were both of less discriminant value than the radiographic score. As
expected, the measurement of cortical width was of no diagnostic value this early in the
evolution of the condition.
Although loss of bone density was the most prominent radiographic feature of
disuse atrophy in this study (Table 19.3), as confirmed by the measurements of bone
density, the other features (lucencies, subchondral lysis and loss of trabecular pattern)
were also detected. This produced a "patchy' peri-articular appearance comparable to
that seen in algodystrophy. The radiographic similarity between disuse and
algodystrophy has been described previously (Steinbach 1964; Jones 1969), but as
demonstrated in this study, the severity of the demineralisation distinguishes
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algodystrophy from disuse. There may therefore be a common pathogenesis which is
accelerated in algodystrophy. In both conditions there is decreased mechanical stress
on the bone which is thought to be an important factor (Trueta 1954; Geiser and Trueta
1958). The reduction in movement causing this alteration in stress however, is
generally equal in both groups or may even be more pronounced in disuse. Therefore
this cannot account for the more marked radiographic findings in algodystrophy.
Trueta (1954) did notice however, a marked increase in vascularity following disuse.
Increased bone blood flow is a feature of algodystrophy reflected in the increased uptake
of technetium labelled diphosphonate into bone (Doury et a/. 1981, MacKinnon arid
Holder 1984). The uptake seen in algodystrophy is in excess of that seen in simple
disuse (Chapter 20) at an identical time after fracture, and therefore increased bone
blood flow may well be implicated in the excessive bone resorption seen in
algodystrophy.
In conclusion, algodystrophy is associated with radiographic abnormalities in
trabecular bone early in the condition which is greater than those following
immobilisation alone. These semi-quantitative assessments were confirmed by
measurements of bone mineral density. The significant difference in radiographic
abnormalities between disuse and algodystrophy may help differentiate between them
in cases which are not clinically obvious, particularly early in the course of the
condition.
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CHAPTER 20: SCINTIGRAPHIC FEATURES. 
Technetium isotope scans are recommended in the early diagnosis of
algodystrophy before radiographic changes become apparent (Doury et al. 1981). They
provide information not only on the metabolic activity of bone in late scans but also on
the regional blood flow in the blood pool phase. These patterns of activity are altered in
algodystrophy (Doury et al. 1981; Mackinnon and Holder 1984) but have not been
directly compared with a control group following trauma. Therefore the reported
increase in tracer uptake has not been adequately differentiated from disuse alone
which may lead to diagnostic confusion. In addition, an alteration in local bone blood
flow and metabolism would have implications with regard to the cause of the excessive
bone loss seen in algodystrophy when compared with a control population (Chapter 19).
There may therefore be an association between tracer uptake and the measurements of
bone loss detailed in the previous chapter.
In order to define the isotope uptake in algodystrophy and disuse shortly after
trauma, the activity seen on Technetium isotope scans was compared in post-traumatic
algodystrophy and a control population following CoIles' fracture.
Methods. 
Technetium 131 1 scans were performed on 43 patients with pain/tenderness,
vascular instability, swelling and stiffness and 10 patients with none of these features.
The scans were taken two weeks after plaster cast removal, when both the radiographic
and densitometric assessments were made. In addition isotope scans were performed
on three patients with a dense hemiplegia seven weeks after a cerebro-vascular accident
(CVA). The uptake in the delayed phase is expressed as a ratio of affected to unaffected
side (metacarpal score), details of which are given in Chapter 11.
The statistical analyses used were the same as in the previous two chapters.
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Results
There was no difference in the age, sex distribution and duration of
immobilisation between the patients with algodystrophy and the control group
(Appendix I).
There was increased uptake in the blood pool phase in 38 out of 43 scans on
patients with algodystrophy with normal uptake in a further two. Due to technical
failure, there was no information available on the remaining three. Increased uptake
was seen in only four of the 11 scans on the control patients, a significant difference
(X2 = 16.58; p <0.0001).
The distribution of metacarpal scores within each group was normal but with
control patients occupying the lower end of the range (Fig 20.1a). The mean metacarpal
score in the algodystrophy group was 2.06 + 0.10 which was significantly greater (p <
0.0002) than the control group (1.14 + 0.04). The mean score for the three patients
with hemiplegia was 1.73 + 0.17 which, although less than the score for the
algodystrophy patients, was not significantly different. It was however, significantly
greater than the score for the control group (p < 0.0001).
Using linear regression analysis there was a good correlation between the
metacarpal score and the bone mineral density of trabecular bone (BMDtrab) defined in
the previous chapter (Fig 20.2). This was not apparent when the metacarpal score was
compared with BMDcort(R = -0.36), combined cortical width (R = -0.18) or radiographic
score (R = 0.24).
ROC analysis of the metacarpal score (Fig 20.3) demonstrated that it was of less
discriminant value than dolorimetry (Fig 17.2). At a metacarpal score of 1.3, the
positive predictive value was maximal (88%) with a sensitivity of 91% and specificity of
82%. This meant that 39 of the 43 algodystrophy patients were positively identified
with only one of 10 controls falsely identified.
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Fig 20.1. The distribution of the metacarpal scores was examined using Probit
analysis in 43 algodystrophy, and 10 control patients who had a Colles' fracture
but no evidence of algodystrophy. The values in both groups were normally
distributed with the score in control patients occupying the lower end of the
range.
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Fig 20.3. The ability of the isotope metacarpal score to identify patients with
algodystrophy was analysed by ROC analysis in 43 patients with algodystrophy
and 10 controls. Though of more discriminant value than radiographic scores
or photon absorptiometry indices, the metacarpal score was still of less value
than dolorimetry.
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Discussion
This study has shown that the increase in uptake of Technetium in disuse
atrophy following trauma is significantly less than that in post-traumatic algodystrophy
and demonstrates that isotope scans can identify post-traumatic algodystrophy at an
earlier stage than we had previously reported (Atkins et al. 1990).
Isotope scanning was of more discriminant value than the radiographic score,
which had a positive predictive value of 83%, and consequently was a more useful
investigation for the diagnosis of algodystrophy than radiography or photon
absorptiometry. A cut off value of 1.3 gave the maximal predictive value (88%) which is
nevertheless short of 100%. Therefore isotope scanning alone cannot be used to
diagnose algodystrophy nor screen a population, but it can provide an adjunct to
diagnosis alongside other clinical indices particularly in the early stages of the
condition.
The early images may be of use in differentiating disuse from algodystrophy, as
in only four of the 10 control patients was there any detectable increase in the vascular
phase. Originally, there was some confusion as to the significance of the early images
in algodystrophy as the response was often variable (Mackinnon and Holder 1984).
Desai and Intenzo (1984) however, have demonstrated the reactional hyperaemia
following tourniquet release would account for a spuriously high uptake in the
unaffected limb, if, as is usually the case, the injection was given in this limb. In this
study an intravenous cannula was inserted without the use of a tourniquet thus
removing this source of error. Vascular instability is one of the criteria for the diagnosis
of algodystrophy and in the early stages of the disease is usually red and warm
(Chapter 15). The increased uptake in the blood pool phase, which indicates a
generalised increase in blood flow, is therefore reflected in the clinical picture. In four
control patients there was also an increase in blood flow but this was not
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complemented by an increase in the delayed phase indicating an increase in bone
metabolic activity.
The degree of uptake in the CVA patients was rather surprising considering
there was no evidence of algodystrophy. The degree of uptake however, probably
represents the maximal uptake possible in the hand due to immobility alone and as
such emphasizes the scintigraphic abnormalities seen in disuse. The scans were
performed seven weeks following a CVA, and therefore the period of immobilisation, if
anything, was greater than in our patients with algodystrophy, but despite this, the
degree of uptake is still more marked in the algodystrophy group (2.06 + 0.10), though
not significantly. It should also be noted that although the algodystrophy patients will
have stiffness and swelling of the hand, the joints are by no means completely immobile
and patients were encouraged to actively mobilise their fingers both during
immobilisation and after cast removal. In addition the algodystrophy group includes
patients with a milder disease process than is typically envisaged by the early
descriptions of Sudeck's atrophy. There is therefore an as yet undefined factor in
algodystrophy which results in the more marked uptake of isotope seen in excess of
disuse.
There was a significant correlation between the trabecular bone mineral density
and metacarpal score which suggests that they may have been causally related. The
loss in bone density was likely to be due to an increase in osteoclast activity and
therefore bone resorption. This is coupled with an imbalanced increase in bone
formation resulting in an increase in the uptake of Technetium but a net loss of bone.
The cause of the increased bone turnover, although in some way related to increased
blood flow is unknown. Burkhart and Jowsey (1967) found that excessive bone
resorption failed to develop in rats following parathyroidectomy, even though complete
immobilisation and secondary hypervascularity of the extremity was induced. They
concluded that circulating parathyroid hormone is the essential effector in disuse
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atrophy and local factors such as hyperaemia induce greater sensitivity to the
circulating hormones in the immobilised part. It is interesting to note that in one of the
control patients, who proved to have primary hyperparathyroidism, there was an
unusually high radiographic score and low BMD. This patient was excluded from the
main study group. It may be therefore that the skeletal effects of algodystrophy are
simply a consequence of an alteration in local blood flow.
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CHAPTER 21: BIOCHEMICAL FEATURES
Traditionally one of the hall-marks of algodystrophy has been the absence of any
measurable biochemical changes in bone metabolism. This is not surprising
considering the regional nature of the condition. There have been recent reports
however, notably by Eisinger et a/. (1974) and Schiano et a/. (1976), claiming changes in
the rates of bone resorption and formation which alter as the disease progresses.
Unfortunately, other authors have not been able to report these findings in as
consistent a fashion. In addition, the normal metabolic response to trauma may
hamper use of the parameters of bone turnover as a diagnostic aid in post-traumatic
algodystrophy.
The aim of this study was therefore firstly to determine the effect of
algodystrophy, a regional osteoporosis, on systemic skeletal homeostasis. Secondly, if
there were any systemic markers of bone metabolism, their ability to differentiate post-
traumatic algodystrophy from disuse.
Methods. 
Forty seven patients with algodystrophy and 29 control patients with a Cones'
fracture but no evidence of algodystrophy were examined 2 weeks out of plaster. The
biochemical parameters measured were corrected serum calcium, parathyroid hormone
(FTH), serum alkaline phosphatase and osteocalcin (markers of bone formation) and
urinary calcium and hydroxyproline (markers of bone resorption); the measurement
techniques have been detailed in Chapter 13. The statistical analysis was the same as
in previous chapters.
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Results
Both groups were matched for age and sex (Table 21.1.). There was a significant
difference in the osteocalcin between the two groups (p <0.0002; Table 21.1) at
presentation but this was not matched with a similar difference in alkaline
phosphatase, the other marker of bone formation. There was no correlation with
between the alkaline phosphatase and osteocalcin using simple regression analysis.
Table 21.1. Biochemical parameters (mean + SEM) at presentation. The only
significant difference between the algodystrophy and control group two weeks after
removal of plaster, was a lower osteocalcin. The normal ranges shown are the
laboratory reference range.
Algodystrophy Control Normal range
Age (years)	 64.2 + 1.5 64.4 + 1.9
Sex (F:M) 39:8 27:2
Serum calcium (mmo1/1) 2.43 + 0.01 2.43 + 0.02 2.12 - 2.63
Serum phosphate (mmo1/1) 1.05 + 0.01 1.05 + 0.01 0.60 - 1.50
Creatinine (umo1/1) 82.0 ±2.1 81.2 ±2.4 60- 120
Parathyroid hormone (pg/l) 51.4 + 2.4 51.4 + 2.5 30 -130
Alkaline phosphatase (IU/1) 93.5 + 7.4 91.4 + 4.0 35 - 105
Osteocakin (ng/ml) 5.09 +0.60* 11.43 + 1.69 8 -36
Urinary calcium mol/
mol creatinine
0.28 + 0.03 0.32 + 0.03 <0.4
Urinary hydroxyproline mmol/
mol creatinine
28.3 + 2.1 28.8 + 3.1 <30
* - p <0.0002.
Although both the urinary calcium and hydroxyproline levels were at the upper
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limit of normal (Table 21.1), there was no significant difference between the two groups. .
The urinary calcium/creatinine did however, correlate well with urinary hydroxyproline
in the algodystrophy group (R = 0.39; p < 0.007), unlike the control group (R = 0.25; p>
0.05). There appeared to be no correlation between the urinary
hydroxyproline/creatinine and alkaline phosphatase in either group (algodystrophy R =
0.14; control R = 0.12).
In both groups, the serum calcium was maintained well within the normal range
with a normal PTH level. There was no correlation between the PTH and osteocalcin as
might be expected if there was an increase in bone formation.
ROC analysis was performed on the only significant biochemical parameter,
serum osteocalcin. The calculated maximal predictive value was 84% at a level of 4
ng/ml or less but this was mainly due to a high specificity (75%). The sensitivity at this
level was only 36% and correspondingly, the ROC curve was only marginally better than
that of no discriminant value (Fig 21.1).
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Fig 21.1. The ability of the serum osteocalcin to identify patients with
algodystrophy was analysed using ROC analysis on 47 algodystrophy an! 29 control
patients. The measurement of serum osteocalcin was of minimal discriminant
value and of less value than the measurement of finger tenderness by
dolorimetry.
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Discussion. 
Eisinger in 1967, reported significant increases in urine hydroxyproline, a
marker of bone resorption, in eight cases of algodystrophy. He elaborated on these
findings in a later study (Eisinger et al. 1974) on 67 patients demonstrating
hydroxyprolinuria in the early stage of the disease, gradually falling to within the
normal range as the disease entered it's latter stages. The main criticism of this paper
is that increased bone resorption occurs secondary to immobilisation alone, and
therefore the changes they observed may have been due to this rather than the
algodystrophic process. In addition, the site and precipitating cause of the
algodystrophy was variable. It is perhaps not surprising therefore that the results of
the present study differ considerably from that of Eisinger et al. (1974). In both groups
the urinary calcium and hydraxyproline were at the upper limit of normal as one would
expect following immobilisation, but there was no evidence of a greater increase in bone
resorption in algodystrophy.
In the absence of any difference in renal function between the two groups (Table
21.1), the significant decrease in osteocalcin in the algodystrophy group does indicate a
reduction in bone formation. This was not mirrored by a similar decrease in alkaline
phophatase which is also a marker of bone formation though not bone specific. This
decrease in formation at a local rather than skeletal level was not sufficient to cause an
alteration in serum or urine calcium and consequently there was no change in PTH.
This local decrease may also account for the absence of any change in the serum
alkaline phosphatase. The imbalance in bone turnover in algodystrophy would lead to a
net loss of bone mineral which explains the significantly greater decrease in the bone
mineral density in cortical and trabecular bone (Chapter 19) at the same time following
fracture. It would be of interest to monitor the progression of bone formation, as
measured by serum osteocalcin, and the recovery of bone mass. This will be addressed
in a later chapter.
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NATURAL HISTORY.
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CHAPTER 22: CHANGES IN CLINICAL FEATURES
The late sequelae of algodystrophy, chronic causalgic pain, atrophy and
stiffness, are well documented but occur relatively infrequently following trauma,
accounting for the 1-2% incidence quoted in the English literature (Bacorn and Kurtzke
1953; Plewes 1956; LidstrOm 1959; Frykrnan 1967; Pool 1973; Stewart et a/. 1984).
The discrepancy between this incidence and the 28% found in this study (Chapter 15)
was probably due to the identification of a milder form of the condition which was not
documented in the retrospective studies. The clinical significance of this milder
condition however, is unclear. There are no prospective studies examining the local
clinical response to trauma, in particular with regard to the development of pain and
tenderness, vascular instability, swelling and stiffness, the fundamental clinical
features of algodystrophy. The time period over which these symptoms progress and
resolve and the degree of morbidity associated with them remains unknown. The lack
of knowledge of the early natural history has particular implications with regard to the
evaluation of therapeutic measures aimed at preventing or speeding recovery of the
condition. In view of the fact that there is such a large discrepancy between the quoted
incidence and the incidence in this study, a large proportion of the cases must resolve
spontaneously. A failure to recognise this fact may lead to falsely attributing the
resolution of the condition to the therapeutic intervention.
In order to study the resolution post-traumatic algodystrophy and define the
morbidity it causes, the clinical progression of algodystrophy following Cones' fracture
was evaluated using the techniques described in previous chapters.
Methods. 
The clinical techniques used to identify pain and tenderness, vascular
Instability, swelling and stiffness, the four basic features of algodystrophy, have been
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described in detail in Chapter 9. They were based on dolorimetry, the measurement of .
hand volume, and direct questioning. In addition, a functional assessment of the
degree of morbidity was made using measurements of grip strength which were
incorporated into a functional scoring system, again described in Chapter 9 (Table 9.3).
The scoring system was based on patients complaints, ability to do everyday tasks,
signs and symptoms, and cosmesis. They were first reviewed two weeks after plaster
removal and then at monthly intervals upto a maximum of six months in patients with
no algodystrophy. Patients with algodystrophy were reviewed monthly until their
symptoms resolved or when they declined any further visits.
The statistical analysis used was the same as in previous chapters with the
addition of actuarial analysis to study the progression in various features of the disease.
This took into account patients withdrawing from the study because the feature
resolved or they were lost to follow-up. Life-tables were calculated using the Kaplan-
Meier technique and the difference between survival curves assessed using Gehan's
method which is a modification of the Wilcoldn Rank test.
Results. 
Two hundred and seventy four patients were studied prospectively of whom 77
had pain and tenderness, vascular instability, swelling and stiffness and were thus
considered to have algodystrophy. Of the remaining 197 patients, 72 were considered
to be a borderline group displaying some of the features and 125 had no features.
Pain and tenderness. The significant difference in the dolorimetry scores (ANOVA p <
0.0001) between the three groups at presentation, seven weeks after fracture, (Fig 22.1)
has previous/3r been shown (Chapter 16). There was however a gradual resolution in
finger tenderness such that the difference between the borderline group and those with
no features of the disease had become insignificant by 19 weeks after the fracture.
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Fig 22.1. The mean (-1-1- SEM) dolorimetry ratio was recorded in 274 patients
with a Cones' fracture divided into algodystrophy, borderline and control
groups. The dolorimetry ratio remained significantly lower in the algodystrophy
group and was below the normal range (0.92 - 1.08) at 31 weeks after fracture.
Although initially significantly lower, the dolorimetry ratio in the borderline
group were indistinguishable from controls by 11 weeks after fracture.
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The same was true of the algodystrophy group but the dolorimetry score remained
significantly lower than the other two groups such that at 31 weeks after the fracture, it
was still below the normal range (0.92-1.08).
Kaplan-Meier life tables were calculated for the algodystrophy (Table 22.1) and
borderline groups (Table 22.2) to examine the resolution of abnormal finger tenderness
between the two groups as only 16 of the 72 patients in the borderline group had
abnormally low dolorimetry scores. A patient was deemed to have resolved when the
dolorimetry score was within the normal range. The internal probability was the
percentage probability of patients entering that interval surviving to the end and the
conditional probability was the percentage probability of those entering the study
surviving to the end of the interval. The variance was that of the conditional
probability.
In the borderline group there was a 12.5% probability that patients, entering the
study with an abnormal dolorimetry score, would have abnormal dolorimetry at to 31
weeks, with 50% resolving by 15 weeks. By comparison, there was a 50% probability
that algodystrophy patients would have abnormally tender fingers at 31 weeks, with
only 23% resolving by 15 weeks. Indeed, at one year there were still two patients with
low dolorimetry scores. A comparison of the survival curves (Fig 22.2) demonstrated a
significant difference (p < 0.03) in the rate of resolution of tenderness between the
borderline and algodystrophy group.
Pain appeared to resolve quicker than tenderness in both groups. In patients
with algodystrophy, there was a 25% probability that pain would persist to 31 weeks in
those who initially complained of painful fingers (Table 22.3), with 40% of patients
resolving by 15 weeks. In the borderline group, only 17 patients complained of pain,
with the majority resolving by 15 weeks (Table 22.4). There was only one patient
complaining of painful fingers in this group after 23 weeks. Although pain settled in
the borderline group at a faster rate and lasted a shorter duration, there was no
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significant difference between the slopes (Fig 22.3).
Table 22.1. Kaplan-Meier life table for the continuation of algodystrophy patients with
abnormal dolorimetry scores.
Interval
(weeks after fracture)
At riskResolved Lost Int.
prob (%)
Cond.
prob 1%)
Variance
8-9 77 2 0 97.3 97.3 0.0004
9-10 75 3 0 95.8 93.2 0.0009
10-11 72 3 2 97.1 90.5 0.0012
11-15 67 9 1 86.4 77.0 0.0024
15-19 57 6 0 89.1 68.9 0.0029
19-23 51 6 14 88.2 60.8 0.0032
23-27 31 3 3 90.3 54.9 0.0037
27-31 25 2 0 92.0 50.5 0.0040
31-35 23 8 2 65.2 33.0 0.0042
35-39 13 1 0 92.3 30.4 0.0042
39-43 12 2 0 83.3 25.4 0.0040
43-47 10 2 0 80.0 20.3 0.0036
47-51 8 1 2 87.5 17.8 0.0033
51-55 5 2 1 60.0 10.7 0.0027
55-55 2 0 0 100 10.7 0.0027
Int. prob. - internal probability
Cond. prob. - conditional probability.
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Table 22.2. Kaplan-Meier life table for the continuation of borderline patients with
abnormal dolorimetry scores.
Interval
(weeks after fracture)
At riskResolved Lost Int.
prob (%)
Cond.
prob (%)
Variance
11-15 16 8 0 50.0 50.0 0.0156
15-19 8 2 0 75.0 37.5 0.0146
19-27 6 2 2 66.7 25.0 0.0117
27-31 2 1 0 50.0 12.5 0.0107
31-31 1 0 0 100 12.5 0.0107
Int. prob. - internal probability
Cond. prob. - conditional probability.
algodystrophy borderline
p < 0.03
1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1
7 11 15 19 23 27 31 35 39 43 47 51 55 59
Weeks
Fig 22.2. Actuarial analysis was performed on the 77 algodystrophy and 16
borderline patients who had abnormally low dolorimetry ratios at presentation.
There was a rapid and significant resolution in the number of patients with
abnormally tender fingers.
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Table 22.3. Kaplan-Meier life table for the survival of algodystrophy patients with
abnormal pain in the hand.
Interval
(weeks after fracture)
At riskResolved Lost Int.
prob (%)
Cond.
prob (%)
Variance
8-9 77 8 0 89.2 89.2 0.0012
9-10 69 7 0 89.4 79.7 0.0022
10-11 62 5 2 91.5 73.0 0.0027
11-15 55 9 1 83.3 60.8 0.0032
15-19 45 5 0 88.9 54.1 0.0034
19-23 40 11 3 72.5 39.2 0.0032
23-27 26 6 1 76.9 30.2 0.0030
27-31 19 3 0 84.2 25.4 0.0027
31-35 16 3 3 81.3 20.6 0.0024
35-55 10 3 7 70.0 14.4 0.0021
IM. prob. - internal probability
Cond. prob. - conditional probability.
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Table 22.4. Kaplan-Meier life table for the continuation of borderline patients with
abnormal pain in the hand.
Interval	 At riskResolved Lost 	 Int.	 Cond.	 Variance
(weeks after fracture)	 prob (%)
	
prob Pk) 
11-15 17 11 0 35.3 35.3 0.0134
15-19 6 1 0 83.3 29.4 0.0122
19-23 5 2 2 60.0 17.7 0.0085
23-23 1 0 0 100 17.7 0.0085
Int. prob. - internal probability
Cond. prob. - conditional probability.
algodystrophy borderline
p > 0.05
1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1	 1
7 11 15 19 23 27 31 35 39 43 47 51 55 59
Weeks
Fig 22.3. Actuarial analysis was performed on the 77 algodystrophy and 17
borderline patients who had pain in the hand at presentation. Although not
significant, the pain resolved more rapidly in the borderline group.
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Vascular instability. Symptoms of vascular instability were slower to resolve than
tenderness resulting in a 29% probability that symptoms would persist one year after
the fracture. In particular, resolution early in the course of the condition was slow
(Table 22.5) with 91% of patients persisting with symptoms of vascular instability at 15
weeks compared to 77% with tenderness. By 31 weeks after fracture the respective %
probabilities were more comparable (vascular instability - 61%; tenderness - 51%).
There therefore appeared to be a more gradual resolution in the symptoms of vascular
instability compared with tenderness.
Over half the patients in the borderline group complained of vascular instability
(Table 22.6). There was a rapid decrease in symptoms by 15 weeks with only 45%
persisting, far less than the algodystrophy group (91%). By 31 weeks there were no
patients complaining of vascular instability in the borderline group. The rapid
resolution of this symptom resulted in a significant difference (p < 0.0001) between the
actuarial curves (Fig 22.4).
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Table 22.5. Kaplan-Meier life table for the continuation of algodystrophy patients with.
symptoms of vascular instability in the hand.
Interval
fweeks after fracture)
At riskResolved Lost Int.
Drab (%)
Cond.
Drob (%)
Variance
8-9 77 1 0 98.7 98.7 0.0002
9-10 76 6 2 97.3 96.0 0.0005
10-11 74 2 2 97.2 93.2 0.0009
11-15 70 2 1 97.1 90.5 0.0012
15-19 67 4 0 94.03 85.1 0.0017
19-23 63 10 10 84.1 71.6 0.0027
23-27 43 4 3 90.7 65.0 0.0033
27-31 36 2 0 94.4 61.4 0.0035
31-35 34 8 5 76.5 46.9 0.0041
35-39 21 2 4 90.5 42.5 0.0042
39-43 15 2 2 86.7 36.8 0.0046
43-47 11 1 2 90.9 33.4 0.0048
47-55 8 1 5 87.5 29.3 0.0052
55-55 2 0 0 100 29.26 0.0052
Int. prob. - internal probability
Cond. prob. - conditional probability.
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Table 22.6. Kaplan-Meier life table for the continuation of borderline patients with
symptoms of vascular instability in the hand.
Interval
	
At riskResolved Lost	 Int.	 Cond.	 Variance
(weeks after fracture)	 prob (%)	 prob (%) 
11-15 38 21 1 44.7 44.7 0.0065
15-19 16 1 0 93.8 41.9 0.0065
19-27 15 7 5 53.3 22.4 0.0048
27-31 3 1 2 66.7 14.9 0.0058
Int. prob. - internal probability
Cond. prob. - conditional probability.
p <0.0001
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7 11 15 19 23 27 31 35 39 43 47 51 55 59
Weeks
Fig 22.4. Actuarial analysis was performed on the 77 algodystrophy and 38
borderline patients who had vascular instability at presentation. There was a
significant difference in the rate of resolution between the groups with
vascular instability persisting in 30% at one year in those with algodystrophy.
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There was no change in the type of vascular instability described by the patients,
with algodystrophy. The warm, hot hand predominated and, at least upto 26 weeks
after fracture, there did not appear to be a transition to the cold, blue hand described in
the later stages of the condition (Table 22.7).
Table 22.7. Vascular instability was defined as an alteration in colour or temperature
of the hand as experienced by the patient. The change in colour was categorized into a
red or blue hand and temperature into a hot or cold hand. The percentage distribution
of change in colour and temperature are given in time points upto 31 weeks after
fracture. There was no difference in the proportions of red/blue or hot/cold hands for
the duration of the study.
Weeks after
fracture
Alteration in colour
% Red	 % Blue
Alteration in temperature
% Hot	 % Cold
7 78 22 93 7
11 84 16 96 4
15 76 24 90 4
19 77 23 88 12
31 91 9 90 10
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Hand swelling. There was a significant difference in mean hand volume between the
algodystrophy, borderline and normal patients at first presentation (ANOVA p < 0.0001),
7 weeks after fracture. This difference was due to the larger hand volume in the
algodystrophy group, there was no difference between the borderline and normal
patients (Fig 22.5). The greater hand volume in the algodystrophy group gradually
resolved such that at 15 weeks after fracture, there was no difference in volume
between any of the groups. Hand volume in the patients with aigodystrophy continued
to decrease steadily until, at 31 weeks after fracture, the volume was significantly less
than the other two groups (ANOVA p <0.02). At no point was there any difference in
hand volume between the borderline and normal group, nor was there any obvious
trend in change in volume as shown in the algodystrophy group.
Kaplan-Meier life tables were also calculated for the patients perception of
swelling of the hand. There were 44 (62%) patients who complained of swelling in the
borderline group. The degree of swelling was minimal however as there was no
detectable difference in hand volume between this and the normal group who had no
symptoms of hand swelling. Indeed the probability of the swelling persisting at 15
weeks after the fracture in the borderline group was only 20% (Table 22.9), the number
complaining having fallen to nine. There was no further follow-up on those patients
with swelling after 19 weeks.
In contrast, in the patients with algodystrophy there was a gradual decline in
the number complaining of swelling and only two were still symptomatic at one year
after the fracture. The probability of the symptom persisting to 15 weeks after the
fracture was 87% (Table 22.8), greater than the probability at the same time point in
the borderline group. There was consequently a significant difference between the
survival curves (Fig 22.6: p <0.0001).
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Fig 22.5. The mean (+/- SEM) hand volume ratio was recorded in 274 patients
with a Col/es' fracture divided into algodystrophy, borderline and control
groups. The hand volume ratio was significantly greater in the patients with
algodystrophy upto 19 weeks after fracture. Following this the mean hand volume
ratio was significantly lower than the borderline or control groups. A smaller
hand was consistant with the atrophic appearance of the hand which is seen in
the later stages of algodystrophy.
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Table 22.8. Kaplan-Meier life table for the persistence of hand swelling in patients with
algodystrophy.
Interval
(weeks after fracture)
At riskResolved Lost Int.
prob (%)
Cond.
prob (%)
Variance
8-10 77 2 0 97.3 97.3 0.0004
10-11 75 2 2 97.2 94.6 0.0007
11-15 71 6 1 91.4 86.5 0.0016
15-19 64 14 0 78.1 67.6 0.0030
19-23 50 14 0 72.0 48.7 0.0034
23-27 28 7 1 75.0 36.5 0.0035
27-31 20 4 0 80.0 29.2 0.0033
31-35 16 8 3 50.0 14.6 0.0022
35-51 5 1 2 80.0 11.7 0.0021
51-51 2 0 0 100 11.7 0.0021
Int. prob. - internal probability
Cond. prob. - conditional probability.
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Table 22.9. Kaplan-Meier life table for the persistence of hand swelling in the
borderline patients.
Interval	 At riskResolved Lost	 hit.	 Cond.	 Variance
(weeks after fracture)
	
prob (%)
	
prob (%) 
11-15 44 35 0 20.5 20.5 0.0037
15-19 9 4 0 55.6 11.4 0.0023
19-19 5 0 0 100 11.4 0.0023
Int. prob. - internal probability
Cond. prob. - conditional probability.
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Fig 22.6. Actuarial analysis was performed on the 77 algodystrophy and 44
borderline patients who had hand swelling at presentation. There was a rapid
and significant resolution in hand swelling in the borderline patients.
Swelling resolved at a slower rate in the algodystrophy group with 11% still
demonstrating the symptom one year after fracture.
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Stiffness and function. A sensation of stiffness in the fingers was the most permanent
feature of algodystrophy with a 66% probability of the symptom persisting for one year
(Table 22.10), that is 25 of the original 77 patients still complained of stiff fingers.
Although ranges of movement were not specifically measured, 14 of these patients also
had clinical evidence of a limitation in movement, particularly fixed flexion deformities
of the proximal inter-phalangeal joints. As with other features of the condition, there
was a gradual decrease in the number of patients with stiffness, unlike the borderline
group in whom stiffness resolved rapidly (Fig 22.7). Twenty-four patients complained of
stiff fingers in the latter group, but only 11 remained stiff by 19 weeks (a 46%
probability; Table 22.11).
Stiffness was therefore the most persistent of the four features of algodystrophy.
To examine whether persistent stiffness was associated with the other features of
algodystrophy or occurred at random, the patients examined at six months were divided
into those with or without stiffness (Table 22.12). Of the 37 patients available, 28 (76%)
complained of stiffness in their fingers. These patients also had significantly greater
finger tenderness (p <0.03) and weaker grips (p <0.05). Although not significant, their
hand volume was less than those patients with no evidence of stiffness which was
similar to the earlier finding that patients with algodystrophy had a smaller hand
volume six months after fracture than controls (Fig 22.5). There was no significant
difference in the proportion of patients with vascular instability or swelling in patients
with or with out stiffness.
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Table 22.10. Kaplan-Meier life table for the persistence of finger stiffness in patients •
with algodystrophy.
Interval
(weeks after fracture)
At riskResolved Lost Int.
prob 1%)
Cond.
Drob (%)
Variance
9-10 77 2 0 97.3 97.3 0.0004
10-11 75 4 2 97.2 94.6 0.0010
11-15 69 2 1 97.1 89.2 0.0013
15-19 66 1 0 98.5 87.8 0.0014
19-23 65 6 14 90.8 79.7 0.0022
23-31 43 2 4 95.5 76.0 0.0026
31-35 37 1 5 97.3 74.0 0.0029
35-43 31 1 5 96.8 71.6 0.0033
43-50 25 2 23 92.0 65.6 0.0043
Int. prob. - internal probability
Cond. prob. - conditional probability.
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Table 22.11. Kaplan-Meier life table for the persistence of finger stiffness in borderline.
patients.
Interval	 At riskResolved Lost	 Int.	 Cond.	 Variance
(weeks after fracture)	 prob (%)
	
prob (%) 
11-15 24 13 0 45.8 45.8 0.0103
15-19 11 3 0 72.7 33.3 0.0093
19-23 8 3 4 62.5 20.8 0.0069
23-23 10 0 0 100 20.8 0.0069
Int. prob. - internal probability
Cond. prob. - conditional probability.
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Fig 22.7. Actuarial analysis was performed on the 77 algodystrophy and 24
borderline patients who had hand stiffness at presentation. Stiffness quickly
resolved in the borderline patients but remained a persistent problem in
patients with algodystrophy. At one year, 65% of patients with algodystrophy
continued to complain of a sensation of stiffness.
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Table 22.12. The mean value (± SEM) of the dolorimetry, hand volume and grip
strength ratios and the proportion of patients with evidence of vascular instability and
hand swelling were calculated in patients with and without finger stiffness six months
after fracture. There was a significant difference in the dolorimetry and grip strength
ratios. Although not significant, the hand volume was reduced in the patients with
finger stiffness.
Stiffness No Stiffness
Number of patients 28 9
Dolorimetry ratio 0.88 + 0.02 0.99 + 0.01 **
Grip strength ratio 0.49 + 0.04 0.64 + 0.07 *
Hand volume ratio 0.98 + 0.01 1.00 + 0.01 NS
Vascular instability 15 2 NS
Hand swelling 7 1 NS
** p <0.03; p < 0.05; NS not significant.
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There are many reasons for a functional loss after inunobilisation for a fracture •
and it was not surprising to find a reduction in grip strength ratio (affected/unaffected
side) in the group with none (0.42 + 0.03) or some of the features of algodystrophy (0.34
+ 0.03) at presentation. The difference in grip strength between these two groups was
not significant. There was however, a significant difference between these groups and
patients with algodystrophy (0.20 + 0.02; ANOVA p <0.0001). There was a steady
Improvement in grip strength in all groups (Fig 22.8) but the significant differences
between the algodystrophy and other two groups remained. By six months the grip
strength in the control population had almost reached parity (0.85 + 0.03) but was still
approximately 50% reduced in the algodystrophy group (0.54 + 0.03). Indeed at one
year, in five patients still being followed, the ratio was still reduced at 0.62 + 0.05).
From the point of view of grip strength alone therefore there was a significant
reduction in functional ability in patients with algodystrophy. This was further
examined using a functional scoring system which takes into account loss of grip
strength (Chapter 9; Table 9.3). Thirty-seven patients with algodystrophy and 32
normal controls were picked at random and reviewed six months following their Colles'
fracture. There was no difference in the age, sex or duration of immobilisation between
the two groups (Table 22.13). In all three sections, complaints, function, and signs and
symptoms, there was a significant difference between the algodystrophy and control
groups. No attempt was made to categorize patients who had some but not all the
features of algodystrophy.
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Fig 22.8. The mean (+/- SEM) grip strength ratio was recorded in 274 patients
with Col/es' fracture divided into algodystrophy, borderline and control groups.
All groups had evidence of decreased grip strength at presentation but the
algodystrophy group were significantly weaker. Strength improved at a
comparable rate in all groups upto 15 weeks after fracture, after which there
was little further improvement in the algodystrophy group.
260
Table 22.13. The functional scoring system assessed patient complaints, the ability tO
perform everyday tasks and symptoms and signs. Each detail was given a value which
increases as the severity of the disability increased. There was a significant increase in
the score for each individual section and in total for patients with algodystrophy.
Algodystrophy Normal p<
Complaints 20.5 + 1.8 14.3 + 1.3 0.01
Function 25.7 + 2.1 11.0± 1.2 0.0001
Signs and
symptoms
7.32 + 0.9 2.56 + 0.2 0.0001
TOTAL 53.5 + 4.3 27.9 + 2.9 0.0001
Discussion
This study has shown that there is a gradual resolution of symptoms and signs
in algodystrophy but still sufficient to cause short-term morbidity in a greater number
of cases than has been previously recognised. The rate of resolution was greatest in the
patients perception of swelling and pain in the hand with a probability that there would
be approximately a 40% decrease in patients with these symptoms at three months
after the fracture. The decrease in swelling mirrored a similar decrease in the direct
measurement of hand volume in that by 15 weeks after fracture, there was no
significant difference between algodystrophy and the other groups. Nevertheless,
despite the relatively rapid initial resolution of swelling, there was still a significant
difference in the patients perception of hand swelling from the borderline group.
The absence of any difference in pain between the algodystrophy and borderline
groups may have been due to pain from the fracture site masking the pain in the hand
and fingers. Indeed, although not specifically recorded, it was my impression that
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patients with algodystrophy complained of more pain from the fracture site and may
therefore have ignored pain from other sites. It was not thought possible to further
quantify this in view of the problems encountered with linear analogue scales or pain
questionnaires (Chapter 9).
The resolution of tenderness and vascular instability was less rapid than that of
pain with a 20% remission at three months. Stiffness was the most persistent feature
with only a 10% remission by three months. It is interesting to note the difference
between the rate of resolution of stiffness and swelling in light of the persistence of poor
grip strength in the algodystrophy patients. It would appear that grip strength is not
dependent upon swelling which confirms earlier findings (Chapter 16).
Overall there was approximately a 30% rate of resolution of symptoms three
months after a fracture. This has important therapeutic implications in the treatment
of post-traumatic algodystrophy in that early recovery may wrongly be attributed to the
treatment. In therapeutic trials therefore, in order to demonstrate treatment efficacy, it
is essential that the study is adequately controlled and that a large number of patients
are enrolled.
By six months after fracture, the proportion of patients complaining of hand
pain and swelling had fallen to 20-30%, vascular instability and tenderness to 50%, and
stiffness to 80%. These factors, along with decreased grip strength, are also associated
with a significant loss of function. For these reasons there was an appreciable short-
term morbidity in patients who exhibited signs of algodystrophy at presentation. This
would be missed in retrospective studies of Colles' fractures which rarely assess
morbidity earlier than one year. In this study, at one year after fracture, pain and
tenderness, vascular instability and swelling had decreased appreciably which may
account for the quoted 1-2% incidence of algodystrophy reported in most studies.
Stiffness however was still apparent in 50% of cases but in the absence of the other
features, would not necessarily be noted or attributed to algodystrophy. This stiffness
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may account, at least in part, for the 24% permanent loss of hand function seen
following Cones' fracture (Bacorn and Kurtzke 1953). It should be remembered
however, that stiffness in this study was based on the patients perception of the
recovery of normal movements of the fingers. It does not always imply clinical evidence
of stiffness although 14 patients, half those at one year, had fixed flexion deformities of
the proximal inter-phalangeal joints.
The existence of a borderline group of patients, who had some of the features of
algodystrophy, was described in Chapter 18. They had signs and symptoms which were
of intermediate severity between the algodystrophy and control group and may thus
have formed a sub-clinical form of algodystrophy. In this group, apart from the
perception of hand pain, the symptoms resolved more quickly than in algodystrophy.
Although function was not formally assessed in this group using the scoring system,
the grip strength was less than the normal group upto six months.
The existence of a borderline group suggests that there was a spectrum of
disease which may have become apparent with more sensitive methods of assessment.
This spectrum ranges from the normal physiological response to trauma, to the florid
examples of algodystrophy which are well recognised. The point at which the
physiological response became pathological was unclear. If the development of
morbidity is taken as an indication of a pathological process, then patients who
developed the four features of algodystrophy (28% of patients following a Colles'
fracture) fall into the latter category, though this may well be an underestimation.
The majority of patients with vascular instability presented with warm, red
hands and persisted with this abnormality until the instability settled or they were lost
to follow-up. There was no significant difference in the type of vascular instability for
the duration of the study upto six months. At this point however, the hand volume in
algodystrophy was significantly lower than in the other groups which implies a degree of
atrophy. It would appear therefore that, at least in the initial stages, atrophy is not
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necessarily associated with a cold, blue hand. Accordingly, although there is great •
variation in the progression of the condition, the development of Steinbrocker's second
stage (Ravault's stage 1; Doury's stage 1 and 2), which describes a cold, cyanotic
atrophic hand with fixed flexion contractures, occurred later than usually recognised
(Chapter 4).
In conclusion this study has described a spectrum of disease activity which
gradually resolved over the period of a year, leaving a small percentage of patients
remaining with all the features of algodystrophy. The resolution of algodystrophy
accounts in the past for the low incidence quoted in other series. There was however,
significant morbidity associated with the milder and largely unrecognised form of
transient algodystrophy. In addition, finger stiffness, in the absence of the other
features, persisted and must contribute to the late morbidity following Colles' fracture.
The features of pain and tenderness, vascular instability, swelling and stiffness after a
fracture should therefore alert the clinician to the likelihood of there being a delay in
rehabilitation and prompt treatment at the earliest opportunity.
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CHAPTER 23: CHANGES IN THE VASOMOTOR SYSTEM.
Conventionally, the circulation is divided into two types, the macrocirculation
and the microcirculation. The macrocirculation is amenable to non-invasive methods of
Investigation such as Doppler ultrasound (Kempczinski and Yao 1982) but until
recently, probes used to measure the microcirculation disrupted blood flow giving
spurious results. The logical extension of ultrasound Doppler angiography is the
optical analogue, laser Doppler angiography which has been developed to examine red-
cell flux in the microcirculation (Nilsson et al. 1980a and b).
Although vascular instability is one of the fundamental features of
algodystrophy it is difficult to quantify. Doury et al. (1981), using Doppler ultrasound,
had inconsistent results when examining 25 patients with algodystrophy. They
attributed this to examining different stages of the disease but if, as we believe, the
sympathetic system is responsible for the clinical vascular changes, any alteration is
likely to occur in the microcirculation rather than the macrocirculation.
The blood pool phase of the Technetium isotope scan gives a static image of the
blood flow to a region incorporating both bone and soft-tissue. Although a less precise
method, it does have the advantage of being more readily available in a clinical setting
unlike laser Doppler angiography which should be considered a research tool.
Quantifying changes in vascular instability would be of value, not only in
investigating the pathophysiology of algodystrophy but also as a measure of therapeutic
response. For these reasons, laser Doppler angiography and the blood pool phase of
Technetium isotope scans were used to investigate the natural history of vascular
instability in algodystrophy.
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Methods. 
Laser Doppler angiography. The laser Doppler system used was the Perimed Periflux
PfII system (Gambro Ltd, Sidcup, Kent). The technique can only be applied to a limited
number of micro-vascular beds because of the shallow penetration depth of the laser
light in tissue (about 1 mm at the low power levels used in laser Doppler flow meters).
Fortunately, the human skin is rich in microvessels and therefore the back of the hand
provided a suitable site for measurement.
Many factors, psychological, neural, metabolic, humoral and physical, influence
blood flow in the micro-circulation (Weideman et al. 1981). Consequently a stimulus-
response measurement was made where the effects of the selected stimulus, heat in
this study, would outweigh all other factors influencing blood flow in the selected
region. In addition, the vascular instability in algodystrophy responds to alterations in
the environment such as changes in temperature, and therefore any change in red-cell
flux should be maximised. The system therefore incorporated a small thermostatic
heater element which allowed skin temperature in the region of the laser probe tip to be
raised over a short range. The skin temperature was monitored by a small thermistor
incorporated in a digital thermometer. The heater element was set to increase skin
temperature to 44°C though, due to heat dissipation by circulating blood, the skin
temperature does not in practice reach this level.
Ten patients with features of algodystrophy were examined using laser Doppler
angiography. In view of the influence of external factors on the microcirculation, the
examinations were carried out in a standardised manner. Patients were requested to
abstain from smoking, and drinking alcohol, tea or coffee prior to the examination. The
same room was used for the test at each visit, in which they rested in bed at least 30
minutes before the examination started. In addition, all examinations took place in the
morning. The probe was applied to the dorsum of both hands between the 2nd and 3rd
metacarpals Just proximal to the metacarpo-phalangeal Joints. This site was used at
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each visit as variations in microvasculature can occur over short distances. Once the
patient was relaxed with a steady baseline measurement, the heater element was
switched on and the response recorded continuously on a heat sensitive plotter. The
first examination was performed, as with the other investigations, two weeks after
plaster removal. Two further examinations were made at four weekly intervals.
The microvasculature response to a heat stimulus has been well characterised
In normal subjects (Cochrane et al. 1986). After an initial delay following switching on
the heater, the red-cell flux rises sharply to reach a broad peak and thereafter declines
to a steady state. The various parameters reflecting microvasculature response were
measured on the thermal response curve (Fig 23.1). Two further parameters were
derived from the basic parameters. The total perturbation caused by heating the skin
was calculated as the area under the curve from time of application of the stimulus to
the time of reaching the steady state. The rate of change of flux was defined as the total
perturbation divided by the time taken to reach a new steady state.
Technetium isotope scan blood pool phase. The methodology for the isotope
examination has been described in Chapter 11. Blood pool phase scans were available
on 36 of the original 43 patients described in Chapter 20. The repeat scan was
performed after a 12 weeks interval. As before, a qualitative assessment was made as
to whether there was increased, normal or decreased uptake in the blood pool phase.
The presence or absence of vascular instability was also assessed at the time of the
repeat scan.
The statistical analysis was the same as that used in previous chapters.
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Fig 23.1. Schematic diagram showing the parameters measured from each of the local
heating response curves. 1, baseline flux; 2, mean peak flux; 3, steady-state flux; 4,
peak-to-peak flux at baseline; 5, peak-to-peak flux at peak response; 6, peak-to-peak
flux at steady state; 7, peak-to-peak depth of vasomotor activity; 8, time to start of
response; 9, time to start of maximum plateau; 10, time to reach steady state; 11,
period of vasomotor activity.
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Results. 
Laser Doppler angiography. All the patients studied were female with a mean age of
63 + 2.05 years. The room temperature during the examinations was fairly constant
(23.3 + 0.28°C).
In all but one patient there was some form of abnormality on the angiogram at
presentation (Table 23.1). Five patients had a poor thermal response with a low peak
and increased time to response (Fig 23.2). Of these patients, two complained of a cold
hand but with red discolouration, the remainder had warm, red hands. Therefore the
response to thermal stressing, although causing some form abnormality, was
unpredictable and did not always accurately correlate with the type of vascular
instability displayed.
Consequently it was not surprising to find no significant difference between the
affected and unaffected hand in any of the parameters (Table 22.2). This is with the
exception of the time to peak flux which was longer on the affected (199 + 15.7 seconds)
than the non-affected side (125 + 23.6 seconds; p < 0.02).
In view of the potential variation between sequential measurements, the
parameters were expressed as the ratio of the affected to unaffected side to examine the
progression of the changes in red-cell flux. Inspite of this however, there were wide
variations in most of the parameters such that no coherent information was available
though all the traces appeared to demonstrate a trend towards a normal thermal
response by 15 weeks after fracture. In four parameters (time to peak, time to steady
state, ratio of perturbation and rate of change of flux), although not significant, there
was a definite trend towards recovery (Fig 23.3).
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Table 23.1. Abnormalities of red-cell flux detected at presentation in the ten patients.
studied. There appeared to be no close correlation with the temperature or colour of the
affected hand.
Patient	 Abnormality	 Vascular instability
Temperature	 Colour
1	 Increased peak	 Hot	 Red
Increased peak flux
Increased time to peak
Increased time to steady state
Increased steady state flux
2	 Increased peak flux	 Hot	 Red
Increased time to peak
Increased steady state
Increased steady state flux
3	 No abnormality	 Hot	 Red
4	 Increased peak flux	 Hot	 Red
Increased steady state
Increased steady state flux
5	 Increased peak flux	 Hot	 Red
Increased time to steady state
6,7,8,9 & 10 Decreased peak	 3 Hot/2 Cold 5 Red
Decreased time to peak
Poor thermal response 
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Table 23.2. The parameters used to measure the red-cell flux (mean + SEM) in
response to a heat stimulus. The only significant difference between the affected and
unaffected side seven weeks after fracture was in the time to peak response.
Affected Unaffected
Baseline flux (mm) 13.0 + 1.97 9.4 + 1.15
Peak flux (mm) 52.0 + 10.23 41.3 + 6.37
Steady state flux (mm) 37.5 + 7.54 30.0 + 5.31
P/P flux at baseline (mm) 1.83 + 0.44 1.50 + 0.21
P/P flux at peak (mm) 7.33 + 1.52 7.40 + 0.49
P/P flux at steady state (mm) 5.00 + 1.05 5.10 + 0.41
P/P depth vasomotor activity (mm) 12.0 + 1.99 13.2 + 1.05
Time to response (secs.) 34.7 + 8.67 63.9 + 12.4
Time to peak flux (secs.) 125 + 23.6 199 + 15.7 *
Time to steady state (secs.) 313 + 19.1 336 + 17.3
Perturbation (mm2) 5737 + 828 4637 + 776
Rate of change of flux (mm-2-isecs) 19.0 + 3.34 13.9 + 2.05
* - p <0.002
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Fig 23.2. In five patients there was a poor thermal response to local heating measured
with laser Doppler angiography.
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Blood pool phase. The age and sex distribution of the patients is given in Appendix I.
Of the 36 scans available, 13 demonstrated increased uptake, 19 were normal and 4
were considered to have decreased uptake. The distribution of the type of uptake had
significantly altered (X2 - 29.89; p <0.0001) from the scans taken seven weeks after
fracture due to an increase in normal and, to a lesser extent, scans with decreased
uptake:
Weeks after fracture 	 Uptake
Increased
	
Normal	 Decreased
7 38 2 0
19 13 19 4
Although there was no increased uptake in the blood pool phase in 23 patients,
this was not reflected in a resolution in symptoms of vascular instability. There was no
significant difference in the distribution of vascular instability between the three types
of scan (X2
 - 0.21; p > 0.05):
Uptake
Increased Normal Decreased
Vascular instability 9 12 3
No vascular instability 5 7 1
Total 13 19 4
Similarly there was no difference in the type of vascular instability between the different
groups.
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Discussion
This study has demonstrated the difficulty in quantifying the vascular changes
seen in algodystrophy. Qualitatively all but one of the responses demonstrated some
form of abnormality. Generally, there appeared to be two types of response; a flat curve
with little thermal response, and a normal looking but more exaggerated curve with a
higher peak and steady state, and increased peak flux. Only one curve looked
completely normal. Theoretically one might assume that the flat curves would be seen
In cold, blue atrophic hands and the exaggerated curves in a warm hot hand, but this
did not appear to be the case. This suggests that even though there may be increased
vascularity on clinical grounds, cutaneous blood flow is not necessarily increased.
There may be alternate episodes of increased blood flow and stasis which would explain
the abnormal thermal responses without correlation to the clinical picture. Indeed, in
all of the patients with flat curves, and therefore stasis in the micro-circulation, there
was increased uptake in the blood pool phase which suggests an overall increase in
blood flow at least to bone.
It was hoped that there may have been a fundamental difference in the thermal
response that was common to all patients regardless of the type of curve. Apart from
the time to peak response, there was no significant difference in any of the parameters
measured. This may in part be due to the effect external factors had on red-cell flux
despite measures taken to decrease environmental effects on the microcirculation, and
use of a thermal response test. Nevertheless, the time to response, may prove to be a
useful parameter in the assessment of vascular instability. Indeed, although no
significant difference was seen, there was a definite trend towards normality when the
ratio of the affected to unaffected side was measured upto 15 weeks after fracture (Fig
23.3).
In all, four parameters (time to peak, time to steady state, ratio of perturbation
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and the rate of change of flux) demonstrated trends towards normality but at 15 weeks
after fracture there were still detectable abnormalities. This was in accordance with the
90% probability that the clinical features of vascular instability had persisted to 15
weeks (Chapter 22). By 19 weeks after the fracture this probability had fallen to 85%
and yet in over half the blood pool phase scans, the uptake was normal or decreased.
Considering the rate of resolution of the laser Doppler features, it was likely they would
still have been abnormal at this stage. This suggests that by 19 weeks, although still
apparent clinically and on laser Doppler angiography, the vascular instability had
resolved to such an extent that the increase in blood flow was insufficient to cause a
qualitative increase on the blood pool phase of an isotope scan. A radionuclide
angiogram, the first of the three-phase bone scan described by Maurer et aL (1983), is a
more accurate assessment of blood flow than the blood pool phase and may well be
sensitive enough to demonstrate an abnormality in blood flow at this stage.
In conclusion, although there are changes in the thermal response test using
laser Doppler angiography, quantitation is difficult due to the variation in response
caused by external factors on the microcirculation. Similarly, there was little statistical
evidence of improvement though the type of curve produced by the thermal response at
15 weeks after fracture approached normal. The increase in uptake on the blood pool
phase of an isotope scan evident at presentation did not persist in over 50% of cases at
19 weeks after fracture despite continuing vascular instability. The sensitivity of this
phase of the scan as a criterion for diagnosis of algodystrophy at this stage must be
questioned.
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CHAPTER 24: CHANGES IN SKELETAL ARCHITECTURE. 
Focal and patchy radiotranslucency of bone is a characteristic feature of
algodystrophy on radiographs, but similar features are seen after fracture, a common
predisposing factor in it's aetiology. Although the radiographic features of trabecular
bone in algodystrophy and disuse atrophy following Colles' fracture are qualitatively
similar, it is possible to accurately differentiate between the two, using a semi-
quantitative scoring system, due to the more pronounced features present in
algodystrophy (Chapter 19). In addition single photon absorptiometry can be used to
differentiate between trabecular and cortical bone and, as seen earlier (Chapter 19),
there is a more pronounced loss of bone, particularly trabecular, in algodystrophy
patients seven weeks after fracture. The purpose of the present study was to examine
prospectively the natural history of bone loss and particularly the focal changes in
trabecular and cortical bone in algodystrophy after Colles' fracture.
Methods 
The radiographic scoring system and the metacarpal morphometry technique
have been described in Chapter 10. The results at presentation in the 44 algodystrophy
and 33 control patients, and the diagnostic ability of the techniques have been
discussed in Chapter 19. The scoring system was used to assess changes in trabecular
bone and is in arbitrary units. The metacarpal morphometry measured combined
cortical width (CCW) and metacarpal diameter and were expressed in mm or as the ratio
of the affected to unaffected side. After the initial radiograph taken at presentation
seven weeks after fracture, they were repeated at three monthly intervals for six
months, and for a further six months in 9 patients with algodystrophy (Table 8.3).
The technique of single photon absorptiometry has been described in Chapter
12. The results seven weeks after fracture in the 29 algodystrophy and 23 control
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patients demonstrated that it was possible to differentiate between trabecular and
cortical bone. The results were expressed as bone mineral content (BMC; g) and bone
mineral density (BMD; g/cm2) or as the ratio of affected to unaffected side. Scans were
performed at the same time as the radiographs.
The statistical analysis used was the same as in previous chapters.
Results. 
There was no significant difference in age, sex, duration of immobilisation
between patients with algodystrophy and controls (Appendix I).
Bone loss and radiographic changes had occurred in all patients at presentation
but the changes were more marked in patients with algodystrophy and more marked at
trabecular (radiographic score and BMD trab) rather than cortical sites (Chapter 19).
During the subsequent follow-up cortical bone width continued to decrease in
patients with algodystrophy whereas it had recovered by 19 weeks in control patients
(Fig 24.1a). Thereafter, there was no further bone loss in the patients with
algodystrophy, but the cortical width remained significantly lower at 31 weeks than that
of the unaffected hand or that of control patients. No changes were observed in the
metacarpal diameter. A similar pattern of events was observed in cortical BMD (Fig
24.1b).
At trabecular sites the radiographic score and BMD were significantly lower in
patients with algodystrophy than in controls at the first assessment (Fig 24.1c and d).
In control patients these measurements returned towards normal by 31 weeks but the
rate of recovery was slower than that seen at cortical sites. In contrast, no subsequent
recovery of trabecular BMD was noted in patients with algodystrophy and radiographic
improvements were incomplete (Fig 24.1c and d).
The decrease in bone density at the cortical site was associated with a decrease
In cortical width. Indeed at 19 weeks there was a significant correlation between these
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measurements (R = 0.51; p <0.05). In order to determine whether the decrease in
BMDcort was due solely to a decrease in the width of bone cortex, the change in
calculated cortical area on metacarpal morphometry (Fig 24.2) and the change in
cortical bone mineral content (BMC) was examined. Since no loss of bone occurred on
the unaffected side, the cortical area and BMC measured at this site were assumed to
represent the values which were present at the fractured side before fracture had
occurred. The change in apparent BMD of cortical bone was calculated from the
change in BMC divided by the change in cortical area. In both control and
algodystrophy groups there was a significant loss in apparent BMD which was more
pronounced in the patients with algodystrophy (Table 24.1), suggesting that metacarpal
osteoporosis was due to an increase in cortical porosity as well as a decrease in cortical
width. The relationship between change in cortical area and change in bone mineral
content was similar in patients with and without algodystrophy (Fig 24.3).
In nine patients with algodystrophy who were reassessed at one year, no further
recovery was observed in cortical BMD, trabecular BMD or radiographic score (Fig
24.4).
............... 
i ......... ....... i
-°- algodystrophy
**A** controls
d	 'i	 19	 31
WEEKS AFTER FRACTURE
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Fig 24.1 a -d. Sequential changes (mean +1- SEM) in indices of cortical (a and
b) and trabecular (c and d) bone. The mean change in CCW and BMD was expressed
as the ratio of affected to unaffected side in patients with algodystrophy and
in controls. A higher radiographic score indicates more marked radiographic
abnormalities.
m - medullary cavity
C - cortex
r - radius
Fig 24.2. Method of calculating the area of cortex measured at the
diaphysis with metacarpal morpheme try:
r2 = metacarpal diameter/2
rl = r2 - CCW/2
area =ff ri	 2-nr1
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Table 24.1. Cortical area and bone mineral content (BMC) a SEM) in algodystrophy .
and controls in the unaffected side, assumed to be pre-fracture values and at 19 weeks
after fracture. There was a greater percentage change in bone density in algodystrophy.
ALGODYSTROPHY NORMAL
DAY 0
Cortical area (mm2) 31.8 + 2.0 33.0 + 1.6
Cortical BMC (g) 13.7 + 0.9 13.2 + 0.5
Apparent cortical 0.43 + 0.01 0.40 + 0.01
Density (g/cm2)
WEEK 19
Cortical area (mm2) 29.2 + 1.7 32.2 + 1.5
Cortical BMC (g) 11.2 + 0.9 12.0 + 0.6
Apparent cortical
density (g/cm2)
0.38 + 0.01 0.37 + 0.01
% CHANGE
Cortical area 7.4 + 2.1 * 1.9± 1.1
Cortical BMC 18.5 + 2.5 ** 9.6 + 2.6
Apparent cortical
density
11.6 + 1.8* 7.8+ 1.1
Asterisks denote significance of differences from control patients (* p <0.05: ** p <
0.02).
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Fig 24.4. Mean (+/- SEM) change in BMD ratio and radiographic score in nine
patients with algodystrophy followed for a year. There was no recovery of bone
loss throughout the one year period of observation.
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Discussion. 
Bone loss is a well recognised feature of immobilisation and of fracture,
particularly at the immediate fracture site (Steinbach 1964; Jones 1969; Feist 1970).
The present study indicates that bone loss also occurs after Cones' fracture at the
carpals and metacarpals. It is not possible, however, to distinguish the components of
loss due to fracture and it's metabolic consequences from that due to immobilisation.
The bone loss in uncomplicated Colles' fracture was however transient and at six
months indices of bone mass were comparable to those measured at the unfractured
side.
Algodystrophy is also characterised by bone loss. Indeed the patchy osteolysis
evident on radiographs is thought by some observers to be diagnostic of the disorder.
The present study indicates that algodystrophy following Colles' fracture is associated
with significantly greater degrees of skeletal losses than that expected in the
uncomplicated fracture.
It might be argued that the greater losses in algodystrophy were due to a
limitation in finger movement caused by swelling and stiffness. This may have resulted
In changes in the BMD of the distal metacarpal, but it is difficult to explain how
Immobility of the fingers could result in increased bone resorption in the mid-
metacarpal and, in particular, the carpus. This suggests a factor inherent to the
algodystrophic process which results in more accelerated bone loss than normally seen
after fracture.
The distal SPA scans measured metacarpal bone which is mainly trabecular and
the proximal scan measured predominantly cortical bone. There was a significant
correlation between the radiographic score (at trabecular carpal sites) and BMD at the
trabecular bone of the metacarpal. There was also a significant correlation between
cortical BMD at the metacarpal and CCW of the diaphysis. There was no correlation
between measurements made at cortical and trabecular sites (Chapter 19). There was
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also a similarity in the pattern of recovery between the two methods of measuring
trabecular bone (Fig 24.1 c and d) and cortical bone (Fig 24.1 a and b). These
observations cross validate the techniques used to asses skeletal losses and indicate
that the pattern of loss differs at cortical from trabecular bone.
In both groups there was greater trabecular bone loss immediately after
immobilisation which was demonstrated by the difference in the BMDtrab and BMDcort
seven weeks after the fracture (Fig 24.1 b and c). This difference was significant (p <
0.05) in the algodystrophy group. The earlier and more marked loss of BMD in
trabecular bone is probably caused by more the greater availability of resorption
surfaces and the higher surface to volume ratio of cancellous bone.
The resorption surfaces available in cortical bone are confined to the endosteal
and periosteal surfaces, and intracortically within the Haversian canals. Kozin et a/. in
1976 using microradiography suggested that changes at all three sites contributed to
the loss in cortical BMD but not to what extent. In this study we have shown that there
was increased cortical porosity and endosteal resorption in both groups, and both these
features were more marked in algodystrophy compared with controls. Indeed, the
relationship between the change in bone mineral content and change in cortical area
was similar in the two groups. Since there was no change in the diameter of the
metacarpal, it is reasonable to assume that the loss in cortical area is due to endosteal
resorption of bone. These observations indicate that the nature of the bone loss is
similar in controls and algodystrophy, but more marked in the latter.
The recovery of bone loss at both trabecular and cortical sites in uncomplicated
Colles' fracture is in marked contrast to that seen in algodystrophy. In the patients
with algodystrophy there was no recovery at six months and cortical and trabecular
losses persisted in all the nine patients that we followed for one year. The reason for
the failure of recovery in algodystrophy is unclear but may be due to increased blood
flow which is also a feature of disuse atrophy (Trueta 1954). Increased blood flow has
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been demonstrated in algodystrophy by the uptake of technetium labelled
diphosphonate into bone (Doury et aL 1981; MacKinnon and Holder 1984). This uptake
is greater than that seen in simple disuse and increased uptake persists for longer than
19 weeks after fracture (Chapter 25). It is possible that increased bone blood flow could
contribute to the excessive bone resorption seen in algodystrophy.
The clinical implications of the failure to recover bone loss in algodystrophy are
unknown. It is relevant to note that the decrease in cortical bone density was greater
than 10% and that of trabecular bone greater than 25%. This degree of bone loss might
be expected in 10 years during the natural history of uncomplicated osteoporosis. If
similar deficits were to be present at the wrist then the risk of refracture are likely to be
proportionately increased. Microscopic analysis on bone taken from areas that had
been affected by algodystrophy for greater than a year, has shown that the loss of
trabecular bone is not only due to a decrease in trabecular width but also to the
complete disappearance of trabeculae (unpublished data). Even if there were to be
recovery of the BMD to normal in algodystrophy, this could only be achieved by
hypertrophy of the remaining trabeculae. This would explain the persistence of
abnormal trabecular architecture assessed by the radiographic scoring system even in
patients with relatively mild disease. This suggests that early treatment with agents
that decrease bone resorption, such as calcitonin, may be worthy of trial to prevent the
Irreversible loss of trabecular structure.
In conclusion, algodystrophy is associated with a more marked and prolonged
loss of bone than is found following immobilisation alone. This bone loss occurs more
markedly at trabecular bone but increased endosteal resorption of cortical bone is also
a feature. Bone loss may result in irreversible changes in the structure and strength in
the bony architecture.
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CHAPTER 25: CHANGES IN SCINTIGRAPHY. 
An increase in bone activity greater than that seen in a control population has
already been demonstrated with 1311 Technetium isotope scans in patients with
algodystrophy approximately seven weeks after fracture (Chapter 20). The increase in
skeletal metabolism however, was not reflected in biochemical evidence of increased
bone turnover. Nevertheless, the increase in uptake on the delayed phase of the scans
provided good diagnostic accuracy in the early stages of post-traumatic algodystrophy.
It remains to be seen for how long this increase in activity persists.
There appeared to be no difference in the degree of bone resorption between
simple disuse atrophy and the addition of algodystrophy (Chapter 21). Bone formation
however, did appear to be suppressed in algodystrophy. A hypothesis was proposed
which explained the greater bone loss, as demonstrated radiographically and with
single photon absorbtiometry, to be secondary to a failure to reform bone in
algodystrophy resulting in a greater net loss of bone at seven weeks after fracture. As
described in chapter 24, the decrease in bone density continued for at least a year, and
therefore if this hypothesis is correct, there should be continued biochemical depression
of bone formation.
For these reasons, the progression of bone metabolic changes have been
prospectively studied using biochemical and scintigraphic indices of measurement.
Methods. 
The technique used for the Technetium isotope scan and the calculation of the
metacarpal score (ratio of uptake in affected to unaffected hand) has been described
previously (Chapter 11). The 43 patients, whose initial results were described in
Chapter 20, had repeat isotope scans 12 weeks later.
The biochemical parameters measured were serum corrected calcium,
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parathyroid hormone (PTH), serum alkaline phosphatase and osteocalcin (markers of
bone formation) and urinary calcium and hydroxyproline (markers of bone resorption);
the measurement techniques have been detailed in Chapter 13. The study included 46
patients with algodystrophy, followed monthly upto 6 months, and 26 control patients
followed for three months after removal of the plaster (Table 8.3).
The statistical analysis used has been described previously.
Results
There was a significant decrease in bone turnover 19 weeks after fracture (p <
0.0001; Fig 25.1), as measured by Technetium uptake in the delayed phase of the scan
compared with the scan at seven weeks. The metacarpal score at 19 weeks (1.45 +
0.06) was however still significantly greater (p <0.008) than the score in the control
population (1.14 + 0.04), seven weeks after fracture. The rate of decrease in the
metacarpal score was 0.05 per week which, if it decreased in a linear fashion would
mean the uptake becoming normal 24 weeks after the fracture (Fig 25.1).
The only biochemical parameter which appeared to be of value was the serum
osteocalcin which continued to be significantly lower in algodystrophy (Fig 25.2). No
control patients were examined later than 19 weeks after fracture, but in the 23
algodystrophy patients followed to 31 weeks, the osteocalcin level continued to be lower
than the normal range (8-36 ng/ml; Fig 25.5) upto 19 weeks, gradually returning to
normal. This apparent depression of bone formation was not reflected in changes in
alkaline phosphatase (Fig 25.2) or urinary hydroxyproline and calcium, the markers of
bone resorption (Fig 25.3). There was no change in serum corrected calcium or
parathyroid hormone level (Fig 25.4).
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Discussion.
This study has shown that the increased metabolic activity, and presumably
bone turnover, following algodystrophy gradually resolved as the condition progressed
to the latter stages. The predicted time at which there would be no scintigraphic
evidence of an increase metabolic rate was 24 weeks after fracture, provided the
decrease was linear. The rate of change however was 0.05 per week which is five times
greater than the weekly decrement seen in the control patients (0.01: Chapter 20). This
suggests that the rate of change may not be linear. It may be high in the initial stages
of the condition and later decrease as the score approaches normality. The
consequence of this is that the increased metabolic activity of the bone, as measured by
bone scans would continue for longer than the 24 weeks originally predicted.
Regardless of this, the delayed phase of the scan would continue to be a useful
diagnostic tool in identifying algodystrophy at least upto 19 weeks following a Cones'
fracture.
The increased activity on isotope scans probably reflects an increase in bone
turnover, although this cannot be detected biochemically. If true, increased turnover
must be associated with net resorption resulting in a net loss of bone. There is recovery
of trabecular bone by 31 weeks after fracture in the control group. There must
therefore have been a reversal of the imbalance in bone turnover originally seen in this
group, favouring net formation of bone. This may be explained by two factors. Firstly,
the rate of bone formation was probably only slightly depressed in the control
population as, although low, the serum osteocalcin was always within the normal range
(Fig 25.2). Therefore, although the rate of resorption was initially greater, bone
formation continued to prevent too great a loss of bone. Secondly, the increase in bone
resorption was probably transient. If so, bone formation must have taken place at a
relatively greater rate achieving normal coupling and balance of bone turnover and
consequently normal bone density by at least 31 weeks.
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In algodystrophy, although there was not a continued loss of bone density, there.
was similarly no recovery of the bone mass initially lost over the period of study
(Chapter 24). The mechanism for this is uncertain but the low osteocalcin values
suggest that for any given rate of resorption, bone formation may be more suppressed
In algodystrophy than in controls. As turnover decreased with the evolution of the
disease, lower formation rates would delay recovery. In addition, the loss of trabecular
structures may be an inevitable event in that once they are destroyed there is no bone
surface available for new bone formation.
296
NASAL CALCITONIN.
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CHAPTER 26: BIOAVAILABILITY OF NASAL CALCITONIN
Most studies use 80-100 units of salmon calcitonin subcutaneously for the
treatment of algodystrophy (Chapter 6). However, this amount appears to have been
arrived at purely empirically and there are few dose-response data available. Similarly,
little known about the bioequivalence of nasally administered calcitonin as compared
with the subcutaneous route. Before studying nasal calcitonin as a treatment for
algodystrophy, the question of it's bioequivalence was first considered. With this data it
was hoped to make a rational decision as to the amount of nasal calcitonin appropriate
to use in the treatment of algodystrophy.
To address this problem the acute hypocalcaemic response to calcitonin was
studied. As hypocalcaemia induced by calcitonin is primarily related to its inhibitory
effect on osteoclasts (Singer 1976) it was considered appropriate to study patients with
increased bone turnover, and therefore patients with Pagets' disease of bone were
chosen for investigation. In the patients studied, a standard dose of intranasal
calcitonin (400 units salmon calcitonin) was compared to varying doses of calcitonin
administered subcutaneously.
Methods 
Forty patients with active Paget's disease of bone were studied. These patients
were divided into five treatment groups, which were matched for disease activity. Nine
patients received, sequentially, and in a random order 1, 10, and 100 units of salmon
calcitonin subcutaneously. These tests were separated in time by at least two weeks.
For the 1 and 10 unit tests, standard salmon calcitonin solution was diluted with
normal saline containing albumin, to minimise its adsorption to the plastic syringe.
Nine further patients were given a subcutaneous injection of normal saline. These two
groups were compared with a third group of 22 patients, who received 400 units of
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intranasal salmon calcitonin, administered as a nasal spray of 200 units into each
nostril.
All patients were admitted to a metabolic ward for the period of the test. After
an overnight fast and after voiding the bladder, the urine produced over the subsequent
hour was collected and saved. Halfway through this period a venous blood sample was
taken for serum estimations. At the end of the first urine collection calcitonin or saline
was administered to the patients, and hourly urine and blood collections made for the
next six hours. The patients remained fasting throughout the six hours of the test, but
were allowed to drink distilled water.
Serum was analysed for calcium, phosphate, alkaline phosphatase, creatinine,
hepatic transaminases, urea and electrolytes as previously described. The urine was
assayed for calcium, phosphate, hydroxyproline and creatinine.
The significance of differences between treatments were assessed using one way
analysis of variance, and Student's t-test for unpaired data. Changes in biochemical
values during each treatment were studied using the t-test for paired observations. In
the case of hydroxyproline and alkaline phosphatase statistical comparisons were made
on log-transformed values, but were antilogged for presentation. Results are expressed
as the mean + SEM, unless otherwise indicated.
Results
Before the start of this study there were no significant differences between the
groups in any of the measured variables. In particular, the prevailing rates of bone
turnover, as judged by the urinary excretion of hydroxyproline and serum activity of
alkaline phosphatase, were well matched in the placebo and each of the test groups
(Table 26.1).
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a) Changes in Serum Calcium
A decrease in serum calcium was observed after the injection of one hundred
units of subcutaneous calcitonin, which was evident by the end of the first hour
(p=0.002), and maximal from 4 to 6 hours (Fig 26.1). The summated change in serum
calcium at 4 to 6 hours was calculated and used as a measure of the maximal
hypocalcaemic response in further analyses.
No significant changes in serum calcium were seen in the placebo group, and
Intermediate responses observed with the lower doses of parenteral calcitonin and with
nasal calcitonin. When the summated calcium drop from 4 to 6 hours was plotted for
each group a significant obvious dose-response was evident (ANOVA, p<0.01; Fig 26.2).
As expected there was a significant correlation between hydroxyproline excretion
before the test and the fall in serum calcium in patients given 100 units of
subcutaneous calcitonin (r = 0.7; p = 0.038). No significant correlation was observed
however at any other dose, since the hypocakaemic response appeared to be blunted
particularly in those patients with the more marked disease activity. In order to explore
this further the relationship between initial disease activity and the hypocalcaemic
response was computed by bivariate regression in those patients given 100 units of
subcutaneous calcitonin. In this way the expected maximal hypocalcaemic response (E)
in the other tests was calculated from the initial urinary hydroxyproline. The observed
(0) and expected hypocalcaemic responses for each patient were then compared by
plotting:
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b) Other Effects
After the administration of 100 units of subcutaneous calcitonin there was an
initial increase in the urinary hydroxyproline excretion (p=0.049 at 2 hours), and this
was followed by a significant fall decrease to below starting values from 4 to 6 hours
(p<0.05). During this period (4-6 hours), as with the serum calcium, there was little
further change in the observed values.
A similar pattern was seen with 10 units of calcitonin. No significant changes in
hydroxyproline excretion were observed with either the 1 unit of calcitonin or placebo.
Nasal calcitonin induced a fall in the urinary hydroxyproline excretion that was
significant by 3 hours (p=0.042) and had reached a steady state by 4 hours. The
cumulative fall from 4 to 6 hours (58.4 + 14.2 mmol hydroxyproline/mol creatinine) was
less than that seen with both 10 and 100 units of subcutaneous calcitonin (75.9 + 34.2
and 67.2 + 29.6 mmol hydroxyproline/mol creatinine).
Serum activity of alkaline phosphatase did not change significantly throughout
the test in any group.
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Discussion
In this study, we have shown that surprisingly low doses of calcitonin appeared
to have acute effects qualitatively similar to those observed with the highest dose used
(100 IU) which are commonly recommended for the treatment of bone disease. The
daily endogenous secretion rate for calcitonin has been estimated at 20 IU, but this is
almost certainly an overestimate (Kanis 1985). It therefore seems possible that such
doses as 10 IU might be exerting pharmacological effects. The physiological role of
calcitonin in man is still speculative (Kanis et cd. 1985), but the small responses evoked
with only 1 unit of calcitonin suggest it may still have a role in extracellular calcium
homeostasis.
In this study 400 units of intranasal calcitonin, given as a single dose, appeared
to have biological effects similar to those observed with the use of subcutaneous
calcitonin. The activity of the nasal spray was however low, since the hypocalcaemic
effect of 400 units of intranasal calcitonin was similar to that of 10 units
subcutaneously. The dose-response of nasal calcitonin was not studied, but the sub-
optimal response in serum calcium suggests a bio-equivalence of approximately 2.5%.
The efficacy of small doses of calcitonin suggest that at low rates of bone turnover the
nasal spray, even with it's low bioavailability, might be suitable for the treatment of
either generalised or, as in algodystrophy, regional osteoporosis.
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CHAPTER 27: THE USE OF NASAL CALCITONIN IN THE TREATMENT OF POST-
TRAUMATIC ALGODYSTROPHY. 
Calcitonin, as a therapy for algodystrophy, has received widespread interest
because of it's analgesic action (Peelle et al. 1975; Fraioli et aL 1982), effects on the
microvasculature and bone resorption (Freidman and Raisz 1965; Chapter 6) properties
which would be expected to be of value in the treatment of algodystrophy. Several
controlled trials of parenteral calcitonin report a beneficial action (Doury et al. 1981;
Martin 1985; Gobolet et al. 1986) and are mentioned in detail in Chapter 6. The need
for parenteral administration may be overcome by formulations which are absorbed
through the nasal mucosa. The use of the nasal spray has had some encouraging
results in the treatment of Pagets' disease (Reginster et al. 1984) and osteoporosis
(Reginster et aL 1987; Christiansen 1988) and for this reason a prospective double-
blind controlled study to evaluate it's use in algodystrophy was performed.
Methods
Two weeks after their plaster had been removed (as in the study design for the
natural history of algodystrophy), any patients who exhibited features of algodystrophy
were asked if they would participate in a trial of treatment of nasal calcitonin. The
clinical techniques and investigations (including radiography, bone scintigraphy,
photon absorptiometry and biochemical assessment) used in evaluating the response to
treatment were identical to those used in the assessment of the natural history of the
condition (Table 8.3) and are described in detail in earlier chapters. During the
treatment period however (weeks 7 to 11 after fracture) clinical and biochemical data
were recorded weekly.
Exclusion criteria included:
1)	 A history of unstable cardiovascular disease or uncontrolled hypertension.
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2) Any medical or surgical condition which would be likely to compromise nasal
absorption, subsequent distribution, metabolism or excretion of calcitonin.
3) A history of alcohol or drug abuse.
4) Known hypersensitivity to salmon.
5) Current treatment with diphosphonates, sodium fluoride, mithramycin,
phosphates or glucagon.
6) Pregnant or lactating.
The trial was designed as a randomised double-blind placebo controlled study.
Forty patients were studied; 20 with the active drug and 20 placebo. The active drug
was given as a daily dose of 400 units of salmon cakitonin (Sandoz, Basle) intranasally
for four weeks. The canisters containing the active drug (Fig 27.1) gave a metered dose
of 100 units of salmon calcitonin in a normal saline carrier. The placebo canister
provided the equivalent amount of normal saline only. After the pre-treatment data had
been recorded, patients were instructed to insert the nozzle of the canister into the
nostril as far as was comfortable and then depress the lever twice to deliver the two
standard doses. This was then repeated in the other nostril providing a total dose of
400 units at one sitting. This procedure was performed every morning for the four
weeks of the study period.
The patients were reviewed weekly during the period of drug administration and
any side-effects noted. At the end of the treatment period, their review continued
according to the protocol specified for the study into the natural history (Table 8.3).
Patients were not formally referred to the physiotherapy department but were given
general instructions on mobilising the upper limb.
The values were expressed as mean + one standard error of the mean (SEM) and
the significance of difference between means calculated using Student's t test.
Differences in proportions were calculated using the Chi-squared test with Yates
correction were appropriate. Kaplan-Meier actuarial analysis was also performed on the
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dolorimetry data and any difference between groups calculated using Gehan's
modification of the Wilcoxin Rank test.
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Fig 27.1. The canister used to administer the nasal calcitonin.
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Results
There was no difference in the mean age, sex distribution or duration of
Immobilisation at study entry between the two groups (Table 27.1). Both groups were
matched for disease activity as judged by clinical, biochemical and skeletal methods of
assessment (Table 27.1). Two patients withdrew from the study, both from the placebo
group. One developed acute cholangitis and the other did not wish to continue
treatment for personal reasons. There were no local or systemic side-effects from the
treatment in any patients.
In both wings of the study there was a progressive and significant improvement
in patient assessment of pain, stiffness, hand swelling and vascular instability (Fig
27.2). This was matched by a progressive decrease in bony tenderness, hand volume
and an increase in grip strength so that values for the ratios (affected to unaffected side)
changed towards unity (Fig 27.3).
There was no significant difference between the calcitonin and placebo group,
with regards to tenderness (dolorimetry), hand volume or grip strength over the study
period (Fig 27.3). Nor were there differences between groups in the perception of pain,
vascular instability, swelling and stiffness between the two groups (Fig 27.2).
There was a trend however, towards a greater improvement in the dolorirnetry
ratio and perception of stiffness in patients given calcitonin. At the end of the study
period, 70% of placebo treated patients had abnormally tender fingers, compared to
60% in those who received calcitonin. Stiff fingers persisted in 90% in the placebo and
80% of the calcitonin group, but actuarial analysis showed no significant difference
between the treatment wings at the end of treatment or at the end of the study.
A small but significant decrease in serum calcium occurred in the calcitonin
treated patients during treatment which reversed when treatment stopped (Fig 27.4).
Mean serum calcium also fell in placebo treated patients but the decrement was smaller
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and the difference not significant. There was no significant change in urinary
hydroxyproline and calcium excretion in either wing of the study.
Tracer uptake on scintigraphy decreased significantly (p <0.001) in the affected
hand and the ratio approached unity in calcitonin and placebo treated patients. The
improvement was the same in both groups (Table 27.2). The measurements of
trabecular and cortical bone mineral density, and radiographic score remained low in
both groups throughout the study period.
There were no local or systemic side-effects in either the calcitonin or placebo
group.
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Table 27.1. Clinical, biochemical and physical findings (mean + SEM) of patients with
algodystrophy at randomisation. There was no significant difference in the pre-
treatment values between the two groups. Where no units of measurement are given,
with the exception of the radiographic score which has arbitrary units, the value
expressed is the ratio of the affected to unaffected hand.
Calcitonin Placebo Normal range
Age (years) 60.8 + 2.7 65.5 + 1.8
Sex (F:M) 15:5 19:1
Time immobilised (days) 38.1 + 1.8 40.6 + 1.9
Dolorimetry score 0.73 + 0.03 0.68 + 0.04 0.92 - 1.08
Hand volume 1.12 ±0.02 1.11 + 0.02 0.90- 1.10
Grip strength 0.21 + 0.03 0.20 + 0.03 0.76 - 1.24
Serum calcium (mmo1/1) 2.43 + 0.02 2.43 + 0.02 2.26 - 2.63
Urinary calcium (mol/
mol creatinine)
0.28 + 0.04 0.26 + 0.05 <0.30
Urinary hydroxyproline
(mmol/mol creatinine)
27.9 + 2.89 28.5 + 3.60 <30.0
Alkaline phosphatase (IU/1) 93 + 4.95 96± 19.19 35 - 105
Osteocalcin (rig/ml) 6.5 + 1.14 4.8 + 0.77 8-32 
BMDtrab 0.72 + 0.06 0.69 + 0.04
BMDcort 0.86 + 0.06 0.84 + 0.06
Combined cortical width 0.97 + 0.02 0.96 + 0.02
Radiographic score 6.81 + 0.87 8.20 + 0.72
Isotope score 2.01 + 0.19 2.07 + 0.19
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Table 27.2. Changes in radiographic, densitometric and scintigraphic assessment after
treatment with calcitonin or placebo. The change (mean + SEM) is shown as a
percentage change of initial value (± SEM). There was no significant difference in the
change between groups nor, with the exception of isotope score, between the pre-
treatment and end of study values. Improvement in values towards normal are
indicated as a positive change.
Percentage change
Calcitonin Placebo
mean + SEM n mean + SEM n
BMDtrab (g/cm2) +3 + 5 10 0± 10 10
BMDcort (g/cm2) +3 + 8 10 -6 + 6 10
Combined cortical width (mm) 0± 1 20 -1 ±2 20
Radiographic score +3± 10 20 +18 + 10 20
Isot OD e score +33 + 5 * 14 +25 + 5 * 13
* - significantly different from pre-treatment value: p < 0.001.
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Discussion,
Since the first report by Eisinger et al. (1973) on the use of calcitonin in
algodystrophy, the beneficial effects of it's parenteral injection have been documented in
several studies (Acquaviva et al. 1976; De Bastiani et aL 1978; Ginsberg et aL 1978;
Doury et aL 1981; Martin 1985; Gobolet et aL 1986). Calcitonin appears to have a
marked effect on signs and symptoms, particularly in the early stages of the disorder,
but many of these claims have been based on open and uncontrolled studies. In one
controlled randomised double-blind study of 28 patients with algodystrophy of the lower
limbs reported by Doury et al. (1981), there was an appreciable improvement in pain in
64% of those receiving calcitonin 100iu daily compared with 25% in the placebo group
after 14 days (p <0.001). By 28 days there was however, no significant difference in
pain between the two groups. Although this study demonstrates a rapid effect of
calcitonin, it also confirms that spontaneous resolution of symptoms occurs commonly
in algodystrophy. Consequently, open studies evaluating the use of calcitonin should
be interpreted with caution.
In the study reported here, calcitonin given as a nasal spray was shown to have
no significant effect on the clinical progression of post-traumatic algodystrophy
compared to that noted with a placebo spray. The methods used to assess
algodystrophy have been shown in previous chapters to be sufficiently reproducible to
discriminate effectively between algodystrophy and a control population following Colles'
fracture. These considerations suggest that the failure to detect a more rapid or
complete response in calcitonin treated patients is unlikely to be due to inadequate
methodology.
A possible, and perhaps the most likely, explanation for not finding a difference
between the treated and placebo wing is that the bio-availability of the nasal
formulation was too low. Although there was a small decrease in serum calcium during
the treatment period, the response was not associated with changes in the indices of
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bone turnover. In particular, the fasting urine excretion of calcium did not change.
This suggests that the decrease in serum calcium was due to a decrease in renal
tubular reabsorption of calcium, a known effect of calcitonin. The absence of clinical
and skeletal effects suggest that, although small amounts of calcitonin were absorbed,
they were insufficient to affect these indices of bone turnover. In addition, there were
no systemic side-effects reported which are a dose - dependent effect of calcitonins.
In studies of the acute calcium lowering effect in patients with Pagets' disease,
400 iu given by nasal spray induces effects similar to those induced by 10-20iu
subcutaneously (Chapter 26). If acute effects can be used to predict long term
responses, and if calcitonin is effective in algodystrophy of the hand, then the minimum
effective daily dose in algodystrophy is likely to lie between 10 and 100 iu. An
alternative to increasing the dose administered would be to add a promoter to enhance
it's nasal absorption. A number of such formulations are currently undergoing
evaluation.
In conclusion. 400 iu of nasal calcitonin in the formulation used is inadequate
for the treatment of post-traumatic algodystrophy though does exert a biochemical
effect. Further studies using higher doses of calcitonin or formulations which enhance
it's absorption will be required to evaluate it's potential use in this condition.
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CHAPTER 28: CONCLUSIONS
The main criticisms of previous studies into algodystrophy have been the
variation in the subject data and methods of assessment. Although the majority of
studies concern post-traumatic algodystrophy, there was often great differences in the
type and time from trauma and the initial management, all factors which may influence
expression of the condition. In addition, the assessment techniques were commonly
subjective and therefore open to observer bias. It was hoped to overcome these
problems by selecting a relatively uniform population with regards to age, sex, type of
trauma and initial management. In addition they were reviewed at identical periods
after fracture using techniques with good reproducibility and precision.
The presence of the classical features of algodystrophy, pain and tenderness,
vascular instability, swelling and stiffness, were used to identify patients with the
condition. This amounted to 28% of patients who displayed all four features. In
addition, the distribution of the features throughout the whole population was highly
significant. This implied that in the presence of one feature, the patient was highly
likely to display all four features, and if one feature was absent, it was likely that none
of the features would be present. Thus it was possible to distinguish two populations,
one with and one without algodystrophy, and also confirmed the high incidence of
algodystrophy detected in a previous study (Atkins et a 1990). Therefore, given this
high incidence of algodystrophy and the uniform nature of the patient population, it
seemed appropriate to use this clinical model in further studies.
It appeared that the degree of trauma sustained did predispose to algodystrophy
in that patients with a higher Frykrnan score or displacement of the fracture
(necessitating manipulation) were more likely to develop algodystrophy. Therefore,
although algodystrophy does occur after minimal trauma, as confirmed in this study,
those with more extensive injury should be considered a higher risk. There was no
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association between the time from injury to treatment, time in plaster or type of plaster,
and the development of algodystrophy.
The most reproducible and accurate method of diagnosing algodystrophy was
dolorimetry. Although the technique is easily learnt and relatively quick to perform, it
Is unlikely to be adopted in the clinical setting. It's high precision however does
Indicate that part of the general examination of patients suspected of having
algodystrophy should include the presence of tenderness distant from the site of
trauma. This can easily be performed by digital pressure. The other two clinical
quantitative techniques, hand volume and grip strength measurements, were of less
diagnostic value. All three however, were used to document the resolution of symptoms
with time. Although the therapeutic trial used in this study did not demonstrate any
alleviation in symptoms, due to the poor bio-availability of nasal calcitonin, it is hoped
that these techniques will be useful in assessing the resolution of symptoms using more
effective treatment regimes.
The most precise diagnostic investigation was scintigraphy with a maximum
predictive value of 88%. This however was only slightly better than using the
radiographic scoring system on plain radiographs of the hand and wrist (maximum
predictive value - 83%) despite potential problems due to simple disuse atrophy. It is
often quoted (Doury et al. 1981) that scintigraphic changes precede radiographic
however this was not true in this study in the presence of disuse atrophy at
approximately seven weeks after fracture. This study did demonstrate that scintigraphy
remained highly specific for the diagnosis of algodystrophy at a stage earlier than has
been reported (Atkins et al. 1990). It is possible that a scan earlier than seven weeks
will identify patients with algodystrophy however a complicating factor may be
confusion caused by increased uptake secondary to disuse atrophy which would reduce
specificity.
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The late sequelae of algodystrophy, chronic causalgic pain, atrophy and
stiffness, are well documented but occur relatively infrequently following trauma,
accounting for the 1-2% incidence quoted in the English literature. The discrepancy
between this incidence and the 28% found in this study became clear after studying the
progression of the condition. There was resolution of pain and swelling in 40%,
tenderness and vascular instability in 20% and stiffness in 10%, three months after
fracture. These symptoms disappeared spontaneously in approximately 30% of
patients. This has obvious implications in the interpretation of uncontrolled
therapeutic trials in that symptomatic improvement may be attributed to the efficacy of
a treatment rather than the normal expected spontaneous improvement.
One year after fracture, the point at which most retrospective papers review
Colles' fractures, there was an appreciable decrease in the number of patients who still
demonstrated tenderness, swelling or vascular instability. Fifty percent however, still
complained of a sensation of stiffness with 14% demonstrating contractures in the
inter-phalangeal joints. In the absence of the other features, stiffness may be assumed
to be a complication of the fracture itself and not the end stage of algodystrophy. This
therefore accounts for the discrepancy between the incidence of algodystrophy in this
study and that reported in other series. It may also explain the 24% with functional
disability reported by Bacorn and Kurtzke (1953) in their large study of Cones'
fractures.
Regardless of the exact percentage of patients who remain with problems due to
algodystrophy one year after fracture, those who had settled spontaneously still
suffered significant morbidity during this period. At six months after fracture, 80% of
patients with algodystrophy complained of finger stiffness which contributed to the
significant difference in the functional scores between algodystrophy and control
patients. Therefore the incidence of algodystrophy following trauma, at least after a
Colles' fracture, is far higher than had previously been supposed and, although many
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may be milder, settling by one year after fracture, they still cause appreciable short
term morbidity. Accordingly, a more careful appraisal of patient's symptoms following
trauma would identify those patients with algodystrophy at an earlier stage and allow
appropriate management to prevent this short term morbidity.
In addition to the patients who displayed all the clinical features of
algodystrophy detailed earlier, there was a population who displayed some but not all of
these features. This borderline group again had an abnormal distribution of features,
either having three or one of the signs which means that the features did not occur at
random. It may be that with more sensitive methods of clinically assessing
algodystrophy, the patients at either end of this spectrum would merge into the groups
with or without algodystrophy, thus increasing the incidence of the condition. Indeed,
although there was no formal functional assessment made in this group, stiffness did
persist for 19 weeks after fracture in 20% of patients. It may be inferred from this that
they did suffer a degree of morbidity.
Although this study used patients with Colles' fracture as the clinical model, it is
reasonable to suppose that the incidence of algodystrophy is also high at other sites of
trauma. Again, there is not likely to be permanent morbidity as the recorded incidence
of algodystrophy is generally low regardless of the site. This is not to say however, that
these milder cases would not cause short-term morbidity as seen in the Colles fracture.
The clinical changes demonstrated in the 28% of patients with algodystrophy,
using the clinical criteria detailed earlier, were associated with a greater and more
persistent loss of bone mineral density than seen after uncomplicated fracture. This
study demonstrated that changes in skeletal mass occurred more rapidly in patients
with algodystrophy than in controls during the period of immobilisation and failed to
recover seven months after fracture. In nine patients followed for one year, there was
still no evidence of the restoration of normal bone mass.
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The loss of bone mineral density occurred in both cortical and trabecular bone,'
but was more apparent in the latter due to it's higher rate of bone turnover. The
pathogenesis of the skeletal changes is unclear but may have been due to an increase
In blood flow which was demonstrated by the correlation between the isotope scan
metacarpal score and bone mineral density of trabecular bone. These vascular changes
were also seen following simple disuse atrophy but to a significantly lesser degree.
Even after a hemiplegia, where there was complete immobility of the limb, the degree of
uptake was less than that seen in algodystrophy. The clinical implications of these
skeletal changes remain unknown. However, there were losses of 10% in cortical and
25% in trabecular bone over a six month period, changes normally seen after ten years
In post-menopausal osteoporosis. Accordingly there may be a higher than normal risk
of refracture or of stress fractures.
The skeletal changes measured by radiological, densitometric and scintigraphic
techniques which to be highly reproducible. However, it was not envisaged that they
would become routine in clinical practice but would provide useful tools to measure
serial changes in skeletal mass and architecture, and response to treatment in
controlled therapeutic trials.
In view of the evidence that parenteral calcitonin had beneficial effects on the
evolution of algodystrophy, a controlled randomised study was performed with nasal
calcitonin. It was hoped that the use of this formulation would increase patient
compliance though there were doubts about it's bioavailability. For this reason, dose
response studies were performed prior to the clinical trial, comparing the hypocalcaemic
effect of subcutaneous with nasal calcitonin. This demonstrated an acute
hypocalcaemic response with 400 units of nasal calcitonin but with an efficacy
equivalent to 10 units of subcutaneous calcitonin. Previous studies of subcutaneous
calcitonin had not identified the optimum dose required to alleviate symptoms, and
therefore, despite it's low bioavailability, 400 units of nasal calcitonin were used in the
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clinical trial. As expected there was a small hypocalcaemic response during the
treatment period, but no significant difference in the resolution of symptoms between
the active and placebo group. It is therefore evident, based on the results in this study
and those of others, that the optimum dose for the treatment of algodystrophy lies
between 10 and 100 units of calcitonin. In it's present formulation, nasal calcitonin
has no role in the treatment of algodystrophy.
In conclusion, the work in this thesis has shown that algodystrophy is common,
resolves spontaneously but causes morbidity in the short-term and results in changes
in skeletal architecture and mass which may not be reversible. Research in the future
Into this condition should be directed to other sites of trauma to determine whether the
Incidence, natural history and morbidity are comparable to that found in Colles'
fracture. In addition, although the condition does resolve spontaneously in the majority
of patients, the morbidity suffered does warrant treatment. Efforts should therefore be
made to firstly identify the condition early, and secondly tailor the treatment to the
degree of morbidity expected. This might require the identification of various features
at presentation which correlate with a poor outcome. Those with the worst prognosis
may need sympathetic ganglion blocks from the outset whereas milder states may
require simple physiotherapy with or without calcitonin. Research should also be
directed towards prophylaxis for the condition. If this is contemplated, the Colles'
fracture model and methods of assessment used in this study would be suitable
material. Indeed any therapeutic study would benefit from such a controlled population
and reproducible methods of assessment.
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ADDENDUM
A number of points have been raised which need further clarification.
Chapter 8.
Although there is no sentence stating that a Colles' fracture is a
fracture of the distal radius with or without a fracture of the ulna styloid,
this is detailed in the description of Frykman's classification (page 71 and
Table 8.2). In addition the age prevalence, incidence, predisposing factors
and mechanism of injury are discussed on page 69.
Chapter 9; page 77-81.
The methodology has been described before in detail and was
referenced in the text (page 80; Atkins et a/. 1989). The tip of the dolorimeter
was applied to the dorsum of the MCPJ, PIPJ, DIPJ, proximal and middle
phalanx from the index to little finger, a total of 20 measurements per hand.
The tip of the examiners left index finger and thumb were used to steady the
tip of the dolorimeter and did not apply pressure. This point is made in the
text (page 80; paragraph 2).
Chapter 11; page 134; paragraph 2.
The ten patients in the uncomplicated Colles' fracture group were
picked at random. Their age and sex prevalence was similar to that found in
the algodystrophy group. Therefore they were comparable groups, though
they were not age and sex matched in a prospective sense.
--1
Chapter 11; page 137; paragraph 2.
There was no intention to draw firm conclusions from these data as
to the exact timing of the resolution in bone scintigraphy after
uncomplicated CoIles' fracture, particularly in view of the small numbers
and different investigators. The time to resolution was calculated on the
assumption that resolution was linear. Because there were only two points,
there was no intention to infer that the resolution must be linear. The
reason for including this graph was to compare with the resolution found in
the algodystrophy group on repeat scintigraphy (Fig 25.1; page 298). The
basis on which this assumption rests can only be tested by prospective
studies.
Chapter 12; page 151; paragraph 2.
Intra-ob server reproducibility of the single photon absorptiometry
technique was carried out on paired measurements (page 146). This
demonstrated a coefficient of variation of 4.2% for proximal scans and 4.4%
for distal scans. This compares favourably with estimates of density and
content errors when single photon absorptiometry is used at other sites. The
long-term reproducibility was not performed on my patients but is well
established for mono-chromatic studies and is 1% or less. The long-term
reproducibility errors depend on changes in fat content within patients and
on the deterioration of the isotope source. These considerations apply
equally to measurement of the forearm as it does to the metacarpal but
changes of fat are less likely in the soft tissues of the metacarpal. In any
event these errors are substantially less than the errors of repositioning
which I have reported.
